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Abstract
The aim of this study was to determine if photoplethysmography (PPG) could 
be used to analyse the foot microvascular changes caused by diabetic 
autonomic neuropathy. The digital PPG signals were collected from 37 
healthy volunteers (Group I), 35 diabetic patients (Group II), and 38 diabetic 
patients with sensory neuropathy (Group III) and analysed using MATLAB. 
Prominent spectral peaks with sidebands were obtained at both the high 
frequency (HF) and the low frequency (LF) end of the Fourier spectrum of 
these PPG signals. Previous studies of microcirculation have shown that both 
are sympathetically and parasympathetically mediated and hence are a good 
measure of the autonomic activity.
In the HF analysis, the heart rate (HR) response from 13 participants in Group 
III was severely reduced and significantly different from the responses 
obtained from the other two groups. However the responses from remaining 
25 participants had similar characteristics to those of Group II. Hence the HF 
analyses failed to both statistically and objectively differentiate between the 
diabetics with and without neuropathy.
The spectral density for the frequency bandwidth of 3-20 cpm was 
significantly reduced in the neuropathic group, compared to the other two 
groups. A Statistically significant difference was observed in the spectral 
densities calculated from Group II and III, though no difference could be 
established between Groups I and III. The LF analysis of this bandwidth 
differentiated between Groups II and III with a sensitivity of 84% and 
specificity of 61%.
Activities at the LF end of the spectrum mostly represent the sympathetic 
control as opposed to the HR variability that is mostly a measure of the 
parasympathetic control. These results suggest that sympathetic dysfunction 
possibly precedes parasympathetic dysfunction and that PPG can assess the 
changes in the skin microcirculation due to sympathetic damage with 
moderate success.
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Research Summary
Ulceration below the knee is a common complication of diabetes with a 
lifetime risk of its occurrence among diabetics estimated at 15% (Kenneth 
2005). If left untreated the ulcerations could become infected and gangrenous 
and finally lead to amputations. In the UK 5000 diabetics are estimated to 
have amputations every year. Foot ulcers precede more than 80% of non- 
traumatic lower limb amputations (Boulton et al 2000). Diabetes can also 
damage the peripheral nerves resulting in neuropathy.
The sensory, motor and autonomic neuropathies are often the major 
components in the critical pathway for the development of diabetic foot ulcers. 
While motor neuropathy disrupts the biomechanics of the foot causing 
deformities and increased stress, the sensory neuropathy is responsible for 
the unawareness to any trauma that may have caused leading to the neglect 
of the wound from the patient’s side. Autonomic denervation on the other 
hand can not only cause dry, callus skin prone to cracks and fissures, there 
by exposing the foot to a greater risk of developing ulcers, but they also 
disrupt the autoregulatory effect of the skin microcirculation causing reduced 
nutritive flow to the wound site and hence delay the healing time. Diabetic 
ulcers if not treated can become infected and ultimately lead to amputation. 
Thus it is imperative that the diabetic patients must be regularly screened for 
any early signs of warning of the disease process in order to reduce the 
incidence of ulceration.
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In the UK diabetic patients generally undergo annual examination which 
includes the detailed examination of the foot to assess the sensory function, 
to check for any neglected wound and to assess the need for special foot 
wear to maintain the biomechanics of the foot. Apart from the annual check 
up, the patients are also advised to book themselves into a podiatry clinic for 
regular foot examination. Currently the autonomic function of the body is 
assessed using the cardiovascular autonomic function tests. Both the 
sympathetic and the parasympathetic branches of the autonomic system are 
assessed by these tests. Although studies indicate autonomic disruption in the 
early stages of diabetes, the protocol generally does not involve tests for the 
detailed assessment of the autonomic function in these patients due to the 
complex and demanding nature of these tests.
Early screening for signs of autonomic dysfunction amongst diabetic patients 
could prevent serious complications of the disease and improve the prognosis 
of the diabetic foot, as it is one of the major components in the ulceration 
pathway. The disruption in the vasomotor responses (sympathetic 
dysfunction) can be found as early as in the pre diabetic stages sometimes 
even before the manifestation of the parasympathetic dysfunction, detected 
by the CAN assessment tests (Meyer et al. 2003). Understanding of the foot 
blood flow at the microvascular level is imperative for the better understanding 
of the diabetic foot ulcers. This study looks at methods to device a simple, low 
cost screening tool to detect the autonomic dysfunction in the early stages of 
diabetes by analysing the foot blood flow. Ideally, the measurement technique 
being developed to study the skin microcirculation has to be relatively simple
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to perform, reproducible, reliable and cheap to be able to be used as a 
screening tool.
In this study attempts have been made to use PPG to measure the changes 
in the skin microcirculation by analysing the PPG signals obtained from the 
soles of the feet. Signals were collected from three groups viz, healthy 
participants, diabetic patients with no neuropathy and diabetic patients with 
sensory neuropathy. Appropriate signal processing tools were applied using 
computing software, MATLAB to separate and analyse the various 
frequencies obtained from this complex signal and to identify any changes in 
the responses between healthy individuals and the diabetics. Further 
analyses were also performed to identify if any changes in the skin circulation 
between diabetics with and without neuropathy could be observed. If changes 
could be identified between the two groups, further analysis was done to see 
if these changes could be successfully used as predictive markers for 
subsequent ulceration of the foot amongst the diabetics without neuropathy as 
this could enable steps to be taken to prevent diabetic foot ulceration in these 
individuals.
3
Chapter I
Background
1.1 Introduction
Diabetes Mellitus has been recognised as a syndrome i.e. a collection of 
disorders resulting from impaired carbohydrate, protein and fat metabolism; 
caused either by a complete lack of insulin or by decreased sensitivity of the 
tissues to insulin or by a combination of both these factors (DeFronzo et al 
2004). This syndrome is accompanied by several complications brought about 
mainly by the pathological and functional changes to the vasculature, right 
from the beginning of its onset. Autonomic neuropathy is one such 
complication of diabetes brought about by changes to the microvasculature of 
the body. In this chapter all the background information relevant to this project 
have been discussed in considerable detail.
1.2 Diabetic Complications
Diabetes is a multifactorial disease with chronic complications that manifests 
itself as a burden for both the patient and the health care system (Spijkerman 
et al 2003). This disease is characterised by an abnormal carbohydrate 
metabolism leading to an imbalance in the plasma glucose concentration in 
blood. Diabetes can mainly be classified into two types, namely the Type 1 or 
Insulin Dependent Diabetes Mellitus (IDDM) and the Type 2 or the Insulin
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Independent Diabetes Mellitus (IIDM). Both genetic as well as environmental 
factors were found to play a key role in the susceptibility of both type of 
diabetes.
The primary pathology of diabetes was found to be an interaction of the 
metabolic and vascular dysfunction. The early effects of hyperglycaemia were 
mostly metabolic changes while the late effects were in the form of 
electrophysiological and morphological changes (Bhadada et al 2001). 
Diabetes Mellitus is usually characterised by an asymptomatic phase of about 
4-7 years before the actual onset of the disease and its clinical manifestation. 
Persistent hyperglycaemia is one of the principle underlying causes for the 
development of diabetes related complications (Duby et al 2004). The chronic 
complications of diabetes manifest themselves in the form of both 
microvascular and macrovascular diseases as shown in the figure 1.1.
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Retinopathy Nephropathy Neuropathy
Macrovascular
Complications
Coronary Heart 
Disease
Microvascular
Complications
Cerebrovascular
Disease
Peripheral
Vascular
Disease
Diabetic Complications
Figure 1.1: Flow chart illustrating the different type of complications due to diabetes
The macrovascular complications account for nearly 50% of deaths among 
Type 1 and 2 diabetics (LeRoith et al 2004). The primary pathology of the 
macrovascular complications is atherosclerosis. It is a condition referring to 
the thickening of the vessel wall with subsequent reduction in the lumen size 
of the large arteries. Though the exact process or cause of atherosclerosis is 
unknown, it has been proposed that diabetes could trigger endothelial 
dysfunction and the build up of plaque within the large vessels. The 
subsequent reduction in the lumen size also causes a decrease in the blood 
flow through these vessels. The three main types of macrovascular 
complications among diabetics are the Coronary heart disease, the 
cerebrovascular disease and the peripheral vascular disease, which often 
leads to myocardial infarction, strokes and amputations respectively. In most
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cases all the three sites of circulation are affected and treatment of one can 
often aggravate the other.
Diabetes can also cause pathological and functional changes to the 
microvasculature of various tissues of the body, mainly affecting the eyes, 
kidneys and the nervous system. The pathogenesis of microvasculopathy is a 
complex process governed by several factors like the type of organ bed 
involved and the type and severity of diabetes. Though the manifestation of 
microvasculopathy occurs during the late stages of diabetes, studies have 
revealed that the structural and functional damage of the microvasculature 
begins from the very onset of raised glucose levels (Wiernsperger 2001). 
Therefore the microvascular complications of diabetes can be studied under 
an initial functional stage and then a structural stage. The initial functional 
stage is a reversible stage that can be achieved through controlled glucose 
level, while the latter involves structural remodelling of the microvasculature 
that ultimately leads to the microvascular failure (Tooke 1995). Retinopathy, 
nephropathy and neuropathy are the three main microvascular complications 
of diabetes affecting the eyes, the kidney and the nervous system 
respectively. Diabetes can also cause damage to the skin microcirculation.
1.2.1 Diabetic Neuropathy
The damage to the peripheral, the autonomic and the cranial nerves due to 
diabetes mellitus is termed diabetic neuropathy. It is a common but serious 
complication of diabetes, affecting almost every type of nerve fibre in the body
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(Duby et al 2004). Long standing hyperglycaemia can cause certain 
pathological alterations in the nerve fibres, parent nerve cell bodies, neural 
vasculature and the supporting connective tissues resulting in nerve damage. 
Of the several models of classifications proposed over the years, a simple 
classification based on anatomical characteristics given by Thomas was 
widely accepted (Bhadada et al 2001). Under this classification diabetic 
neuropathy was broadly classified into diffuse and focal neuropathy as 
shown in the figure 1.2.
Diabetic Neuropathy
v
Diffuse Focal
3wZ
Distal Symmetric Autonomic Systemic proximal
Sensory- Motor Neuropathy Lower limb
Polyneuropathy Neuropathy
JI
Sudomotor
3Z
Cardiovascular
iZ
Gastrointestinal
E
Genitourinary
JI
Cranial
E
Radiculopathy
E
Entrapment
Neuropathy
3E
Asymmetric Lower 
Limb 
Motor Neuropathy
Figure 1.2: Classification of Diabetic Neuropathy
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The distal symmetric sensory-motor polyneuropathy is by far the most 
common type of diabetic neuropathy, involving both large and small fibres 
(Bhadada et al 2001). As the name suggests, this type of neuropathy has a 
distal symmetrical form of disorder predominantly affecting the large nerve 
fibres and following a distal-proximal pathway also called the “stocking 
distribution” pattern. Progression of this disease occurs in several stages with 
varying degrees of severity in the symptoms (Bhadada et al 2001).
The proximal motor neuropathy primarily involves the motor neurons and is 
accompanied by wasting and weakening of muscles causing muscle atrophy. 
The weakening of muscles is accompanied by muscle imbalance and foot 
deformities, which cause abnormal concentrations of forces and stress in the 
soles of the feet thereby increasing the risk of trauma. This type of neuropathy 
may be symmetrical or asymmetrical, may or may not involve the loss of 
sensory nerve fibres and is also labelled diabetic amyotrophy. This disorder 
mostly tends to occur in the background of sensory polyneuropathy. Unlike 
the distal symmetrical sensory motor polyneuropathy, the motor neuropathy 
has a better prognosis and is a reversible condition (Bhadada et al 2001).
Both focal and multifocal neuropathies occur rarely among the diabetics, have 
an asymmetrical form of distribution and manifest themselves as isolated or 
multiple lesions of cranial, limb and truncal nerves. This is also a reversible 
condition where the patient recovers within three to four months (Bhadada et 
al 2001). Diabetic autonomic neuropathy is another important type of
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symmetrical neuropathy that will be dealt in detail in the next section of this 
chapter.
1.3 Diabetic Autonomic Neuropathy or DAN
DAN is a complex heterogeneous disorder affecting the autonomic neurons of 
the peripheral nervous system (Vinik 2002). Most organ systems of the body 
are dually innervated with both sympathetic and parasympathetic divisions of 
the autonomic nervous system. Thus damage to these nerve fibres can cause 
widespread dysfunction of most organ systems of the body (Vinik and Erbas 
2001).
Although the subclinical autonomic dysfunction can occur within a year or two 
of the diagnosis of diabetes mellitus, the clinical symptoms of this disorder 
remains asymptomatic until long after the onset of the diabetes (Vinik and 
Erbas 2001). Poor glycaemic control, age, duration of diabetes, female sex 
and obesity are some of the major risk factors in the development and 
progression of this disease (Vinik 2002). DAN was found to increase patient 
morbidity and mortality and to have a profound negative impact on the quality 
of life. Like all other neuropathies the early detection and treatment of this 
disease was observed to be vital for its delayed progression and improved 
quality of patient life.
10
1.3.1 Manifestation of DAN
Both the sympathetic and parasympathetic nerve fibres dually innervate most 
organ systems of the body; therefore the effects of DAN are varied and 
serious (Vinik 2002). Depending on the organ system that is damaged, DAN 
can be classified into four major divisions as shown in the figure 1.2.
Damage to the autonomic neurons that innervate the cardiac smooth muscles 
causes Cardiovascular Autonomic Neuropathy or CAN. The cardiac 
denervation involves both parasympathetic and sympathetic fibres. 
Abnormalities in the HR control and the vascular dynamics were observed in 
individuals with CAN (Vinik et al 2003). Decrease in the HR variability was 
considered to be one of the earliest indicators of symptomatic CAN. 
Individuals suffering from CAN were observed to have impaired exercise 
intolerance and were also associated with higher risk of suffering from silent 
myocardial infraction. The CAN could also cause orthostatic hypotension, 
which is the fall in blood pressure of more than 30 mmHg on standing. The 
symptoms include dizziness, weakness, fatigue and even occasional visual 
blurriness. Although DAN can remain asymptomatic for long period of time, 
the CAN dysfunctions occur in the early stages of diabetes. The tests to 
assess the cardiac autonomic function are sensitive, objective and 
reproducible. Thus they form the standard tests for the diagnosis of DAN 
(Vinik et al 2003).
The denervation of the autonomic neurons supplying the gastro-intestinal tract 
causes gastro-intestinal (Gl) autonomic neuropathy. The resulting Gl
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disorders were varied and complex with symptoms that were common and not 
unique to this disease. These symptoms included diarrhoea, faecal 
incontinence, heartburn, constipation, bloating and nausea. Faecal 
incontinence due to impaired sphincter tone was also common among 
diabetics with this form of autonomic dysfunction (Vinik et al 2003).
Damage to the afferent nerve fibres supplying the genito-urinary system of the 
body due to autonomic neuropathy can cause both bladder dysfunction and 
sexual dysfunction. Autonomic neuropathy can also impair the respiratory 
reflexes, the bronchomotor tone and cause damage to the skin and eyes.
1.3.2 Current Diagnostic Approach for DAN
Historically research for the development of methods for the objective 
assessment of autonomic dysfunction has lagged behind those for the 
assessment of the more common sensory-motor neuropathies due to its 
largely asymptomatic nature (Vinik et al 2003). It was a common belief that 
autonomic neuropathy was a rare complication that affected only certain 
individuals. However in reality, though symptomatic autonomic neuropathy is 
rare, autonomic dysfunction has been observed to occur within the first couple 
of years of diagnosis of diabetes. Since DAN manifests itself as dysfunctions 
of several organ systems with symptoms being varied and common, objective 
diagnosis of the same is not always straightforward. Unlike the sensory-motor 
nervous system in which individual nerves can be tested, the study of the 
autonomic system is usually achieved by assessing the end organ function.
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The symptoms of Gl and GU autonomic dysfunctions are mostly subtle and 
non-specific. Therefore, traditionally the diagnosis of DAN has been through 
the assessment of the cardiovascular reflexes. These tests are both sensitive 
and reliable. They provide a direct and an objective assessment of the extent 
of the autonomic dysfunction (Vinik and Erbas 2001). A summary of the 
different diagnostic tests currently in use has been tabulated in figure 1.3.
Assessment of Cardiovascular Autonomic Function
Cardiovascular autonomic dysfunction is studied by assessing the 
performance of the heart. Both the sympathetic and parasympathetic fibres 
dually innervate the heart and work in opposition to each other. Thus one has 
to take into account the complexities of the autonomic innervations of the 
heart when interpreting the cardiovascular assessment test results. The tests 
currently in use include the measurement of the HR variability (HRV), 
measurement of the HR response during the Valsalva manoeuvre test or 
under deep breathing, HR response to standing up, pressure response to 
postural change and the pressure response to sustained hand grip. Of these 
tests, the resting HR and the HR response to deep breathing and standing are 
early indicators of the parasympathetic dysfunction, while the blood pressure 
response to standing, deep breathing and sustained handgrip is a measure of 
the sympathetic activity (Vinik et al 2003).
An increased resting HR of greater than 100 bmp and the measurement of the 
loss of normal HRV due to cardiac denervation is probably the best and the 
simplest test of the autonomic function (Mackay et al 1980). The HR
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response to deep breathing measures the beat-by-beat variation in the HR 
with breathing. The parasympathetic branch of the autonomic nervous system 
mainly influences the extent of the HR response to deep breathing. This test 
has a universal protocol and is considered to be extremely reliable. HR 
variations of less than 10 bmp and the expiration to inspiration ratio of greater 
than 1.17 are considered abnormal (Vinik and Erbas 2001).
Type of DAN Current Diagnostic Tests
Cardiovascular 
Autonomic Neuropathy
1. HRresponse to deep breathing and standing
2. Valsalva manoeuvre
3. Diastolic pressure response to sustained hand 
grip
4. Spectral analysis of the HR
Gastro-intestinal 
Autonomic neuropathy
1. Scintigraphic imaging of gastric emptying
2. Endoscopic examination
3. Manometric Tests
4. Detailed patient history
Genito-Urinary
Autonomic
Dysfunction
1. Ultrasound Imaging of bladder
2. Cystometrogram
3. Nocturnal penile tumescence
4. Penile -brachial pressure index measurement 
using Ultrasound
5. Detailed patient history
Sudomotor Autonomic 
neuropathy
1. Sudomotor axon reflex test
2. Sympathetic sweat response
3. Thermoregulatory sweat test
Figure 1.3: The current diagnostic tests for DAN
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The HR response to standing measures the cardiovascular response 
brought about by the change from horizontal to vertical position. 
Parasympathetic innervations play a vital role in the regulation of the HR due 
to short-term postural change. Healthy individuals exhibit well-regulated 
variations in the heart rate. However among diabetics with autonomic 
dysfunction, this regulatory mechanism is disrupted. The ratio of the maximum 
HR at the 15th beat to the minimum HR at the 30th beat on standing is 
calculated and a ratio of less than 1.03 is classed abnormal (Vinik and Erbas 
2001).
The Valsalva Manoeuvre represents a more complex reflex arc involving the 
sympathetic and parasympathetic pathways to the heart, the sympathetic 
pathways to the vascular tree and the baroreceptors in the chest and the 
lungs (Maser 1998). During the test the individual is asked to blow forcefully 
into a mouthpiece of an open manometer at a specific resistance of 40mmHg 
for around 15 seconds while the HR is continuously recorded and monitored 
using an Electrocardiogram from one minute before the manoeuvre till a 
minute after (Vinik et al 2003). Throughout the straining, release and recovery 
segments of the manoeuvre the HR is reported to exhibit well defined 
changes in healthy individuals (Kalbfleisch and Smith 1978). Since this 
exercise has both sympathetic and parasympathetic involvement, the 
Valsalva ratio is a good indicator of the progression of DAN in diabetics.
Sympathetic dysfunction leads to altered pressure response to postural 
changes and sustained handgrip. The extent of this response is used as a
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measure to determine the extent of sympathetic damage due to autonomic 
neuropathy. A fall in diastolic pressure by more than lOmmHg or a drop in 
systolic blood pressure of more than 20mmHg within two minutes of standing 
is considered abnormal. The Diastolic pressure response to sustained 
handgrip is also a good indicator of sympathetic dysfunction. The muscle 
contraction is measured using a dynamometer. The dynamometer is first 
squeezed to maximum then held at 30% of the maximum strength for next 5 
minutes. The muscle contraction causes a rise in systolic and diastolic 
pressure as well as a rise in the heart rate. An increase in diastolic pressure 
of less than 10mmHg is considered abnormal. With rapid advancement in 
technology most of these tests are performed using computerised system and 
are also simple to use (Vinik et al 2003).
Assessment of GU and Gl autonomic dysfunction
Although the symptoms of both the GU and Gl autonomic dysfunction are not 
any major cause of morbidity, they can be debilitating and reduce the quality 
of life. Tests like endoscopy, scintigraphic imaging and various manometric 
tests are performed at different levels of the digestive tract to diagnose and 
analyse Gl autonomic dysfunction. Ano-rectal manometry is also performed to 
evaluate the internal and external anal sphincter tone and the rectal-anal 
inhibitory reflex that can be damaged due the autonomic dysfunction. 
Cystometrogram, renal function and urine culture tests are some of the 
diagnostic tests used to diagnose bladder dysfunction in the event of GU 
autonomic dysfunction (Vinik et al 2003). The measurement of nocturnal
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penile tumescence and vaginal plethysmography are used to diagnose sexual 
dysfunction in both male and female (Vinik and Erbas 2001).
Though specific tests were available for the assessment of different types of 
autonomic dysfunctions, they were not considered to be sufficiently well 
standardised for routine clinical use (Vinik et al 2003). On the other hand CAN 
diagnostic tests were non-invasive, validated, sensitive and reproducible and 
therefore formed the core diagnosis of autonomic neuropathy Confirmed 
diagnosis of autonomic dysfunction was only provided in the event of one or 
more abnormal CAN tests. The CAN assessment tests, due to its reliability 
and precision were recommended as the gold standard test for diagnosing 
autonomic neuropathy (Vinik et al 2003).
Although CAN tests remain the gold standard for diagnosing autonomic 
neuropathy, they are only reliable once the clinical manifestation of the 
disease sets in. It is also known that DAN remains asymptomatic until long 
after the onset of diabetes. Early diagnosis of the autonomic damage is 
crucial for the delayed progression of the disease and for a better prognosis. 
Besides these tests are complex and require specialist’s skill and equipment 
to perform. Therefore there is a need for a simple, non-invasive test that can 
be easily performed in GP surgeries and detect any early microvascular 
changes due to the autonomic dysfunction.
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1.4 Cutaneous Microcirculation
The skin is a highly vascularised organ and its structural and functional 
complexities indicate its role in several important homeostatic mechanisms. 
The skin vasculature in general consists of an extensive arteriolar-capillary- 
venular network, which contains the slow flowing superficial vascular plexus 
and the deep vascular plexus. The middle layer of the skin known as the 
dermis consists of an extensive network of arteries, arterioles, capillaries and 
venules. The capillaries reach close to the skin surface and help in the 
exchange of nutrients, wound healing and fight infection. Besides this general 
structure, the cutaneous circulation of the palm, soles of the feet and on the 
face especially the extremities also consists of special capillary bypasses 
termed arteriovenous (AV) anastomoses. The cutaneous microcirculation of 
the soles of the feet was the primary site of interest in this study.
These AV anastomoses are coiled channels with a highly muscular wall and a 
lumen that connects the arterioles to the venules at the level or slightly 
superficial to the sweat glands (Frewin 1969). They are a specialised type of 
vessel that helps blood to bypass the capillary circulation by directly entering 
the venules from the small arteries and the arterioles. Each shunt consists of 
an arteriolar portion and a funnel shaped venous portion that terminate in the 
veins. They possess a small lumen but thick muscular wall. Vascular smooth 
muscles are attached to the tunica media of the arterioles, the venules and 
the AV nodes (Levick 2000). The capillaries arising from the small arteries 
and arterioles do not have any smooth muscles but the pre-capillary
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sphincters attached to their point of origin and the venules control the capillary 
blood flow.
1.4.1 Regulation of Cutaneous Microcirculation
The main aim of peripheral circulation is to regulate the arterial blood pressure 
and maintain adequate metabolism, temperature and capillary filtration. The 
terminal arteries, arterioles and the venules are the principle resistance 
vessels of the body. The regulations of the blood flow though the skin is 
complex with autonomic fibres controlling both the vascular tone and the local 
reflexes within the skin. Several factors affect the cutaneous circulation, 
making it difficult to compute. Temperature regulation is an important function 
of the cutaneous microcirculation and the short muscular AV shunts play a 
vital role in the same.
The sympathetic vasoconstrictor nerve fibres innervate the AV anastomoses 
and these shunts provide a low resistance pathway by which the blood flow 
can be diverted from the arterioles to the venules, bypassing the capillary 
network. These shunts are usually maintained in a constricted state by a high 
sympathetic tone to ensure capillary flow to the skin tissue. But in the wake of 
any thermoregulatory disturbances this sympathetic tone is lost and the blood 
is diverted away from the skin.
From the above discussion it can be said that the skin microcirculation has 
two pathways viz, the capillary bed and the AV shunts (Fagrell and Intaglietta
1997). The capillaries exhibit a higher basal tone and are generally mediated
19
by local factors. On the other hand the AV shunts are highly innervated 
entities with little local mediation as they are found to dilate maximally when 
the nerves are cut off (Rushmer 1976). Both intrinsic and extrinsic factors 
regulate the cutaneous circulation
The intrinsic factors are those present within the end organ itself. The 
myogenic response, temperature, metabolites such as nitric oxide (NO) and 
chemicals generated locally are some of the main intrinsic factors. They 
mainly help in the local control and in autoregulation. The intrinsic control 
forms the primary level of control that looks after the needs of the individual 
organ (Levick 2000). The extrinsic factors control the basal tone from outside 
the end organ, serve the more general needs of the body and are more 
central in origin. Neural and hormonal factors belong to this category. While 
the local factors maintain the local needs of the organ system, the extrinsic 
factors represent a higher level of control that can modulate or override the 
local factors for the overall benefit of the individual.
In spite of the presence of several levels of control of the peripheral 
circulation, there always exists a balance between the intrinsic (myogenic, 
etc) and the extrinsic (neuro-hormonal) factors (Peter 1978). These controls 
tend to exhibit a random time dependant behaviour which produces an 
optimal steady state when averaged over time and space and can be termed 
as a chaotic process (Intaglietta 1990). This is representative of a healthy 
system and therefore any abnormal changes in microcirculation could 
potentially be linked to pathological conditions like diabetes.
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Diabetic patients with neuropathic foot are observed to have distended foot 
veins, raised skin temperatures and increased skin blood flow, both in 
ulcerated and non-ulcerated foot (DeFronzo 2004). Studies have shown a 
possible relation between the increased skin blood flow and AV shunting. It is 
hypothesised that sympathetic denervation could lead to the loss of neural 
control on the AV shunts, thus opening up the low resistance pathway causing 
excessive shunting of blood into the venules, bypassing the capillary bed. The 
skin blood flow represents both the capillary and the AV flow (Shapiro et al
1998).
From the above discussion it can be rightly said that the skin blood flow can 
be used as a good indicator of the sympathetic activity of the peripheral 
nervous system. The ability to quantify the extent of sympathetic damage in 
the cutaneous circulation can provide valuable information in developing new 
treatment methods, for prevention and better prognosis of diabetic foot 
disease.
1.4.2 Cutaneous Flow Measurement Techniques
The skin blood flow is a complex entity comprising of both nutritional and non- 
nutritional flow. Though the skin is the largest and the most assessable organ 
for the study of microcirculation in the human body, it possesses some 
inherent limitations. The dual function of nutrition and thermoregulation and 
the highly unstable character of the skin blood flow make its measurement a 
challenging task. Both invasive and non-invasive methods have been 
developed to measure different aspects of the circulation. Doppler ultrasound
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and Laser Doppler flowmetry are currently the most popular methods for 
blood flow measurement (Chittenden 1993).
The ultrasound blood flow meter used to measure the blood flow velocity is 
based on the Doppler principle. The pulsed wave in combination with colour 
duplex provides a measure of the mean velocity of the blood within a vessel. 
The Duplex scan is effectively being utilised to evaluate the blood flow in most 
parts of the body specially the arms, legs, heart and the neck. This method is 
currently the forerunner in blood flow measurement techniques and is the 
closest gold standard test available for blood flow measurement. However this 
technique has fallen short in measuring skin blood flow, as it involves very 
small Doppler shift due to the slow moving blood cells within the skin capillary 
bed.
One of the biggest disadvantages of the duplex ultrasound technique was that 
it could not be successfully applied to measure the blood flow in the 
microcirculation. The velocities of the blood cells within the capillaries were 
significantly lower, in the order of about 1 - 2  mm.s'1. Thus the very low 
Doppler shift frequencies of the order of only a few Hz were extremely difficult 
to extract resulting in a poor signal to noise ratio. This disadvantage was 
overcome using light instead of sound waves where the high frequencies of 
the visible and infrared light were utilised to measure the tissue perfusion 
using the Doppler principle (Chittenden 1993). Laser Doppler flowmetry had 
the dual advantages of non-invasiveness and the real time monitoring of the 
tissue perfusion. However this technique also had several disadvantages.
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Motion artefacts, multiple Doppler shifting, biological variations, expensive 
technology, dependency on the thickness and optical properties of individual 
skin type and the lack of a universal calibration unit due to the large inter and 
intra variations in the microvascular physiology were some of the 
disadvantages of this technique (Chittenden 1993)
The unpredictable nature of the microvascular architecture and physiology 
had rendered it impossible to compare any two techniques of the skin blood 
flow measurements at a given time. In spite of the presence of a wide array of 
techniques, there exists no ‘gold standard’ method for measuring skin blood 
flow. Each method investigates a different aspect of the skin microcirculation 
and has its own advantages and disadvantages. Thus it is vital to pre 
determine the exact nature of information that is to be extracted for any study 
before selecting a suitable method. This research project aims to diagnose 
neuropathy in its early stage by analysing and comparing the vasomotor 
changes in the microcirculation of the diabetics and the healthy individuals. 
Continuous research with improved electronics and computing has led to the 
development of several new measuring techniques. Amongst these the PPG 
has gained considerable importance for its operational simplicity, ruggedness, 
simple electronics and low cost. PPG is a non-invasive optical technique for 
measuring tissue perfusion. This study aims to investigate the cutaneous 
circulation using PPG and hence it has been dealt in great detail in the next 
few sections of this chapter.
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1.5 Photoplethysmography (PPG)
Plethysmography is defined as a technique that measures any change in 
volume. It is derived from the Greek word plethysmos, which means to 
enlarge (Creager et al 1992). The history of PPG goes back to over 70 years. 
In 1938 Hertzman first discovered the relation between the intensity of the 
reflected light and the skin blood volume (Neumann and Maessen-Visch
1999). His device consisted of a light source, detector and an analyser and 
was used to record the arterial pulsations in the skin. In 1970’s PPG was first 
used in the examination of the peripheral venous circulation (Blazek et al 
1996). With increased application several potential sources of errors were 
reported such as the errors due to the incorrect positioning, skin contact, skin 
movement or the type of light source used (Allen 2007). The technical 
difficulties in calibrating and in the quantitative analysis of the measured data 
further limited its applications (Blazek et al 1996) . It was however the 
advancement in semiconductor technology, computing power and clinical 
instrumentation that led to the re establishment of PPG (Allen 2007). Blazek’s 
and Schultz -  Ehrenburg’s group devised a self-calibrating system using the 
modern computing technology that lead to PPG’s widespread application as a 
vascular diagnostic tool (Blazek et al 1996).
1.5.1 Working Principle
PPG is an optical technique that consists of a light source and a photosensor. 
Modern PPG sensors use low cost light emitting diodes (LED) and 
appropriate photodetectors working at the red or the near infra-red (IR)
24
wavelengths (Allen 2007). The LED and the photodetectors can be placed 
either on the same side of the skin surface under investigation or opposite to 
each other. Depending on the position of the source and the detector PPG 
probes can be classified into two functional modes. When the tissue under 
investigation is placed between the light source and the detector as shown in 
figure 1.5, it is known as the transmission mode and is widely used to 
investigate certain areas of the body with limited width e.g. fingers, ear lobe, 
etc. In this arrangement the detector receives the light after being transmitted 
through the tissue of interest. However, this kind of arrangement has its own 
limitation and cannot be used to measure skin blood volume for most parts of 
the body. When both the emitter and the detector are placed on the same side 
of the skin being measured it is known as the reflection mode. This 
arrangement is illustrated in figure 1.4. In this mode the incident light 
undergoes attenuation within the different tissue layers before being reflected 
back on to the detector. The intensity of this reflected and back scattered light 
is measured and the variation in the photo-detector current thereby produced 
is assumed to be related to the blood perfusion changes under the probe 
(Oberg and Lindberg 1991).
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The working principle of PPG is based on the optical properties of the skin. 
The light photons incident on the skin undergoes reflection, absorption, 
scattering, transmission and collision as they pass through the various layers 
of the tissue (Allen 2007). The choice of an appropriate wavelength is very
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important, as most of the optical characteristics such as absorption, scattering 
and penetration are all wavelength dependant. The scattering and absorption 
co-efficient of various biological tissue layers also vary with skin depth and 
colour (Blazek et al 1996). Biological tissue is considered to be largely opaque 
in the red or the near IR region of the electromagnetic spectrum (Blazek et al 
1996) while blood is found to absorb the IR light more strongly. Figure 1.6 
depicts the light reflection characteristic of the biological tissues and the blood 
as a function of the wavelength.
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Figure 1.6: Light reflection (R) characteristics of the blood and the bloodless skin and 
light absorption (A) characteristic of the epidermis. Note that the light at the optimum 
wavelength 940nm is reflected from the bloodless skin 10 times more than the blood
(Blazek et al 1996).
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From the figure it can be rightly inferred that biological tissue without any 
blood reflects light many times greater than the blood. However between 780 
nm and 940 nm this difference is found to be maximal and is also known as 
the favourable measurement window for optical sensing (Blazek et al 1996). 
Higher wavelength also has greater penetration into the tissue layers. The 
oxygenated and deoxygenated blood have different absorption coefficient for 
wavelengths less than 805nm (Allen 2007). Thus most modern sensors use 
LED of around 900 nm wavelength to achieve the maximal difference in the 
absorption characteristics of tissue and blood, the minimal difference in the 
absorption characteristics of oxygenated and de- oxygenated blood, and for 
the optimum skin penetration.
The PPG probe senses the blood volume change by measuring the amount of 
light reflected back onto the detector. An increase in the blood volume due to 
dilatation of the blood vessels results in increased absorption of light. The 
amount of light received by the detector decreases and hence a decrease in 
the PPG signal is registered. The reverse holds true during a decrease in the 
blood volume due to constriction of the blood vessels. Modern PPG sensors 
have a penetration depth of up to 4mm. This not only helps to detect the 
nutritional capillary flow but also provide valuable information on the deep 
vascular plexus containing the AV shunts, an area responsible for peripheral 
haemodynamic (Blazek et al 1996). Both the light source and the detector 
used in modern PPG probes are compact, low cost, mechanically robust, and 
reliable and have a fast response time (Allen 2007).
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In a typical PPG measurement, of the total amount of light received by the 
detector, about 90% is estimated to be directly reflected back from the skin 
surface and the static biological tissues, 10% from the venous blood volume 
and only 0.1% from the oxygenated arterial blood volume. Thus a typical raw 
PPG signal consist of a large permanent offset from the static bloodless tissue 
layers, a slow moving DC (direct current) component and a pulsatile AC 
(alternating current) component (Blazek et al 1996). The pulsatile AC 
component is found to be superimposed on the slow moving DC component 
and the latter usually has amplitude of 1-2% of the former (Oberg and 
Lindberg 1991). The slow moving DC component provides information 
regarding the total blood volume change within the skin microcirculation and 
represents the total amount of blood pooling or blood flow under the detector. 
The AC component represents the blood volume change for every pulse due 
to the pumping action of the heart. Much of the skin has poor pulsatility but 
the pre capillary activity is present throughout. Both the gross volume change 
and the pulsatile change are closely related to the autonomic activity of the 
body and the combined information from the AC and the DC components 
provide a clearer understanding of the vascular changes in the skin 
microcirculation (Kamal et al 1989). Being a relatively inexpensive, non 
invasive and non traumatic technique, makes PPG a popular vascular 
diagnostic tool (Kamal et al 1989)
1.5.2 Limitations of PPG
The signal detected by the PPG is dependent on several factors such as the 
location of measurement, skin properties of the individual being measured,
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environmental factors, movement artefacts, oxygen saturation of the blood, 
blood flow rate, and the initial blood volume under the probe. The 
reproducibility of such a measurement technique was also affected by factors 
such as method of probe attachment, movement artefacts, posture, 
relaxation, room temperature, breathing, wakefulness and acclimatisation. 
There are no international standards set for a photoplethysmographic 
measurement thereby limiting the replication of the study between research 
centres (Allen 2007). These limitations hindered the use of PPG as a 
diagnostic tool for many years. A study conducted by Jago and Murray 
(1988), stressed on the importance of taking bilateral measurements as they 
tend to be more repeatable than an individual site measurement (Allen 2007).
1.5.3 Quantitative Photoplethysmography
Of the various factors, the dependency of the PPG signal on the skin 
characteristics of an individual being measured was its greatest limitation. The 
optical properties of the skin were observed to depend on factors such as 
degree of pigmentation and its thickness. Besides, the amount of light 
received by the photo detector was also dependent on the degree of initial 
skin perfusion at the site of measurement. Thus a same amount of blood 
volume change could produce different PPG signals in different individuals 
due to the variation in their skin characteristics making it practically impossible 
to produce a quantitative measure of the blood volume change that was 
comparable with measurements from different individuals.
This further limited its use as a popular diagnostic tool for several years till the 
introduction of the quantitative PPG by Blazek and Schultz -  Ehrenburg. This
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involved an automated electronic calibrating system that used an optical 
closed loop measuring principle controlled by a microprocessor. This enabled 
the calibration of the signal before every measurement. Thus instead of using 
a uniform amount of optical radiation for all skin types, the amount of optical 
light incident was altered using the optical loop principle till a desired baseline 
of the PPG signal was obtained before every measurement. This ensured a 
constant starting value for every measurement that was both reliable and 
reproducible for every skin type. The quantitative PPG revolutionised its use 
as a diagnostic tool. The automated calibration helped to achieve a uniform 
initial reflection value irrespective of the individual skin characteristics and 
made intra individual comparisons of the PPG signals possible. Greater 
control on the measurements with signal storage possibilities along with 
quantitative and precise analysis of the measured data was made possible 
with the introduction of the quantitative PPG (Blazek et al 1996) .
1.5.4 Application of Photoplethysmography
PPG has been widely used in clinical physiological monitoring and various 
vascular assessments. The blood oxygen saturation measurement is 
regarded as one of the most significant contributions of PPG. Other 
physiological parameters that are monitored using PPG include beat-by-beat 
heart rate, pressure and respiration. The pulsatile AC component of a PPG 
signal represents the heartbeat. Complex computer algorithms have been 
developed to use this information to detect the beat-by-beat HR of an 
individual and have found its use in hospital based and ambulatory patient 
monitoring systems. The skin vascular changes influenced by the breathing
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cycle can be monitored using PPG (Allen 2007). It has also been successfully 
used to measure both the arterial and venous circulation. The slow moving 
DC component of the PPG signal represents the total amount of blood pooling 
under the probe and this provides vital information of the venous circulation.
Studies have also been conducted to look into the feasibility of using the 
photoplethysmographic technique in the autonomic function assessments. In 
this project we aim to use PPG to study the vasomotor responses obtained 
from the soles of the feet of both healthy and diabetic patients with and 
without any known neuropathy.
1.6 Diabetic Foot Disease
Ulceration below the knee is a common complication of diabetes with a 
lifetime risk of its occurrence among diabetics estimated at 15% (Kenneth and 
Cummings 2005). Diabetic foot disease not only complicates and reduces the 
quality of life for the patients but also has a huge economic impact on the 
health care system. If left untreated the ulcerations could become infected 
and gangrenous and finally lead to amputations. In the UK 5000 diabetics are 
estimated to have amputations every year. Foot ulcers precede more than 
80% of non-traumatic lower limb amputations (Boulton et al 2000).
The international consensus on diabetic foot defines a diabetic foot ulcer as a 
full thickness wound below the ankle in a patient with diabetes, irrespective of 
duration (Boulton et al 2000). There is no one universal method of classifying 
ulcers and all diabetic ulcers are commonly known as diabetic foot disease.
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However the most widely used system grades ulcers on the extent of 
damage. The lowest being grade 0, which indicates pre ulcerative lesion. 
Untreated grade 0 ulcers could spread the infection from the outer skin, 
through the various tissue layers into the bone resulting in osteomyelitis. At 
this stage the ulcer becomes necrotic causing gangrene, a grade 4 ulcer. The 
final stage or grade 5 is when the whole foot becomes gangrenous and has to 
be amputated (Boulton et al 2000).
Diabetic ulcers have a very poor prognosis and the recurrence rate is very 
high. The principal risk factors for developing diabetic foot ulcers are duration 
of diabetes, presence of neuropathy and peripheral vascular disease, prior 
ulcers and prior amputations. The preoperative mortality rate of amputation 
within the UK was estimated to be around 10% to 15% with the median 
survival duration being 2 to 5 years. The recurrence rates of foot ulcers were 
reported to be around 35% to 40% in the first 3 years and as high as 70% 
over 5 years (Boulton et al 2000).
1.6.1 Pathogenesis of ulceration
Pathogenesis of diabetic foot disease is a complex interaction of various risk 
factors and environmental hazards around the patient that can potentially lead 
to lower limb amputations as shown in figure 1.6. Diabetic ulcers have an 
insidious onset and the progression from a minor trauma to gangrenous foot 
occurs in several stages. It has been observed that the primary risk factors for 
ulcerations like peripheral vascular disease and diabetic neuropathy very 
rarely can cause ulceration individually; rather it is a combination of these risk
33
factors and some minor trauma that leads to the breakdown of the diabetic 
foot (Boulton et al 2000).
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Figure 1.6: P athw ay to  the low er lim b am putation  in d iabetics
The risk of developing peripheral occlusive arterial disease (POAD) is two to 
three folds amongst diabetics as compared to the non-diabetics (Hittel and 
Donelly 2002). POAD occurs in the early stages of diabetes and affects the 
peripheral blood vessels. It is a macrovascular complication of diabetes where 
the distal vessels become artherosclerotic causing narrowing of the large 
distal vessels and thereby heavily compromising the blood supply to the 
extremities. A minor trauma followed by infection in the feet, considerably 
increases the demand for blood supply. In the event of blocked peripheral 
arteries this excess demand cannot be met and hence the process of wound
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healing is delayed. This condition is followed by ischaemic ulceration and if 
left untreated ultimately leads to amputation.
Diabetic neuropathy is another major risk factor for the development of 
diabetic foot disease and in almost all cases combines with PAOD to develop 
neuro-ischaemic ulcers (Kenneth and Cummings 2005). Diabetic neuropathy 
is a common complication of diabetes and can affect the sensory, motor and 
the autonomic neurons of the peripheral nervous system. Distal symmetrical 
sensory neuropathy is very common and the principal clinical presentation of 
this type of neuropathy is loss of sensation. In most cases the patients are 
often unaware of the loss of sensation in their feet and may also often 
experience other symptoms like sharp shooting pain, numbness, tingling 
sensation or pain while walking. These symptoms occasionally exacerbate 
during the night.
Due to the loss of sensation of the feet, the patient may suffer from trauma 
and be completely unaware of it. Little or no pain or sensation can lead to the 
neglect of the wound and in some cases the patient may suffer from multiple 
traumas. The increased duration of wound healing among diabetics coupled 
with neglect can cause infection that often leads to ulceration of the foot. The 
damage to the motor neurons causes extensive muscle wastage and foot 
deformities. This could alter the pressure distributions and cause abnormal 
pressure loading at the metatarsal heads. Pressure ulcers tend to occur 
mainly at the metatarsal heads due to repetitive pressure application while 
walking (Levin and Bowker 1993). Presence of peripheral sympathetic
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autonomic neuropathy can further aggravate the risk of ulceration. The skin 
under the foot becomes very dry and thick and callus tissues develop as a 
consequence of sympathetic neuropathy, thus putting the diabetic foot at a 
greater risk of ulceration.
Microvascular dysfunction among diabetics may not directly cause ulceration 
but there is sufficient evidence to link this to delayed wound healing among 
diabetics. Sympathetic dysfunction in the skin causes increased shunting of 
blood through the AV shunts. This leads to decreased capillary flow and 
hence to a decreased tissue nutritive flow. This is one of the few possible 
explanations for delayed wound healing among diabetics. Some of the other 
risk factors include age, duration and severity of diabetes and prior foot 
ulceration. The risk of ulceration and amputation is found to increase two to 
fourfold with both age and duration of diabetes (Levin and Bowker 1993). 
Studies have revealed that the rate of the re-occurrences of diabetic foot 
ulcers is often very high amongst diabetics and is one of the risk factors for its 
development (DeFronzo et al 2004).
Sympathetic dysfunction is one of the major components in the pathway to 
diabetic ulcerations. Sympathetic dysfunction is also known to cause 
alterations at the microvascular level. Several studies have been conducted to 
study the microvascular changes under pathological conditions like diabetes. 
In the next chapter I have reviewed some of the studies relevant to this 
project.
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Chapter II
Literature Review
2.1 Introduction
DAN is a complex disorder with multiple causative mechanisms that cause 
wide spread damage to the whole of the autonomic nervous system. A 
combination of metabolic and microvascular dysfunction causes damage to 
the nerve fibres. The complete understanding of the pathogenesis of DAN and 
its affects on skin microvasculature was vital for the development a screening 
tool. Besides, several studies have been conducted over the years looking at 
the various methods of analysing the skin microcirculation under pathological 
conditions. A detailed literature review on the pathogenesis of this diabetic 
complication along with previous work done in analysing skin microcirculation 
for the diagnosis of DAN has been discussed in this chapter.
2.2 Pathogenesis of DAN
In spite of several studies conducted worldwide, the exact pathogenesis of 
DAN still remains unclear (Tooke 1995). It is suggested to be a multifactorial 
disease where several factors combine to damage the autonomic nervous 
system. Progression of this disease can be explained in three stages. The 
initial stage is that of functional neuropathy where biochemical alterations in
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the nerve function occurs with no visible pathology. This is a reversible 
condition, which is followed by structural neuropathy. Here the structural loss 
of nerve fibres is observed and this stage is also found to be reversible. The 
final irreversible stage is that of nerve death, where a critical decrease in the 
nerve fibre density is observed leading to neuronal death (Vinik 2002). Poor 
glycaemic control, prolonged duration of diabetes, increasing age, and a 
higher BMI was found to have a profound negative impact on the progression 
of DAN.
Similar to other microvascular complications of diabetes, hyperglycaemia can 
cause structural and functional alterations to the nerve cells and the adjoining 
neurovasculature (DeFronzo et al 2004). The autonomic nervous system and 
the microcirculation have strong physiological co dependence. The 
microcirculation relies on the autonomic branch for its normal functioning 
while the autonomic nervous system relies on the microcirculation for the 
nutritive flow. It has been suggested that both microvascular dysfunction and 
neuropathy occur early in diabetics and forms a potential pathogenic vicious 
cycle where damage to the peripheral nerves disrupts the auto regulatory 
function of the microcirculation and damage to the latter cause’s neural 
hypoxia leading to further nerve degeneration (Kilo et al. 2000).
Several hypotheses regarding the pathogenesis of DAN have been put 
forward based on studies carried out in this field. The aetiological factors 
suggested by these hypotheses include hyperglycaemic activation of the 
polyol pathway, advanced glycosylation, generation of free radicals and
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oxidative stress, neurovascular insufficiency, autoimmune damage and 
neurohormonal growth factor deficiency. Almost all these complex process 
occurs at a cellular level. In healthy tissues at cellular level the redox 
(reduction -  oxidation) homeostasis is always maintained and hence the 
accumulation of reactive oxidative species (ROS) like O2 ' and H20 2 is 
prevented. But under pathological conditions like diabetes, this homeostasis is 
lost and hence an increased accumulation of ROS will lead to an increase in 
the oxidative stress. This rise in oxidative stress causes endothelial damage 
of the microvessels and structural damage to the neurons (DeFronzo e al 
2004).
Another popular hypothesis suggests the activation of the polyol pathway at 
the cellular level when exposed to long-term hyperglycaemia (DeFronzo et al 
2004). In this pathway the first half of the reaction converts the excessive 
cellular glucose to sorbitol and the second half converts this sorbitol to 
fructose. At each half of the reaction, nicotinamide adenine dinucleotide 
phosphate (NADP) was generated from its reduced form, NADPH. The 
increased activation of the pathway under hyperglycaemia caused excessive 
accumulation of sorbitol and fructose within the cell, as these substances 
were found to be relatively impermeable through the cell membrane. Besides, 
a reduction in the NADPH to NADP ratio was also observed during the first 
half of the pathway. A decrease in the NADPH concentration within the cell 
interrupts the NO synthesis causing excessive concentration of the oxygen 
free radicals. These toxic substances cause damage to the endothelial lining 
of the vessel wall. The second half of the pathway causes the acceleration of
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advanced glycosylation due to increased fructose production. The 
accumulation of the end products of the advanced glycosylation reaction also 
causes damage at the cellular level. Thus we can see how a combination of 
these factors can cause widespread structural damage to the neuro- 
microvasculature especially in the form of endothelial dysfunction among 
diabetics.
As mentioned earlier the pathogenesis of DAN involves damage to both the 
nerve cells and the neurovasculature. Besides, damage to the autonomic 
system also causes wide spread damage to the microcirculation. The study of 
the evolution of diabetic microangiopathy is a complex process as the 
progression of the disease varies with the type of organ bed involved and also 
with the type and severity of diabetes. However it can be studied under an 
initial functional stage and then a structural stage. The initial functional stage 
is a reversible stage with controlled glucose level, while the latter involves 
structural remodelling of the microvasculature ultimately leading to 
microvascular failure.
The “haemodynamic” hypothesis is another well-known hypothesis that 
could provide a possible insight to the mechanisms of diabetic 
microangiopathy (Tooke 1995). The semi rhythmic contraction/dilatation of the 
arterioles helps to produce an economic flow through the capillary units at a 
controlled rate thereby increasing the efficiency of the capillary bed. Reserve 
channels are present for use when needed. Early measurements of the blood 
flow in the vascular beds reveal an increased perfusion, which forms the basis
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of the haemodynamic hypothesis. According to this hypothesis, early diabetes 
is characterised by increased microvascular flow. This increased perfusion 
can cause shear stress and tangential pressure on the vascular endothelium 
leading to tissue injury. As a response to tissue injury accumulation of 
extracellular matrix occurs resulting in endothelial basement thickening. This 
causes a decreased vasodialatory capacity of the blood vessel in times of 
increased flow demands and also may interfere with the flow autoregulation. 
The vasodialatory capacity was found to decrease with the increased severity 
and duration of diabetes. The pathogenic mechanism of diabetic 
microangiopathy was found to vary with the type of diabetes. Unlike Type 1 
diabetes where the haemodynamic hypothesis holds well, Type 2 early 
diabetes is characterised by a normal flow. Here the occurrence of arterial 
hypertension profoundly decreases the vasodialatory reserve (Fagrell and 
Intaglietta 1997).
As per the various hypotheses proposed, changes in the microvascular flow 
occur with autonomic dysfunction. Increased shunting of blood flow through 
the AV shunts bypassing the capillaries due to sympathetic denervation was 
observed in diabetics. These specialised vessels called the AV shunts that 
are completely innervated by the sympathetic branch of the autonomic 
nervous system are found in abundance in the skin microcirculation. Thus of 
all the microvasculature, the skin microcirculation should mainly respond to 
any autonomic dysfunction that occurs within the body.
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2.3 Vasomotion
Vasomotion is another physiologically important characteristic of the 
microcirculation. Microvasculature is markedly different from the large vessels 
of the body as it has specific roles like pressure regulation and delivery of 
nutrients to the organ bed. While the second and third order arterioles of the 
microvasculature respond to changes in the local pressure under myogenic 
control, the lowest order of arterioles and capillaries ensures autoregulation of 
the flow under sympathetic control. As mentioned earlier the vascular bed is a 
highly innervated entity and is under sympathetic control. They play a vital 
role in regulating blood flow by opening and closing of the AV anastomoses 
and capillary arterioles (Lefrandt et al 2003). Hence damage to these nerves 
in pathological conditions like diabetic neuropathy, can cause disruptions to 
the regulated blood flow. The flow through the microcirculation has been 
observed to be chaotic with only a fraction of the capillary units being 
perfused at a time under resting conditions (Wiernsperger 2001). Generally 
the capillaries are arranged into units being fed by a single arteriole. The 
sympathetic nerves control the anastomoses of these arterioles in a semi 
rhythmic manner and the phenomenon is called vasomotion (Stansberry et al 
1996).
Vasomotion can be defined as oscillations of vascular tone generated from 
within the vascular wall (Nilsson and Aalkjaer 2003). In spite of several years 
of study the exact mechanism of the generation of these oscillations still 
remain unclear. Vasomotion is the spontaneous semi rhythmic oscillations of 
the diameter in the arterioles and venules. These semi periodic changes in
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the diameter of the blood vessels enable the supply of nutritive blood to the 
tissues in an economic fashion. As per the Poiseuille’s law, the resistance of 
the vessel whose diameter changes in a sinusoidal manner is less than that of 
a vessel of fixed diameter (Shapiro et al 1998).
Thus vasomotion helps to decrease the total vessel resistance, there by 
increasing local flow and proper perfusion of the tissues. Vasomotion has 
been a difficult entity to measure due to its unpredictable nature. Besides it 
has been non repeatable and difficult to replicate under in-vitro conditions. 
While some debate the occurrence of vasomotion only under pathological 
conditions, other studies have revealed the presence of vasomotion under 
normal conditions. Several factors contribute to the exact occurrence of this 
phenomenon. However current studies have revealed the presence of 
vasomotion at all times with a decreased activity under pathological conditions 
(Wiemsperger 2001).
Vasomotion is a local activity, with unsynchronised signals contributing to its 
chaotic appearance. Some of the factors that influence this phenomenon 
include neural, chemical or transmural pressure. The sympathetic control of 
vasomotion could be either through periodic nerve discharges or through 
facilitations of an endogenous vascular pacemaker. The neural influence on 
vasomotion can be reinstated as this phenomenon is completely eliminated 
under anaesthesia (Bernardi et al. 1997).
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Whatever may be the exact mechanism of its occurrence, vasomotion was 
found to be of profound functional importance. Its functions include delivery of 
blood to the tissues in an economic fashion, to ensure a local pressure for 
blood flow, the transmural exchange of fluids and cyclic contraction of the 
lymphatics. The decreased effective vessel resistance due to vasomotion was 
found to increase the blood flow thereby providing proper tissue perfusion and 
oxygenation (Nilsson and Aalkjaer 2003).
2.3.1 Pathophysiological Role of Vasomotion
There is sufficient evidence that the phenomenon of vasomotion is disrupted 
under pathological conditions, particularly in diabetics with autonomic 
neuropathy (Wiernsperger 2001). Tests conducted revealed a significantly 
reduced vasomotion in both Typel and Type 2 diabetics at rest. These 
abnormalities were found to be present as early as in pre diabetic stages. 
Stansberry et al observed a marked decrease in the amplitude of vasomotion 
in the finger to about 20% among both types of diabetics and thereby 
concluded that vasomotion was impaired in 75% of diabetics (Nilsson and 
Aalkjaer 2003).
Diabetic microangiopathy was reported to affect most capillary beds in a 
similar pattern (Rendell et al 1989). As mentioned earlier the skin 
microvascular bed was found to be most accessible, hence was extensively 
studied using several techniques, which included video microscopy, venous 
occlusion plethysmography and Laser Doppler flowmetry. The extremities 
were considered as desirable sites for the study due to its easy accessibility
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for the placement of probes and also as they tend to have a higher density of 
AV anastomoses under sympathetic control. In one study the nail fold 
microcirculation was analysed by measuring the blood velocity using a dual 
window television automatic estimating system (Yuan et al 1999). Their 
results showed a marked decrease in the middle, high and ultra high-speed 
peaks in the blood flow indicating microcirculatory disturbances among 
diabetics.
Diabetic neuropathy resulting from the neurosensory loss may cause the 
Charcot Joint leading to deformity of the bones and loss of sensation. 
Shapiro, et al in their study examined the possible relationship between the 
Charcot Joint and vasomotion at the dorsum of the foot. Here the blood flow 
was measured using a Laser Doppler flowmetry with local skin warming. The 
signal obtained was subjected to Fast Fourier Transform (FFT) to obtain the 
vasomotion index. Both the vasomotion as well as the blood flow velocity was 
considerably increased in healthy individuals and patients with the Charcot 
foot under locally increased temperature. However both the pattern of 
vasomotion as well as the blood flow velocity was severely distorted among 
diabetics with neuropathy alone. It is still unclear as to why the Charcot foot 
despite being one of the manifestations of diabetic neuropathy shows healthy 
vascular responses. However the author is suggestive of the fact that his 
results might be an indication of vasomotion as an autonomic entity (Shapiro 
et al 1998).
45
In their study, Shapiro et al, 1998 did a three-way comparison of healthy 
controls, diabetics with neuropathy but no Charcot deformity and diabetics 
with both neuropathy and Charcot foot. Here the two groups of the diabetic 
patients were age matched but they were not age matched with the healthy 
controls. In this study I had also aimed to make a three-way comparison 
between healthy controls, diabetics with no neuropathy and diabetics with 
neuropathy. Also the two groups of the diabetic patients in my study were age 
matched, but the healthy controls had a much younger age range. The 
diabetic patients with and without Charcot arthropathy in this study were 
classed as moderately to severely neuropathic only after a detailed sensory 
and autonomic function testing using the standard tests available. The study 
was unable to explain the similarities in the result obtained from the normal 
and the patients with Charcot arthropathy, although they belonged to the two 
extremes of the disease spectrum. However their conclusion of vasomotion as 
an autonomic entity was highly relevant to my study
In another study the arteriolar vasoconstriction was observed to be defective 
in both the pre diabetic as well as in the advanced diabetic stages 
(Wiernsperger 2001). The microcirculation mostly was studied using the Laser 
Doppler flowmetry or the venous plethysmography (Eicke et al 2003). 
However Eicke et al used an alternative technique of continuous wave 
Doppler sonography to assess the vasomotor responses in the radial artery. 
They calculated a resistance index as an indicator to the vasomotion activity 
by measuring the mean blood flow velocities at the radial arteries of 25 
diabetic patients with the diabetic foot syndrome. Their data suggested the
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existence of decreased vessel elasticity among the diabetics with autonomic 
neuropathy, perhaps due to the presence of endothelial dysfunction of the 
autonomic vasomotor system as mentioned in the previous section (Eicke et 
al 2003). This study compared the Doppler results from the patient group with 
their nerve conduction velocities to evaluate potential correlation between the 
autonomic and the somatosensory system. Results indicated a decreased 
vasomotor response in most of their patient group although they were 
diagnosed with moderate to severe sensory neuropathic. This conclusion was 
relevant as in my study the patient group were selected mainly on the basis of 
their vibration perception threshold (VPT) scores.
Lefrandt et al in 2003 recorded the blood flow velocity oscillations using a 
laser Doppler flowmetry at the median ankle. They studied the sympathetically 
mediated vasomotion by determining the power spectrum of the recorded 
data. The LF components between 0.02-0.14 Hz were most affected by 
postural stimulation and anaesthetics thereby suggesting their representation 
of vasomotion. The total power of the LF components of the blood flow 
velocity spectrum i.e. the vasomotion amplitude was considerably reduced in 
diabetics with neuropathy as compared with that of healthy individuals. Their 
study once again demonstrated abnormalities in sympathetic modulation in 
diabetic patients with autonomic neuropathy (Lefrandt et al 2003).
The characterisation of the subjects recruited for this study was excellent. 
Lefrandt et al, 2003 in their study had three groups similar to my research 
project. They were the control group, diabetics with no neuropathy and
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diabetics with peripheral sensory neuropathy. The groups were individually 
matched for age, sex and the BMI index. The diabetic groups were also 
matched for the type of diabetes. The protocol used for my study was largely 
based on the study protocol used by Lefrandt et al, 2003. However once 
again this group similar to the previously discussed study assessed their 
neuropathic subjects only for the peripheral somatosensory dysfunction and 
not their autonomic function. The results once again indicate that the 
sympathetically mediated vasomotion decreases with the sensory motor 
neuropathy.
A few years prior to Lefrandt et al, similar study was also conducted by 
Bernardi, et al (Bernardi et al. 1997). They suggested that the spectral 
analysis of the Doppler data would provide precise quantitative identification 
of the different sources of the fluctuations present within the signal. They 
observed the presence of at least two main sources of fluctuation within the 
power spectrum of the Doppler signal. The lower frequency components of 
the range 0.1 Hz was found to be influenced by the sympathetic control and 
the higher frequency components between 0.18 Hz and 0.40 Hz linked to 
respiration, was found to be mostly independent of the sympathetic tone. 
Results from twenty-three controls and diabetics were compared and one of 
their principle exclusion criteria was the absence of any clinical manifestation 
of DAN. The microvascular fluctuations studied using the Doppler signal was 
also compared with the standard autonomic function test results obtained 
from the subjects. Some interesting and useful conclusions were drawn from 
this study. Firstly, reduced LF fluctuations were observed in diabetic patients.
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This decreased response was not only obtained from patients with or more 
altered CAN tests, but also in those with normal cardiovascular reflexes and 
therefore extrapolated their results to conclude the possibility of impaired 
vasomotion as an early index of autonomic neuropathy among diabetics. 
Secondly this study also indicated a significant influence of age on the 
amplitude of both the LF and HF fluctuations.
A similar study was also conducted by Meyer et al, where they analysed the 
vasomotion by laser Doppler anemometry (Meyer et al. 2003). In this method 
a highly focused beam of about 10 jjm diameter was used to measure the 
blood cell velocity in single capillaries and hence unlike the laser Doppler 
flowmetry the rhythmic variation of the blood cell velocity caused due to 
vasomotion was visible directly without the spectral analysis of the signal 
obtained. The velocity of the blood cell was directly proportional to the 
Doppler frequency shift of the reflected Laser beam. The pulsatile component 
corresponding to the HR was removed from the Doppler signal using an 
appropriate filter. Along with the assessment of vasomotion the test subjects 
were also assessed for CAN using the standard tests that included the 
Valsalva manoeuvre, the HR response to deep breathing and the HR 
variability test. They were also assessed for sensory neuropathy, retinopathy 
and nephropathy. Impaired vasomotion was diagnosed if the amplitudes of 
the signal obtained were two standard deviation below the mean value 
obtained from normal individuals. Their study revealed the existence of 
impaired vasomotion in 90% of Type 1 diabetic patients with one or more 
altered CAN tests and in 40% of those with normal CAN assessment results.
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The latter results help to justify the hypothesis that the disruption in the 
vasomotor responses in the microcirculatory flow of the skin may be an early 
disturbance in the natural history of the disease. Their data indicates that the 
impairment of the 0.1 Hz vasomotion which corresponds to sympathetic 
dysfunction precedes the parasympathetic dysfunction assessed by the 
various CAN tests and there by can be considered as an early index of 
peripheral sympathetic dysfunction amongst diabetics. Bernardi, et al 1997 
and Meyer et al 2003 drew similar conclusions from their study but used 
different methods to study the skin microcirculation. They both concluded the 
impairment of the LF fluctuations in the diabetics with one or more altered 
CAN tests and also in some patients with normal CAN results. However this 
group could not establish any correlation between the impairment of sensory 
threshold and autonomic dysfunction.
Most studies reviewed so far have established vasomotor responses as an 
autonomic entity (Shapiro et al). Reduction in these responses was observed 
in diabetic patients with abnormal cardiovascular reflexes (Lefrandt et al) and 
sometimes also in diabetics with normal CAN test (Meyer et al, 2003) 
(Bernardi et al). Studies have also suggested the possibility of sympathetic 
dysfunction occurring together with sensory neuropathy. These results further 
strengthen the possibility of observing altered vasomotor responses from the 
neuropathic group recruited in this study in spite of recruiting them mainly on 
the basis of their VPT scores. Review of these studies has also provided vital 
information regarding the spectral make up of the various signals obtained
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from the skin where the different frequency fluctuation peaks were matched 
with specific physiological process of the body.
2.4 PPG and Autonomic Function Tests
PPG is an optical technique that has been widely used in clinical physiological 
monitoring and various vascular assessments. Only limited studies have 
been conducted to look into the feasibility of using the photoplethysmographic 
technique in the autonomic function assessments. The skin microcirculation is 
a complex entity. The raw PPG signal contains both LF and HF information. 
While the LF information represents respiration, blood pressure regulation and 
thermoregulation, the HF components represent the cardiac activity of the 
individual (Kamal et al 1989). These physiological functions are indicative of 
the autonomic activity of the body and hence could potentially be used for 
autonomic function testing. The very small frequency components and the 
spontaneous fluctuations of the PPG signal represent the vasomotor activity 
of the microcirculation. These relate to the sympathetic activity of the body 
and this is further corroborated by the decrease of these components under 
anaesthesia (Buchs et al 2005).
In a study by Barron, et al work was done on comparing and analysing the DC 
component of the PPG signal obtained from the response of the finger 
vasculature to standard tests of vasomotor function. The main aim of this 
study was to detect the changes in the vasomotor responses in the skin 
vasculature using PPG and attempt to analyse the role of PPG in early 
diagnosis of the diabetic neuropathy. Conducting simultaneously standard 
tests for the assessment of diabetic neuropathy and comparing the two
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achieved the latter part of the aim. Here due to the variability in the PPG 
signal amplitude even among the healthy individuals, the results were 
regarded as abnormal only under total absence of the signal. In this study, 
patients with abnormal PPG signals were found to have at least one abnormal 
cardiovascular assessment test. Since the DC component of the PPG signal 
represented the volume content, a sudden change in the blood volume 
caused due to a sudden inspiratory gasp, or ice water immersion, was clearly 
exhibited by the PPG signal. PPG was chosen for the study due to its 
operational simplicity and cost effectiveness (Barron et al. 1993). This study 
was of particular interest because of the similarities in the aim of this group 
and my research project. They conducted this study to assess the potential 
role of PPG in the evaluation of diabetic sympathetic neuropathy. They too 
tried to analyse the results by having a three-way comparison between 
healthy controls, diabetics with no neuropathy and diabetics with known 
autonomic dysfunction. The healthy controls and the diabetics with no 
autonomic dysfunction were assessed for both autonomic and somatosensory 
function. Barron et al, 1993 in their study however used a transmission PPG 
and the site of interest was the index finger. Besides, they only performed 
visual analyses of the signal looking into the amplitude variability as 
responses to several external stimuli. In my study the analysis of the PPG 
signal was to include both visual and spectral analysis and this is where the 
next study reviewed was hugely relevant.
This study by Bernardi, et al the autonomic control of the microcirculation was 
closely assessed using the power spectrum of the photoplethysmographic 
signals. Several factors of both local and central origin were found to control
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the PPG signal from the skin microcirculation giving it a chaotic appearance. 
These frequency components were analysed using spectral analysis. An 
infrared photoplethysmographic probe was used for the purpose. Apart from 
the PPG signal, the ECG, respiration and the blood pressure were also 
recorded for a 4min period in supine and in active standing positions. Detailed 
analysis of the power spectrum of these signals revealed the LF components 
around 0.1 Hz to be common through out. Besides, the spectra of the blood 
pressure oscillations as well as the PPG signal were found to be similar in 
normal individuals with similar directional and proportional changes with 
sympathetic activation observed in both these signals. This suggested the 
possibility of further analyses of these frequency components for the study of 
autonomic regulation of skin microcirculation (Bernardi et al 1996). This group 
studied the PPG fluctuations obtained from multiple sites of the body from 
both healthy controls and patients admitted to the intensive care who required 
the monitoring of arterial blood pressure by the catheterisation of the radial 
artery. The aim and the study protocol in their study were very different from 
what I had set out to do. However the detailed discussion provided useful 
information regarding the spectral analysis of PPG signal, the wealth of 
information that can be obtained from them and stressed on the importance of 
assessing the reproducibility of PPG signals obtained from multiple sites. The 
latter was of particular importance as PPG signals from both the left and right 
feet were used in my study.
In another study conducted by Nitzan and his team, they looked into the 
possibility of using the variability of the PPG signal as a potential method for 
the evaluation of the autonomic function. Here for each PPG pulse three
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components were identified namely a) the pulse baseline, b) its amplitude and 
c) Its period corresponding to one heart beat. The signal variability for each of 
these parameters were noted and was found to be adequately reduced for 
diabetic patients as compared to the healthy individuals and hence could be 
identified as an index of autonomic function among the individuals (Nitzan et 
al 1998). Nitzan et al, 1998 did not perform any spectral analysis on their PPG 
signals obtained from both healthy controls and diabetic patients, instead they 
performed a detail visual analysis of the signals from the two groups. Their 
analysis indicated certain features of the raw PPG signals that could be 
potential markers of autonomic activity and this information was useful during 
the visual analysis of the raw PPG signals obtained in my study.
Another paper that was repeatedly cited in this study is a review article by 
Kamal et al, 1989. This review article discussed a wide range of topics on 
PPG. The topics included discussion on the different skin blood flow 
measurement techniques available, introduction to skin PPG, basic 
construction of PPG, detailed discussion on the PPG signal and finally the up 
to date information on the applications of PPG. The spectral components of 
the PPG signal were explained in great detail and the different frequencies in 
the spectrum were matched with various physiological process of the body. 
This was important information for the better understanding of the PPG 
signals collected and analysed in this study. They suggested that the very LF 
components of the spectrum are a direct effect of the sympathetic control on 
the pre capillary sphincter itself. These very LF components represented 
physiological activities like breathing, blood pressure regulation also called the
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Traub-Hering-Meyer wave (THM) and temperature regulation (Burton waves) 
and these could be represented as markers of the autonomic activity of the 
body(Kamal et al 1989) . Another more recent review article by (Allen 2007) 
on PPG was also reviewed for this study. Although both the review articles 
discussed similar topics, greater emphasis was given to the applications of 
PPG in this paper.
The literature review done so far provided vital information regarding the 
pathogenesis of DAN, vasomotion and its pathophysiological role and finally 
regarding studies that have used PPG to evaluate autonomic changes due to 
diabetes. In this project we aim to use PPG and study the signal responses 
obtained from the sole of the feet of both healthy and diabetic patients with 
and without any known neuropathy.
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Chapter III
Signal Analysis Method
3.1 Introduction
The PPG signals collected from the participants of all three groups was post­
processed using the mathematical and technical computing software, 
MATLAB®. FFT, Complex Demodulation (CDM), Digital Filtering along with 
various graphical techniques were used for the purpose. The results obtained 
were also statistically analysed. This chapter explains in detail the various 
methods used to process and analyse the raw PPG signal.
3.2 Fast Fourier Transform
The word transform in mathematics means a method to convert one form of 
data set to another form of data set (Smith 1997). The Fourier Transform is a 
mathematical technique based on the principle of decomposing a periodic 
signal into a number of sinusoidal components of suitable amplitude, 
frequency and phase (Lynn 1993). Here the input signal in its time domain is 
converted into amplitudes of the component sine and cosine waveforms also 
known as the frequency domain of the signal. Biological signals such as the 
raw PPG signals are mainly periodic in nature and are almost in all cases 
sampled at a fixed rate by the investigating device to produce a discrete data. 
The Fourier Transform of discrete periodic signals such as the PPG signals
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obtained in this study is termed Discrete Fourier Transforms (DFT) (Smith 
1997).
The FFT is a complex algorithm developed to calculate the DFT of a time 
domain signal efficiently and at least 100 times faster than by solving 
simultaneous equations or by correlation (Smith 1997). This algorithm was 
based on the principle of complex DFT where the time domain signal was also 
composed of two parts (N points each) viz the real part and the imaginary 
part. The actual data was however present only in the real part of the signal 
while the imaginary part was padded with zeros. FFT converted these two 
parts of the time domain signal into N point real and imaginary frequency 
domain signals. These N sinusoidal waves of unit amplitude of the DFT are 
termed the basis functions. Each of these basis functions are scaled 
according to its contribution in the input signal such that these can add up to 
form the original input signal. Though each part constituted of N points, only 
the first half of the data points (0 -  N/2) for both the real and imaginary parts 
contained the relevant frequency domain information (Smith 1997).
The FFT algorithm, though very complex, could be broken down into three 
main stages. In the first stage the N point time domain signal was 
decomposed into N time domain signals each composed of a single point. 
This decomposition occurred in stages where at each instance the signal was 
separated into its even and odd numbered samples. The number of stages 
required to completely decompose a N point time domain signal into N time 
domain signals was given by log2 N, where N is the length of the raw data.
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The second stage involved calculating the frequency spectra for each of the N 
time domain signals. Finally the N frequency domain spectra calculated were 
summarised by a complex process to obtain an N point frequency spectrum. 
This algorithm was also repeated for the imaginary part of the time domain 
signal. Though both parts were calculated simultaneously, for practical 
purposes only the real FFT was used to process the raw PPG signals in this 
study (Smith 1997).
3.2.1 MATLAB implementation of the FFT
In MATLAB the DFT of a time domain signal is calculated using the ‘fft’ 
function. The practical use of this function can be explained using a simple 
example that has been illustrated in figure 3.1. A random signal of 1000 
samples with a sampling rate of 1 kHz was generated using MATLAB and this 
was mixed with two sinusoidal waves of 30 Hz and 100 Hz. As per the 
Nyquist-Shannon sampling theorem the maximum frequency that could 
possibly be detected using FFT on this signal was 500 Hz. The time domain 
signal generated was subjected to DFT using the fft function in MATLAB.
The time domain signal as shown in Figure 3.1a does not reveal any 
information regarding the two sine waves present within the raw signal. 
However the fft of the same produced amplitudes of the two component sine 
waves at 30 Hz and 100 Hz respectively within the random signal spectrum 
(Fig 3.1b) there by providing valuable frequency information of the raw signal 
which otherwise could not be obtained from the analysis of the signal in its 
time domain.
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As explained earlier, the FFT of an N point signal though results in an N point 
frequency spectrum, all the information is present in the first half of the signal. 
The other half is the exact mirror image of the actual frequency spectrum as 
shown in the figure 3.1 (b).
The x-axis of the Fourier spectrum as shown in the figure 3.2 can be 
represented in different ways. It could be expressed as the number of data 
points in the spectrum as shown in image (b). Here the x-axis has been 
labelled from 0 to 1000 samples corresponding to the total length of the 
Fourier spectrum. Each point on the x-axis represents the nth sample of the 
signal of length N. The x-axis could also be represented as frequencies as 
shown in figure 3.2(c).
According to the Shannon sampling theorem, the sampling rate of the signal 
should be at least twice the maximum frequency to be detected in order to 
avoid aliasing effects on the signal. This maximum frequency that can be 
detected is also known as the Nyqyst frequency and is calculated as half of 
the sampling rate of the signal. In the given example the signal was sampled 
at a sampling rate of 1 kHz and hence the range of frequencies that could be 
detected without any aliasing was from 0 Hz to 500 Hz. In such representation 
each data point along the x-axis was represented as a fraction of the Nyqyst 
frequency. Thus frequencies at any particular sample say ‘n’ could be 
calculated as per equation 3.1.
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f n = ( n / N ) x  f s Equation: 3.1
Where
f n = Frequency at the nth sample 
N = Length of the Spectrum 
f s = Sampling rate of the raw signal
This kind of representation of the x-axis was more in real time and convenient 
to identify the frequency components present within the spectrum of the signal 
and therefore was used through out this study. The frequency unit used in this 
study was Hz. The y -axis represented the amplitude of the component 
sinusoids present within the spectrum and was expressed in absolute units.
A raw PPG signal is a typical example of a biomedical signal with a plethora 
of information contained in it. An example of a raw PPG signal collected for 10 
minutes is illustrated in figure 3.2 (a). The segments of the raw PPG signal 
corresponding to the two stress tests of two minutes each have also been 
marked in the figure. Decreased amplitude of the PPG signal indicated 
increased blood flow under the probe and vice versa. In the example provided 
an increase in the blood flow (decreased amplitude) during the two stress 
tests was observed. However no information regarding the frequency 
characteristics of the signal could be obtained from the raw signal. An FFT on 
the signal however produced several frequency peaks in its spectrum. 
Spectral activity was observed at both the HF and the LF end of the spectrum. 
The three major frequency bands present in the spectrum have been 
illustrated in figure 3.2(b).
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3.3 Complex demodulation
The raw PPG signal obtained in this study was a measure of the 
instantaneous blood volume changes in the skin microcirculation in response 
to the local and central stimuli. The central stimuli at the microcirculatory level 
were more autonomic in nature while the local stimuli were myogenic, 
hormonal or chemical in origin. These stimuli manifest themselves as rhythmic 
variations of the microcirculation. These variations were extracted and 
analysed from the raw signal through spectral analysis. These rhythmic 
variations were a dynamic entity, constantly changing with time. The raw PPG 
signal in this study was collected over ten minutes. Information on the 
variation of a particular frequency over the whole ten minutes could not be 
ascertained using spectral analysis; therefore another signal processing 
method called CDM was used for the purpose.
The CDM of a signal provides information regarding the changes in the 
amplitude and phase of a particular frequency component of the signal as a 
function of time. This method was first used in physiological signal analysis by 
Shin et al to examine the HR variability in dogs (Kim and Euler 1997). CDM 
was subsequently used in several studies to analyse the HR variability and 
the autonomic function in both animals and humans. CDM is a non-linear time 
domain analysis capable of providing information regarding the dynamic 
amplitude and phase changes of a particular frequency as function of time 
(Kim and Euler 1997).
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3.3.1 Principle of CDM
CDM can be explained in three simple stages. Once the frequency of interest 
was established in a signal, the spectrum of the signal was shifted to the zero 
frequency end of the spectrum. This was achieved by multiplying the original 
signal with its complex sinusoid centred on the chosen frequency. In the next 
stage the resultant complex signal was low pass filtered to obtain only those 
frequency components centred on and around zero. Finally the real and the 
imaginary parts of the filtered complex signal was converted to the polar form 
to obtain the amplitude and phase information of the signal centred on the 
chosen frequency as a function of time. These steps can also be illustrated 
through the following set of equations.
Let us consider a time domain signal x,of a particular frequencyX, 
amplitude ^ , phase cpt and a constant DC component ofz,. Such a signal can 
be expressed as
xt = At cos(>fo + cpt ) + zt Equation: 3.2
The aim of CDM was to obtain the changes of At and cpt as a function of time. 
The complex equivalent of equation 3.3 can also be written as:
X, = \ l 2 A t { e ^ * t +  (pt^  + e (~ 1^  +  + z{ Equation: 3.3
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The first step of CDM involved shifting the time domain signal of a particular 
frequency of interest to the zero frequency by multiplying the signal with its 
complex sinusoid centred on the chosen frequency. Let the new complex 
signal generated be y, .
yt = 2 x xt x Equation: 3.4
This can be further expanded as
yt = 2 x \ / 2 A t ]) + ] ) }e~iXt + 2x  zte~m  Equation: 3.5
y t = At x e(iAj+,v,‘ ) x e~iM + A, x x e~iXt + 2  x zt x e~iM
Equation: 3.6
y t = Atei(f>t + Ate ^ ~ ^ t+i<Pt^  + 2zre-7^  Equation: 3.7
The resultant complex signal that had all its frequencies shifted by-X  
contains three components. The first term does not contain any frequency 
component and is centred on the zero frequency. The second term oscillates 
at a frequency of 2A while the third DC term was assumed not to have 
frequencies centred on the zero frequency. CDM not only shifts the region of 
interest but also all the other frequency components present within the signal 
b y - X . Thus all the frequency components with the original frequency above 
A (the second term) do not reach the zero frequency and those below X , such
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as the DC component move to the negative part of the frequency axis. Thus 
the last two terms of the complex signal do not appear to oscillate with 
frequencies centred on zero frequency.
The second stage of CDM involved passing this complex signal through a low 
pass filter with a cut-off frequency around the zero frequency. Such a filter 
would only allow those frequency components with very low frequencies 
centred on zero frequency such as the first term of the complex signal to pass 
while eliminating the second and the third term of the complex signal. Let the 
filtered complex signal be yt which can be expressed as equation 3.9.
yt = At xe (i(Pt) Equation: 3.8
The last stage involves obtaining the amplitude and the phase information 
from equation 3.9 using equations 3.10 and 3.11.
At=\yt \ Equation: 3.9
(pt -  tan \imaginary(h) /  real(h)] 
Where h = yt f\yt \ Equation: 3.10
Thus by altering the desired frequency component of interest, most frequency 
components within the raw time domain signal were analysed. The cut-off 
frequency used for the low pass filter helped to identify the bandwidth of
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frequencies that needed to be analysed and this could vary with every 
application and study requirements. The ability of the CDM to distinguish 
between adjacent frequencies depended on the performance of the low pass 
filter. Increasing the order of the filter at the cost of lost data points could 
enhance filter performance (Hayano et al 1993), (Hayano et al 1994).
3.3.2. Application of CDM in this study
The spectral analysis of the signal revealed several frequency bands of 
interest. Each of these frequency bands were analysed separately in this 
study. Further analysis of the very HF band of 1-2 Hz (60-120 cpm) required 
the extraction of the beat-by-beat HR of the individual. The HR extraction 
program was written using MATLAB and was made up of several stages. The 
spectral analysis of the raw PPG signal revealed the frequency location of the 
very HF bandwidth within its spectrum that was associated with the 
individual’s heart rate. Once this band of frequencies were identified within the 
spectrum, it was essential to characterise its dynamic changes with time. This 
information was extracted using CDM. CDM was used to extract the 
amplitude and phase changes of the signal centred on the chosen frequency 
(between 1-2 Hz) calculated in the previous step. The complex demodulated 
signal was then subjected to a zero crossing detector to identify the time of 
the occurrence of the peaks and thereby help in the beat-by-beat extraction of 
the individual’s heart rate.
CDM was performed using MATLAB. The central frequency of interest i.e. the 
mean HR of the individual was calculated from the previous step. The raw
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PPG signal was multiplied by a complex sinusoid with a frequency centred on 
the mean heart rate. This complex signal was then subjected to a 5th order 
Butterworth filter with a cut off frequency of 0.33 Hz (20 cpm) using a ‘filtfilt’ 
function in MATLAB. Thus if the individuals mean HR was calculated to be 
1.33 Hz (80 cpm), then the desired bandwidth of frequency ranged from 1 Hz 
(60 cpm) to 1.66 Hz (100 cpm).
The amplitude of the filtered signal was obtained by calculating the magnitude 
of the complex signal while the phase information was obtained using the 
MATLAB function called angle. This function returned the phase angles of 
every element of the complex signal in radians and had a value of ± n . The 
complex demodulated signal X, was then generated by combining the 
amplitude and phase information, just calculated using equation 3.11.
X t = Amplitude x sin(\centerfrequency x time} + phase) Equation: 3.11
The complex demodulated signal thus calculated gave insight into the 
dynamic changes of the amplitude and phase of the signal with a central 
frequency of the mean HR with time. A zero crossing detector principle was 
used to detect the number and location of the peaks of the complex 
demodulated signal as it occurred in the time domain. A zero crossing 
detector detected the transition of the signal from positive to negative value 
and each such transition points represented a peak in the complex 
demodulated signal as shown in figure 3.3. Each of these transition points 
along the time axis also represented the time of occurrence of a single heart
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beat. Thus CDM was successfully used to extract the beat-by-beat HR trace 
of the individual from the raw PPG signal.
CDM of a raw PPG signal with a central frequency of the mean heart rate
Point of interest for the zero crossing 
detection program
1 1.05 1.1 1.15 1.2 1.25 1.3 1.35 1.4 1.45 1.5
time in mins
Figure 3.3: CDM  of a high pass filte red  raw  PPG signal w ith  a central frequency of
1.3 Hz (77 cpm ).
3.4 Digital Filters
Filters are essential tools in signal processing used in either separating the 
signals or restoring them. Most of this study involved separating and 
analysing several frequency bands within the raw PPG signal. The frequency 
domain filters were used under such circumstances to separate the different 
frequency bands present within the signal (Smith 1997). The frequency 
response of such a filter consisted of a pass band region that allowed
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frequencies to pass through it unaltered and a stop band region that stopped 
the frequencies from passing through itself.
Ideally the transition from the stop band to the pass band should only consist 
of a single frequency but in reality was represented by a bandwidth of 
frequencies. The roll off was a measure of this transition of the frequency 
response between the stop band and pass band. The presence of ripples in 
the pass band could cause signal distortion. The final criterion that determines 
the filter characteristics was its ability to block the frequencies completely in 
its stop band and is measured by the stop band attenuation. Thus, to 
summarise a good frequency domain filter must have a fast roll-off, no ripples 
in the pass band and good stop band attenuation. Figure 3.4 illustrates a 
typical frequency response of a band-pass Butterworth filter with an upper and 
lower cut-off frequency at 8.4 kHz and 13.2 kHz respectively.
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Frequency Response - band-pass Butterworth filter
Frequency (kHz): 8.44043 
lower cut off
Frequency (kHz): 13.24512 
upper cut offno ripples
-20
pass band
stop bandstop band
*  -60
-80
Filter order: 4
Sampling frequency: 48 kHz
-100 -
-120
-140
-160
Frequency (kHz)
Figure 3.4: The frequ en cy dom ain  p roperties  o f a 4 th order band-pass B utterw orth  filter 
w ith an upper and low er cu t o ff frequ en c ies  at 8.4 kH z and 13.2 kHz respectively . The  
stop band region o f the  filte r lies on e ith e r s ide o f the cu t-o ff frequencies.
The primary requirement of the study was a digital filter that was simple, fast 
with excellent frequency domain characteristics. Though a window sine filter 
(FIR filter) had excellent frequency response, it could be implemented only in 
a large number of stages and hence was slow in its execution. Thus an HR 
filter with moderate frequency domain characteristics but excellent execution 
speed was used. Throughout this study the frequency domain HR filter used 
was called the Butterworth filter. The HR filters can be a low pass, high pass, 
band pass or a band stop filter as per its function in the frequency domain 
analysis. All the other filter kernels can be mathematically derived from the 
low pass filter kernel that provides the base for digital filter design.
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3.4.1 L P Butterworth Filter and its MATLAB implementation:
Both Chebyshev and Butterworth filters are examples of the frequency 
domain MR filters. Like any other frequency domain filters, these were also 
characterised by parameters such as their pass band ripple, stop band 
attenuation and their roll off time. A Chebyshev filter with its ripple set to 0% is 
called the Butterworth filter (Smith 1997). With a pass band set to maximally 
flat and a monotonic stop band, this digital filter filtered the signal with 
practically no distortion. In this study distortion to the raw signal was not 
desirable and hence a Butterworth filter was used in spite of its slow roll-off. 
These filters were implemented using the signal processing toolbox of 
MATLAB.
In MATLAB the Butterworth filter was implemented using the ‘butter’ and 
Tiltfilf functions. Most digital filters were generated from their analog 
counterpart and a suitable transformation algorithm was used to transform the 
analog filter output into its digital form (Lynn 1993). In MATLAB, three 
parameters were usually specified to design a filter viz, the desired cut-off 
ratio, the order of the filter and the type of filter (low, high, band pass or band 
stop filter) required. The cut-off frequency of the filter required was expressed 
as a fraction of the Nyquist frequency of the signal to be filtered. Thus if a low 
pass filter with a cut off frequency of 50Hz was designed to filter a signal 
being sampled at 1kHz then the cut-off frequency was specified as a ratio of 
50/500 i.e. 0.1.
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In MATLAB a five step algorithm called the called the bilinear transformation 
method was used to convert an nth order analog filter with n s-planes to a 
digital HR filter with n z plane poles and n z plane zeros (© 1994-2005 The 
MathWorks, Inc). The order, the cut-off ratio and the type of the filter required 
were specified and this transformation was carried out using the ‘butter’ 
function. This step generated a set of recursion co-efficients for the specified 
filter design. The signal was then filtered using the ‘filtfilt’ function using these 
co-efficients. Figure 3.5 is an example of a 9th order low pass Butterworth filter 
with a cut off frequency of 50 kHz and a sampling frequency of 48 kHz 
generated using MATLAB.
Frequency response of low pass Butterworth filter
100
-100
stop band
-200
-400
Filter order: 9
-600
Sampling frequency: 48 kHzh  Cutoff frequency of 6 kHz
-600
-700
-800
Frequency (kHz)
Figure 3.7: The frequ en cy response o f a low  pass B utterw orth  filter w ith a cu t-o ff 
frequency o f 5 kH z and filte r o rd er o f 9 generated  using M ATLAB
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The phase response of an MR filter was mostly non-linear. This was because 
in the design of MR filters only the recursion co-efficients were specified and 
hence in almost all cases the impulse response thus produced were 
asymmetrical. In digital signal processing this short fall of the IIR filter was 
compensated by a method called bi-directional filtering. This process involved 
filtering the raw signal in one direction say from sample 0 to the end of the 
signal. Then this filtered signal was further subjected to the filter kernel in the 
opposite direction i.e. from the last sample to the first sample. In performing 
such bi-directional filtering all IIR filters were converted into a zero phase filter. 
In MATLAB such bi-directional filtering was achieved by simply using the 
‘filtfilt’ function instead of the ‘filt’ function while implementing such IIR filters 
(© 1994-2005 The MathWorks, Inc).
3.4.2 The 'window’ Function and its MATLAB implementation
Fourier Transforms were performed with a basic assumption that the signals 
being analysed were repetitive and of infinite length. In reality almost all 
physiological signals collected are discrete. The FFT on such signals, with 
distinct discontinuities at the start and the finish, produced a very broad 
frequency spectrum that was termed spectral leakage. For example the 
Fourier transform of a pure sine wave should be a single line in the spectrum. 
However in reality, the spectral line was broadened. Thus, instead of the 
signal energy to be concentrated only on one frequency it was spread out to 
the neighbouring frequencies as well. The spectral leakage resulted from the 
abrupt discontinuities of the signal ends. If these discontinuities were made to 
be gradual rather than abrupt, the spectral broadening could be significantly
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reduced. Spectral leakage does not arise because of the finite length of the 
FFT; instead it arises due to the finite length of the measurement time (Lynn 
1993; Smith 1997). The spectral leakage could mask frequencies of interest 
during signal analysis and hence was not a desirable parameter.
The raw PPG signal analysed in this study were also discontinuous signals of 
a finite length. These signals do not gradually become zero but come to an 
abrupt end after a finite length of time. The resulting spectral broadening was 
minimised using a window function. This was a special function that had a 
range of values within a certain period of time but was zero outside this 
period. Multiplying the raw signal with a suitable window in the time domain 
was equivalent to convolving the two in its frequency domain. Multiplying the 
signal with a suitable window that had gradual tapering ends ensured a 
smooth fall in value of the signal at its ends there by terminating the truncating 
problems of the signal (Lynn 1993). Gaussian, Blackman, Bartlett, Hamming, 
Hanning, etc are some of the popular window functions used in signal 
processing analysis and each of these windows can be represented using a 
set of equations. The window function used in this study was a Hanning 
window also known as a raised cosine bell function (Lynn 1993). Such a 
window can be defined using equation 3.12. Figure 3.6 is an example of a 100 
point Hanning window generated using MATLAB function ‘win’. The length 
and the name of the window required were specified when using this function.
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wn = 0.5 + 0.5cos(«;r/A0, for -  N  < n < + N
= 0 elsewhere Equation: 3.12
A l^ 00 -point 
Hanning Windgyv
20
Time domain Frequency domain
0.8
-20
-400.6
-60
0.4 -80Tapering ends
-100
0.2
-120
-140
0 0.2 0.4 0.6 0.8
Normalized Frequency (x7i rad/sample)
60
Samples
80 10020 40
Figure 3.6: The tim e and frequ en cy dom ain  o f a 100-po in t H anning w indow . Note the  
bell shaped cure  in the tim e  dom ain  w ith  g rad ua lly  tapering  ends that are very useful in 
reducing th e  spectra l leakage during  signal processing .
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3.5 Statistical Analysis
Statistics forms a vital research tool used to describe the data, design studies 
and test various relationships between variables. It also helps to extend the 
inferences from the results of smaller studies to the larger population. 
Statistics contribute to the various stages of the study from its design to the 
interpretation of the results. In the study design stage the power of the study 
and the population size to be used was calculated using statistical methods. 
This will be discussed in detail in Chapter IV. Most of the statistical analysis 
was carried out using the statistical analysis software called SPSS and Excel. 
In the next few sections the different statistical methods used to analyse and 
interpret the results of this study will be discussed.
Study Design
A good study design is essential for sound statistical analysis of the data. 
Study designs can be classified into different types which include cohort 
study, longitudinal study, case control study, etc. Though the data in this study 
was collected from participants of all the three groups, most significant 
comparisons were performed on variables of interest calculated from Group II 
and III. This study has been loosely based on the case control type of study 
design. The participants of Group II were diabetic patients with no known 
diagnosis of neuropathy. They therefore represented the ‘control’ group 
without the disease of interest, which was neuropathy while the participants of 
Group III were the ‘cases’ with known neuropathy. When comparisons were 
made between Groups I and II or between Groups I and III, participants from
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Group I formed the control group while Groups II and III formed the ‘cases’ for 
the study.
Bland Altman Plot
Both tabulation and graphical representations were used to present the data 
analysed and observed in this study. The Bland Altman plot was one such 
graphical representation that was widely used. Two statisticians, J. M. Bland 
and D.G. Altman developed this plot to compare the same variable obtained 
from two different measurement techniques. In this study the Bland Altman 
was used to measure the degree of agreement between the left and the right 
beat-by-beat heart rate. The plot first calculated the mean difference in the 
two variables and its standard deviation. The mean ± 2 SD limits were also 
calculated. Then the differences in the beat-by-beat HR trace from both legs 
were plotted against the mean difference and the limits. In case of good 
agreement between the two variables, 95% of these differences should lie 
within the agreement limits calculated previously. Wider limits with a large 
spread in the difference values indicate poor agreement between the two 
variables (Bland and Altman 2003).
Parametric Test
The selection of a suitable statistical test for analysing a given set of data 
depends on several assumptions and the nature of the data set itself. Factors 
such as the type of the data, its distribution, the null hypothesis selected, etc 
were considered prior to selection of a suitable test. Both parametric and non-
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parametric tests have been used in this study. These tests were used to 
compare the inter-group relation of the variables being analysed.
In this study the mean spectral density for a bandwidth of 0.33-0.13 Hz (2- 
8cpm) calculated for each participant across the three groups were compared 
using a parametric test. Parametric tests are based on three main 
assumptions i.e. the data set to be analysed must follow a normal distribution, 
secondly the groups to be compared must be independent of each other and 
lastly they should have equal variances. The one way ANOVA (analysis of 
variance) was a preferred statistical test when the means from more than two 
groups were compared using a parametric method. This test was also less 
stringent about the assumptions made on the data set prior to the analysis 
(Riffenburgh 2006).
One-way ANOVA is a two-part test. The test can be explained through the 
following steps
1. The first part of the test was to verify the null hypothesis
2. The difference of each observed value (k) from the overall group mean 
(m) was calculated, squared and the ‘sum of squares within groups' 
was calculated for each group as shown in equation 3.13
Sum o f  squares (k - m )2 Equation 3.13
3. The ‘sum of squares between groups' was calculated using 
equation 3.14 where m was the individual group mean and n^ was the 
overall mean for all three groups
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Sum o f squares between groups -  Z (*" -/Wj)2 Equation 3.14
4. The sum of squares calculated for both within groups and between 
groups was converted to a known variance by dividing them by their 
respective degrees of freedom and this was called the ‘ mean 
squares' value.
5. The ratio of the mean square value within groups and the mean square 
value between group was calculated and was called the F distribution
F = mean square value between groups 
mean square value within groups
6. Ideally the value of F should be 1 and this value would be indicative of
equal variance between the three groups being compared
7. The p value denotes the significance of the test. A value of less than 
0.05 was said to be statistically significant
8. If the first result was found to be statistically significant, the null 
hypothesis was rejected
9. The second part of the ANOVA analysed these differences between 
the groups further
10. In this part multiple comparisons were made between the group means 
using two main tests viz; the Tukey HSD (honestly significant 
difference) and the Fisher LSD ( least significant difference)
11. These two tests compared the mean values obtained from each group, 
a pair at a time
12. A very small p value in each case indicated unequal mean for the pair 
being compared
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Thus the one way ANOVA not only gave us the overall relation between the 
mean spectral densities obtained from the three independent groups but also 
the relation of the variable of interest between the groups
Non -  Parametric Test
The data set that does not follow any specific distribution cannot be compared 
using the parametric methods; rather they were compared using non- 
parametric tests. In this method parameters such as medians and ranks were 
used for the comparison (Altman 1992). Non parametric methods are free of 
assumptions and hence more appropriate for hypothesis testing rather than 
directly comparing the medians (Altman 1992).
Different tests were applied depending on the number of groups being 
compared. When two, independent, continuous data sets with a non -  normal 
distribution were to be compared, the Mann-Whitney test was the preferred 
method of comparison. This is the non-parametric equivalent of a simple t- 
test (parametric method). The Mann -  Whitney test ranks the observations 
from both groups in a particular order before analysing them. It involves the 
calculation of two test statistics viz the Wilcoxon T statistic and the Mann- 
Whitney U statistic. While the T statistic was the sum of the ranks obtained 
from the smaller of the two groups, the U statistic was calculated using 
equation 3.15, where ni and r\2 were the number of observation in both 
groups. The SPSS package calculated the probability value along with the U 
and Z statistics. A very low p value indicated a statistically significant result.
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U = n\ri2 +1 /2  n\(n\ + l ) —T Equation 3.15
The Kruskal- Wallis test was used when three or more independent, 
continuous data sets that do not follow the basic assumptions of parametric 
testing were compared. They are the non-parametric equivalent of the one­
way ANOVA method. Once again the test required all the observations across 
all three groups to be ranked. The SPSS package calculated the mean rank 
for each group, the x 2 value, the degrees of freedom and the corresponding 
probability value for this test. A very low p only indicates that the median for 
the different groups being compared were significantly different. Further inter 
group relation could not be obtained using this test.
The raw PPG signals collected in this study were analysed using methods 
detailed in this chapter. The results of the study and the subsequent 
discussion are discussed in chapters V and VI.
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Chapter IV
Materials and Methods
4.1 Introduction
As mentioned earlier in chapter 1, prevention remains the best method to 
avoid the debilitating effects of the diabetic foot ulcers. It has been estimated 
that up to 80% of the diabetic foot ulcers can be prevented with a proper 
screening programme involving regular visual and clinical examination of the 
foot and the neurological and vascular assessment of the ‘at risk ‘ diabetic 
patients (DeFronzo et al 2004). Changes in the microvascular blood flow 
under pathological conditions are a well-recorded fact and could potentially be 
linked to conditions like diabetes.
Till date PPG has been successfully used in various vascular assessments 
under clinical settings. The primary objective of this research project was to 
identify if a simple optical device such as the digital PPG was able to detect 
the changes in the skin microcirculation in diabetics with sympathetic 
denervation. Secondary objective was to further investigate if these changes 
in the skin microcirculation could be detected in the early stages of diabetes 
before clinical diagnosis of diabetic neuropathy. The answers to these 
objectives could help to develop a simple, cost effective screening method to 
identify those diabetic patients at risk of developing diabetic foot ulcers of
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neuro-ischaemic nature. In this chapter the study protocol, the equipments 
used and the preparatory work done have been discussed in detail.
4.2 The Vascular PPG Assist
The DPPG device used in this study was the Huntleigh Vascular Assist® as 
shown in figure 4.2. It is a simple portable device with a docking station. The 
docking station is used for recharging purposes and contains ports to connect 
to the computer and the printer. Huntleigh Vascular Assist comes with a dual 
PPG probe that can be used to measure the skin blood flow at any two places 
simultaneously. These circular probes have an IR emitter and a photodetector 
built in a reflection mode configuration. The probes are attached to the skin at 
the site of investigation with help of a double-sided adhesive tape as shown in 
figure 4.1.
DPPG probe Probe positioning on participants
f
r
LED and
photo- I  (
detector 1  '
\
Figure 4.1: The D PPG  probe from  the V ascu lar A ssist and it’s position ing  on the
partic ipants
84
The LED emits IR light of wavelength of 940 nm that undergoes absorption, 
refraction, attenuation and reflection as it passes through the various layers of 
the skin. The skin blood volume under the probe influences the amount of 
light received by the detector. The analog output generated by the 
photodetector is digitised by the analog to digital converter where the signal is 
sampled at 6.25 Hz. The digitised PPG signal is displayed on the screen in 
real time as shown in figure 4.2c. The digitised data can be stored on the hard 
drive inbuilt in the Assist. The system is also provided with a card reader to 
store the digital data on an external storage device such as a personal 
computer (PC) card. The data from the PC card can be transferred to other 
external sources like a computer for further analysis of the PPG signal.
Figure 4.2: a) H untle igh  V a s c u la r A ss is t®  on a docking station; b) Left and right PPG  
probes; c) A ss is t record ing  screen - raw  PPG signal during data collection
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4.3 Experiment Design
The ethical approval of the study was obtained from the South East Wales 
Research Ethics Committee. As per the research ethics committee rules, a 
detailed study protocol along with the participant information sheet and the 
consent form to be used in the study was submitted with the application. The 
sample size required for the study was also calculated. The sample size is a 
measure of the number of measurements to be taken for obtaining statistically 
significant result. The factors effecting the sample size calculation include the 
effect size, the confidence level or the study error and the desired power for 
the study.
4.3.1 Sample size calculation
Only limited studies looked at the evaluation of the autonomic function using 
PPG. Those relevant to my project have been reviewed in detail in Chapter II. 
Among the papers reviewed, the study by Nitzan et al, 1998 titled "The 
variability of the photoplethysmographic signal - a potential method for the 
evaluation of the autonomic nervous system was referenced to calculate the 
sample size for this study. Visual analysis of the raw PPG signal obtained 
from the different groups was intended to be one of the main methods of 
analysis to be used in my study. The study by Nitzan et al 1998 also analysed 
certain physical parameters of the raw PPG signal while comparing between 
the groups and hence was chosen to be referenced for the sample size 
calculation. In their study, Nitzan et al 1998 analysed the variations in the 
baseline, amplitude and the period of the raw PPG signal. The intensity of the
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spontaneous fluctuations for these parameters were assessed by the relative 
standard deviation i.e. the standard deviation of the parameter divided by its 
mean (Nitzan et al. 1998). The results indicated the relative standard 
deviation of the amplitude to be 11.26 in the non-diabetic group, and much 
lower at 7.12 in the diabetic group. These values provided the expected effect 
size required for the two groups for the sample size calculation. The power of 
the study was set to 80%, and the significance level of the study was also set 
to 5%. A mean standard deviation of the amplitude of the PPG signal of 11.26 
% was set as the expected effect size for the normal population and 7.12% for 
the diabetic population. The sample size was calculated using a sample size 
calculator and the minimum sample size required for a statistically significant 
result was calculated to be 63. With the minimum sample size calculated as 
63 for a two-group study, the number of recruits in each group would be an 
average of 32 participants. However in this study the PPG signals from three 
groups were to be analysed. In order to compensate for converting from a 
two-sample study to a three-sample study, the strength of the third group was 
made similar to the other two groups. Considering the potential for participant 
dropouts, difference in the two studies and three groups of participants to be 
recruited rather than two, a total sample size of 105 was decided for this 
study.
4.3.2 Participant Recruitment
As per the sample size calculation participants were recruited for three distinct 
groups viz, Group I with 35 healthy individuals with no evidence of diabetes or 
any familial history of the disease, Group II constituting of 35 diabetics with no
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evidence of neuropathy and Group III of 35 diabetics with confirmed diagnosis 
of one or more types of neuropathy (primarily sensory neuropathy).
The participants for Group I were mainly recruited from amongst the staff 
members at the department of Medical Physics and Clinical Engineering, 
University Hospital Wales due to the likelihood of some level of flexibility to 
allow attendance to the hospital during normal working hours. An email was 
sent to all staff members in the department detailing the purpose and aims of 
the study and an appointment was then provisionally made with the interested 
candidates at least 7 days prior to the test date and was asked to confirm their 
participation nearer to their appointment date. They were also informed of the 
questionnaire regarding their general health that they would have to answer 
when they arrived for the experiment. The questionnaire was used to identify 
if any of the participants had a strong familial history of the disease or 
presented with undiagnosed diabetes and manifested some common 
symptoms of diabetes mellitus like; frequent thirst, frequent urination, 
tiredness, blurring of vision or sudden weight loss. Those with three or more 
of these symptoms were then excluded from the study. The participants that 
did not comply with the inclusion criteria set for the study were also excluded. 
In total 37 healthy individuals with no known diabetes were recruited and 
among them were 20 males and 17 females.
The participants for Group II were primarily recruited from the Diabetes 
Investigations Clinic at Llandough Hospital, Cardiff and they were diabetics 
with no known neuropathy. These patients were reviewed on a yearly basis by
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the Consultant diabetologist Prof David Owens and his team. During this 
review appointment their fasting blood glucose level, eyesight, blood pressure 
and sensory functions were tested and the records were updated yearly. They 
were approached on a one to one basis during one of their review 
appointment and the information sheets and consent forms were made 
available to the interested candidates. In order to avoid patient inconvenience 
of returning to the clinic on another day just to partake in the study and also to 
prevent the disruption of the normal working procedures and clogging up of 
the patients list of the diabetes clinic the patient were asked to decide on the 
same day. A total of 35 diabetics, 1 Type I and 34 Type II were recruited. 25 
of the participants were males and 10 were females.
The participants for group III were recruited from a list of diabetic patients who 
had previously participated in another study conducted by a diabetes 
specialist nurse based at Llandough Hospital, Cardiff three years prior to this 
project. Her study involved at identifying diabetics across Cardiff and Vale 
area that may be at risk of developing diabetic foot disease. The study 
involved looking at the general foot hygiene, general health of the patient and 
evaluating the sensory function of the foot using a biothesiometer. Those 
patients at risk of developing the foot disease were primarily identified using a 
biothesiometer reading of their vibration perception ability at the sole of their 
feet. Studies have indicated that patients with a VPT score of greater than 25 
V were at a greater risk of developing foot ulceration (Young et al 1994; 
Lavery et al 1998).
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Studies have also indicated the presence of sympathetic dysfunction along 
with sensory impairment (Eicke 2003; Lefrandt 2003). Due to funding 
difficulties and lack of resources the patients recruited for this group did not 
undergo the assessment of their autonomic function using the CAN tests. 
Neuropathy is an irreversible condition, where the structural and functional 
damage to the peripheral nerves cannot be reversed. Although the 
participants for Group III were selected from the patient population who were 
assessed for their sensory impairment three years prior to this study, it was 
assumed that the neuropathy would have only progressed or at the least be at 
the same level over the three year period. Therefore only those patients with a 
VPT score of around 25 V and greater were approached for this study by 
telephone. This way attempts were made to ensure that all participants of this 
group were patients with varying degree of sensory impairment. A brief 
overview of the aim and the purpose of the study were explained during the 
conversation. A detailed copy of the patient information sheet, a consent form, 
an appointment letter and a site map was posted to these interested 
candidates. For their convenience most of the participants were recruited from 
within a 5-mile radius of Llandough Hospital. Prior to the experiment, their 
height, weight, blood pressure and temperature of their feet were noted. They 
were also asked about their medications and their general heath. A brief 
history of their other cardiovascular problems was also noted. A total of 30 
males and 8 females were recruited for this group. They all were diabetics (5 
Type I and 33 Type II) with primarily sensory neuropathy indicated by their 
high VPT score. The VPT score in this group ranged from 25 V to a maximum 
score of 48 V.
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4.3.3 Inclusion and Exclusion Criteria
The participants of the control group or Group I were healthy individuals within 
the age range of 24 to 61 years. The mean age ± SD for the control group 
was 40.75 ± 12.6 years. Smokers, individuals on drugs known to affect the 
blood flow like the anti coagulants, vasodilators, etc, participants with cardio­
vascular diseases either arterial or venous, individuals suffering from any 
known neurological abnormalities or diseases affecting the microcirculation 
such as dermatitis, psoriasis, collagen vascular diseases and Reynaud’s 
syndrome were excluded from the study.
The participants of Group II (diabetics) and Group III (neuropathic) belonged 
to an older population within the age range of 45 -  80 years. The mean age ± 
SD for Group II was 63 ± 7.0 years while the mean age ± SD for Group III was 
70 ± 5.5 years. No attempts were made to age match the disease group 
(Groups II and III) with the control group. Studies have indicated age related 
changes in the vasomotor responses(Bernardi et al. 1997). The digital PPG 
device used in this study was never used before to assess the vasomotor 
responses. If the diseased and the control group were age matched, the 
signal from older healthy individuals could have age related changes. This 
would make differentiating an abnormal signal from a normal PPG signal very 
difficult. Therefore PPG signals from young healthy individuals were used for 
the analysis. The general exclusion criteria for Groups II and III were similar to 
Group I. Participants with any known symptoms of neuropathy were also 
excluded from Group II. Diabetes is also a major risk factor for cardiovascular 
complications and hence it was difficult to exclude participants suffering from
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CVD while maintaining the number of participants required for the study. 
However only 6 diabetics (17%) of Group II out of a total of 35 suffered from 
some form of cardio vascular complications. However around 47% (18 out of 
38) of the participants in Group III had at least some form of cardiovascular 
complication in the past. All participants were refrained taking any caffeinated 
drinks two hours prior to the study.
4.6.4 Stress Tests
The diagnosis of DAN is usually achieved by evaluating the cardiovascular 
autonomic function of the individual. The common tests for the evaluation of 
CAN include evaluation of the HR and the pressure responses to certain 
stimulus viz, breathing, grip or postural change. Thus a need arose while 
designing the study protocol to introduce some stress tests to evaluate the 
autonomic function of the body at both the relaxed and the excited condition. 
The PPG signal is very sensitive to movement artefacts, thus tests involving 
postural changes were avoided and the breathing and grip tests were adopted 
for the experiment protocol.
The Valsalva manoeuvre has been a popular test for evaluating the cardiac 
autonomic reflexes. Well defined changes were observed in the HR and the 
blood pressure of healthy individuals during this manoeuvre (Kalbfleisch and 
Smith 1978). The HR fluctuations with deep breathing are a result a vagal 
control of the sinus rhythm and hence this manoeuvre is a very good index of 
the parasympathetic activity of the individual (Kamal et al 1989). Though very 
useful, this test was difficult to perform specially for the older population. The
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target population for this study who may be at risk of developing foot ulcers 
due to long-term diabetes tend to be over 60 years. As the main aim of the 
study was to devise a screening tool it was necessary to keep the protocol 
simple, with good patient compliance.
A simple breathing test mimicking the Valsalva Manoeuvre, but with reduced 
intensity was devised as a part of the experiment protocol. A special device 
called the PowerLung® was used to aid the participants during the breathing 
test. PowerLung® as shown in figure 4.3b is a commercial breathing device 
used to train and strengthen the respiratory muscles*. The model has 
separate inhalation and exhalation control with five different levels that can be 
altered independently. Using the PowerLung® the participants were in effect 
inhaling and exhaling at a particular set resistance which was normally set to 
its minimal level of 1. Set at its minimum resistance, it was expected to mimic 
the Valsalva Manoeuvre in evaluating the baroreflex integrity of the individual, 
however with better patient compliance than the manoeuvre itself.
Another popular diagnostic test for CAN is the blood pressure response to a 
sustained hand grip where the participant is made to grip a hand held device 
at their maximum capacity initially and then at 30% of his/her maximum grip 
strength for the next 5 minutes. During this exercise the sympathetic reflexes 
are triggered and as a result an increase in both the blood pressure and the 
HR is observed. This test was observed to be a good indicator of the 
sympathetic function of the body. Maintaining a 30% level of grip for 5 minutes 
could be a challenging task even for a healthy young individual, thus to make
*  For more Technical Details visit: htto://www.Dowerlune.com/us/en/
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it more patient compliant it was decided to decrease the level to 10% of the 
individual’s maximum grip strength and the time to 2 minutes. A commercial 
device called the Baseline® Hydraulic Hand Dynamometer as shown in figure 
4.3c was used as the gripping device. It was robust and simple to use with the 
strength reading available in both pounds and kilogram. The device had a 
standard dial gauge with a mechanical reset that could measure grip strength 
of up to 90 kg. The handgrip also had a 5 level adjustment for better and 
stronger grip. By the introduction of these two stress tests, it was hoped to 
achieve a measure of both the sympathetic and the parasympathetic activity 
of the individuals using PPG.
Figure 4.3: a) H untle igh  V ascular A ssist® ; b) Pow erLung ®  B reatheA ir®  
c) B aseline®  H ydraulic  Hand D ynam om eter; d) IR tem peratu re  sensor and
e) PPG probes
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4.6.5 Experiment Protocol
The study protocol involved taking the photoplethysmographic blood flow 
signals from the sole of the participant’s feet using two PPG probes of the 
Vascular PPG Assist ® of Huntleigh Diagnostics. The Assist was a simple 
device to operate and required very little operator skills. Before the beginning 
of the test the participant’s height, weight, blood pressure and the temperature 
of their feet were noted. Participants of the control group (Group I) were also 
asked to complete a questionnaire regarding their general health and were 
checked of any familial history of diabetes. The participants were then asked 
to be in a supine position and had their legs covered with a blanket to prevent 
cold feet. The experiments were to be carried out in the same room under 
similar conditions each time to produce a uniform test environment through 
out the study. The participants were given time to relax for about 10 to 15 
minutes before the beginning of the study as it was essential to achieve a 
baseline PPG recording before the stress tests. Before the beginning of the 
experiment the maximum grip strength of the participant was also determined 
using the dynamometer. The sequence of the different stages of the protocol 
is illustrated in figure 4.4. The signals were recorded for 1 minute under 
complete rest and then the participants were asked to breathe in and out of 
the Power Lung™ set at the minimal level for two minutes. After this exercise 
they were asked to relax for further three minutes. The PPG signals from the 
sole of the participant’s foot were recorded continuously through out the 
procedure. After the three minutes of rest the subjects were once again asked 
to perform the second stress test of sustained handgrip using the 
dynamometer. The participants gripped the dynamometer at 10% of their
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maximum grip strength (determined before the beginning of the procedure) for 
two minutes and then relaxed completely for the remaining two minutes. The 
PPG signals from the soles of the feet were recorded and stored automatically 
on to the memory card by the Assist™ for further analysis. The whole 
experiment did not take more than 25 minutes and once the procedure was 
complete the participant could leave immediately as there were no side 
effects to the procedure.
Figure 4.4: D ifferent s tages o f the study protocol; a) initial resting phase o f 2 m inutes; 
b) 2 m inutes breath ing phase; c) in term ediate  resting phase o f 3 m inutes; d) 2 m inutes
grip phase and final 1 m inute  o f resting
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4.4 Preparatory Work
The Vascular PPG Assist ®, the Baseline® Hydraulic Hand Dynamometer 
and the PowerLung Breathe Air® were the three main pieces of equipments 
used in this study. Apart from these, an automatic Blood Pressure monitor 
and an infrared (IR) temperature sensor were also used. These were all 
commercial devices and were provided with their specifications. Though the 
inhalation and exhalation circuits of the PowerLung Breathe Air® could be 
controlled independently, their characteristics were not very clear. The device 
was calibrated using an old mechanical ventilator, which helped to mimic the 
inhalation and exhalation cycle. The changes in the peak flow and the peak 
pressure with the Resistance index level of the device during the two cycles 
were measured, calibrated and their characteristic graphs plotted.
4.4.1 Calibration of the PowerLung BreatheAir®
The calibration of the PowerLung BreatheAir was done using a Cape Waine 
mk3 anaesthetic mechanical ventilator and a PTS -2000-calibration analyser. 
The mechanical ventilator was used to simulate the inhalation and exhalation 
technique and the calibration analyser was used to measure the peak flow 
rate and the peak pressure through the breathing device during each cycle at 
a set resistance Index level. The Cape Waine is a mechanical ventilator 
manufactured by Cape Engineering Company Ltd. It could produce a 
maximum relief pressure of 7.0 kPa with the respiratory frequencies ranging 
from 10-50 cycles/min. The expiratory assistance had a maximum and 
minimum range while the volume could range from 300 ml to 1700 ml. The
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ventilator had two independent circuits that were driven by bellows. While one 
mimicked the inhalation process and blew air into the patient at a +ve 
pressure, the other produced a -ve  pressure and helped to suck air out of the 
patient’s lungs.
Calibration of the inhalation circuit of the PowerLung®
The expiratory circuit of the ventilator was used to calibrate this part of the 
PowerLung®. The ventilator was connected to the High flow exhaust of the 
PTS 2000 calibration analyser and the PowerLung® was connected to the 
high flow inlet of the same in a straight line such that the negative pressure 
generated by the expiratory circuit of the ventilator could suck the air through 
the PowerLung® mimicking inhalation at various load. This set up is illustrated 
in figure 4.5. Both the peak pressure and the peak flow rate were noted for 
each cycle and five such readings were taken at each resistance index of the 
PowerLung® device. The characteristic graphs for both the peak pressure 
and the flow rate were also plotted using Microsoft Excel spreadsheet.
(ve) pressure
Figure 4.10: The experim enta l set up fo r the calibration  o f the inhalation c ircuit o f the
P ow erLung®
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Figure 4.6: The Inhalation characteris tic  o f the Pow erLung B reatheA ir®
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Each resistance index level indicated a particular load with 1 as the minimum 
value and 6 as the maximum. With an increase in this resistance level the 
peak flow rate through the PowerLung® was found to decrease i.e. it would 
be harder to suck air through the PowerLung device with subsequent increase 
in the resistance level. The peak flow rate decreased from 8.7 kPa to 3.5 kPa 
as the resistance level was increased from 1 to a maximum level of 6. 
However with each increase in the Resistance Index the negative pressure 
generated by the ventilator was found to increase, which indicates that greater 
negative pressure would be required to suck air through the device as the 
load increases
Calibration of the expiration circuit of the PowerLung®
The inspiratory circuit of the ventilator was used to calibrate this section of the 
PowerLung®. This time the PowerLung® was attached to the high flow 
exhaust of the PTS 2000 calibration analyser and the ventilator was attached 
to the high flow inlet of the same as shown in figure 4.7 in a straight line such 
that this time the positive pressure generated by the inspiratory circuit of the 
ventilator could blow a known volume of air into the device across a load and 
mimic the exhalation procedure. Once again both the peak flow rate and peak 
+ve pressure were noted for each cycle and five such readings were taken at 
each PowerLung® resistance index. The graphs were produced using the 
Excel spreadsheet as shown in figure 4.8
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Figure 4.7: C alib ration  o f the exhalation circuit of the Pow erLung®
The exhalation circuit of the PowerLung device was provided with only 3 
different resistance levels. Here the peak flow was also found to decrease 
with the increase in the load as in the previous case. However this decrease 
in the flow rate was found to be less than that of the inhalation process, 
thereby indicating a lower equivalent load on exhalation as compared with 
that of the inhalation circuit of the PowerLung® for each resistance index. The 
drop was from an average peak flow rate of 5.7 kPa to 4.4 kPa. The peak 
pressure increased with an increase in the resistance index. A maximum peak 
pressure of approximately 6.2 kPa was achieved at the highest resistance 
index.
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Figure 4.8: The Exhalation characteris tic  of the Pow erLung BreatheAir®
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BreatheAir™ and Trainer™ were similar products from PowerLung. The two 
models were calibrated in a similar manner in order to compare and select the 
appropriate device for this study. During the calibration the peak pressure was 
found to reach a staggering level of 11.7 kPa in the Trainer™ as compared to 
a maximum of 6.2 kPa in the BreatheAir™ model. Thus for better patient 
compliance the BreatheAir™ was selected to be used as the breathing device 
for this study.
4.5 Initial Study
Signal from 5 healthy individuals were taken using the PPG device as per the 
experiment protocol and these signals were visually analysed. The study 
revealed a decrease in the probe signal to noise ratio. Thus the signals 
obtained were slightly noisy. Besides in order to appreciate the HR and for 
further analysis of the same the sampling frequency of 6.25 Hz was 
considered insufficient. The length of the study was a total of 10 minutes and 
the PPG signal was to be collected throughout the experiment. The PPG 
Assist® was designed commercially for venous measurements in patients 
with DVT. Thus the program had to be modified by the Company to provide 
10 minutes of continuous PPG signal. These modifications were made and 
the actual study was carried on all the participants recruited for the three 
Groups. The new sampling frequency of the PPG Assist® was 1 kHz and the 
data was directly stored onto a memory card. The data was then transferred 
at the researcher’s convenience on to a P.C. for further analysis.
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Chapter V -  Results
Visual Analysis
5.1 Introduction
PPG signals were collected from the participants of all three groups as 
mentioned in chapter IV. These signals measured the instantaneous skin 
blood volume present under the probe. An increase in the instantaneous 
blood volume resulted in a decrease in the signal amplitude and vice versa as 
per the optical properties exhibited by the probe. The skin microcirculation is 
controlled by both intrinsic and extrinsic factors. While the intrinsic factors are 
more local in origin resulting in more spontaneous local vascular changes, the 
extrinsic factors are central in their origin and causes uniform rhythmic 
changes in the entire microcirculation. The raw PPG signal obtained from the 
participants were analysed using the signal processing toolbox of the 
mathematical software MATLAB. The results obtained in this study has been 
divided and discussed in three chapters viz; Visual Analysis (Chapter V), HF 
Analysis (Chapter VI) and the LF Analysis (Chapter VII). This chapter details 
the visual analysis of the raw PPG signal and its Fourier spectrum.
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5.2 Visual Analysis of the raw PPG signal
The raw PPG signals obtained from all three groups were first visually 
analysed. The raw signals from each group did not have waveforms 
characteristic of their own group. However certain interesting features were 
observed for each of the three groups. The two stress tests used were a 
breathing exercise and a handgrip test. The former was conducted between 
the first and the third minute and the latter between the sixth and the eighth 
minute. Any change in the PPG baseline during these two, 2 minutes period 
was considered as a response to these stress tests. Figure 5.1, illustrates 
sample raw PPG signals obtained from each of the three groups.
In Group I (healthy participants), most waveforms had a very strong AC 
component superimposed on the slow moving DC component indicating a 
very strong pulse being detected by the PPG probe. Figure 5.1a is a good 
representative of the PPG signals obtained from this group. A sudden dip in 
the PPG baseline with a gradual recovery over the two-minute period was 
observed during the breathing test. Presence of a similar response in PPG 
signals obtained from both the left and the right foot indicate a more central 
response rather than a local reflex. This sudden dip in the baseline indicates 
an increase in the instantaneous total blood volume under the probe during 
the onset of the breathing exercise. A dip in the baseline of the signal was 
once again observed during the handgrip test. However the degree of dip in 
the baseline was considerably lower when compared to the breathing test. 
This pattern was observed in most participants from this group.
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The AC component was superimposed on the slow moving DC component in 
the raw PPG signal obtained from participants in Group II (diabetic 
participants with no known neuropathy). However the strength of the pulses 
detected in these signals was weaker when compared to the signals from 
Group I. The amplitude changes observed in Group I during the two stress 
tests was considered as the bench mark for comparing the signals from the 
diseased groups. A dip in the signal baseline at the onset of the breathing 
phase but with a quick recovery of the signal was observed in this group as 
shown in figure 5.1b. The degree of the dip in the baseline observed in this 
group was reduced when compared with those of the healthy participants The 
response to the grip test was found to be similar in both Group I and II.
The raw PPG signals obtained from Group III (diabetic patients with known 
neuropathy) were influenced by several factors. Most patients in this group 
were old and frail and many were not able to perform the tests as well as the 
participants from other groups. Besides, the group also contained signals from 
diabetics with different degrees of neuropathy. All these factors in combination 
resulted in large variations between the signals within the group. Over all, 
once the large DC offset was removed, the amplitude variations in the signal 
were severely reduced compared to the other two groups and in some cases 
even absent (flat raw PPG signal) with little or no response to the two stress 
tests as shown in figure 5.1c.
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Fig 5.1: The Raw PPG signal from  a normal (a), diabetic (b) and neuropathic (c) participant. 
Each signal is from both left (above) and right (below) leg
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5.3 Spectral Analysis of the raw PPG signal
The raw PPG signals obtained from all three groups were further analysed 
using spectral analysis. While the raw PPG signal provided valuable time 
domain information, the spectral analysis of the signal provided valuable 
frequency domain information of the same. Fig 5.2 illustrates the Fourier 
spectrum calculated from the raw PPG signal from a participant of each of the 
three groups. As seen in the figure, the spectrum of the signal consists of 
several frequency bands.
The frequency bands greater than 2 Hz or 120 cpm were not of any clinical 
significance as they were the harmonics of the fundamental HRfrequency. 
The above figure also illustrates the presence of some activity at the lower 
and the higher end of the frequency spectrum.
The LF end of the spectrum between 0.01 Hz (0.6 cpm) and 0.5 Hz (30 cpm) 
represented the sympathetic and the breathing activity of the individual while 
the fundamental frequency bandwidth between 0.5 Hz (30 cpm) and 2 Hz 
(120 cpm) represented the HF end of the spectrum. The highest peak in this 
region was related to the fundamental HR of the individual.
The spectrum obtained from Group I showed good response at both the HF 
and the LF end of the spectrum. In comparison to the spectrums from Group I, 
there was a significant reduction in the response at the LF end of the 
spectrum in Group II.
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Figure 5.2: The Fourier spectrum o f the raw PPG signal from a normal (a), diabetics (b) and 
neuropathic (c) participant. Each signal is from both left (above) and right (below) leg
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The response at the HF end of the spectrum was, however, preserved in this 
group. A significant reduction in the frequency response at both the HF and 
the LF end of the spectrum was observed in the spectrum from the 
participants of Group III.
Visual analysis of both the raw PPG signal and its spectrum revealed some 
differences between the three groups. While little or no amplitude changes in 
response to the two stress tests were observed in the raw signals from Group 
III, significantly reduced activity at both the LF and the HF end of the spectrum 
were also seen in this group. Thus the signals from the three groups in almost 
all cases could be visually differentiated.
Further analysis was conducted to obtain an objective method to differentiate 
between the three groups. The raw PPG signal obtained from both the 
participants’ feet were analysed and compared. For all further analysis only 
those frequency bands common to both the left and the right leg spectrums 
were studied as they represented the central influence on the vascular bed. 
These common frequency bands represented the changes in the vascular bed 
in response to various activities under the central autonomic control viz, 
breathing, cardiac cycle, blood pressure regulation, etc. Thus these 
spectrums provided valuable information regarding the individual’s autonomic 
activity. The spectrum was divided into the HF and the LF end and analysed 
individually for all three groups. Detailed analyses of the two ends of the 
spectrum have been discussed in the next two results chapter.
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Chapter VI -  Results 
High Frequency Analysis
6.1 Introduction
The response at the HF end of the spectrum represents changes in the skin 
microcirculation due to the individual’s cardiac cycle. The HR of an individual 
is not represented by a single frequency but by a bandwidth of frequencies 
where the central prominent frequency represents the individual’s 
fundamental heart rate. Damage to the autonomic fibres can result in 
abnormalities of the cardiac and the vascular dynamics. The HR of an 
individual varies with every beat and thus is represented in the HF end of the 
spectrum as a bandwidth rather than a single frequency. Both divisions of the 
autonomic nervous system viz, the sympathetic and parasympathetic 
branches work in finely balanced opposition to each other to control the HR 
and various other end organs of the body (Vinik and Erbas 2001). Several 
tests to objectively measure and diagnose the CAN are in routine clinical use. 
Almost all these tests use the HR trace obtained from the ECG. In this study, 
attempts were made to extract the HR information from the raw PPG signal 
and to try to use the information to differentiate between the three groups. A 
MATLAB program was written to extract the HR bandwidth from the HF end of 
the spectrum. This program was further improved to also extract the beat-by- 
beat HR trace from each of the spectrums. Both the bandwidth and the HR 
trace were then compared and analysed for all three groups.
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6.2 Analysis of the HR bandwidth
In general the HR for most individuals lies between 60-100 beats per minute 
(bpm). While extracting the HR information from the spectrum, the highest 
peak between 0.8 Hz (48 cpm) and 2 Hz (120 cpm) was regarded as the 
fundamental HR of the individual. Any other peaks obtained beyond 2 Hz 
were considered to be the harmonics of the fundamental heart rate. A 
MATLAB program was written to detect the highest peak between 0.5 Hz and 
2 Hz. Seventy percent of this maximum peak was then used as a threshold to 
obtain the lower and the upper limit to calculate the HR bandwidth from the 
spectrum as shown is figure 6.1. The size of the bandwidth represented the 
degree of variability present within the HR of the individual. Broader 
bandwidths obtained in Group I meant a greater number of frequencies within 
the bandwidth, and a higher HR variability. The reverse was true for sharp 
narrow bandwidths obtained from the participants of Group II.
The bandwidth of the HR and the fundamental HR frequency (the highest 
peak) were calculated for both legs from each participant of all the three 
groups. Three variables were calculated from these parameters viz; the mean 
bandwidth for both feet, the degree of agreement of the bandwidth calculated 
from both feet (left leg bandwidth -  right leg bandwidth) and the degree of 
agreement in the fundamental HR obtained from both feet (Left leg 
fundamental HR -  right leg fundamental HR) using Excel. The scatter plots of 
the latter two variables calculated from both feet were analysed. They 
however did not produce any significant results and hence were not analysed
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any further. Only the mean bandwidth calculated for each of the participants 
across the three groups were compared and analysed.
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Fig 6.1: The HF end o f the spectrum from a typical raw PPG signal with a fundamental HR 
bandwidth and the subsequent harmonics
6.2.1 HR bandwidth comparison by visual analysis
The HR bandwidths calculated from the spectrums from all three groups were 
visually analysed. The typical HR bandwidth obtained from the participants 
from Groups I and II have been illustrated in figure 6.2. In all these figures 
generated by MATLAB, signals from both the left (above) and right (below) 
foot are shown. The bandwidth obtained from Group II participants were found 
to be narrower when compared to the bandwidth calculated from the 
participants in Group I. Smaller bandwidths obtained from the diseased group
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suggest decreased HR variability. Earlier studies have shown decreased HR 
variability to be one of the earliest signs of parasympathetic dysfunction.
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Fig 6.2: The HR bandwidth obtained from a Group I (a) and Group II (b) participant. Note the 
narrower bandwidth observed in a Group II participant as compared with the one from
Group I.
114
Visual analysis of the bandwidth extracted from the participants in Group III 
produced some interesting observations. A variety of bandwidth sizes were 
obtained in this group. In groups I and II the bandwidths obtained from the 
spectrum from both feet were symmetrical. However this symmetry was lost in 
nearly 35% (13 out of 38) of the participants in Group III. In these thirteen 
individuals the spectral analysis of the signal produced severely reduced 
amplitude at the HF end of the spectrum and in some cases only generated 
random noise. The program, in these cases failed to locate the peaks and 
thereby failed to identify the upper and the lower limits of the bandwidth 
accurately resulting in its erroneous calculation as shown in figure 6.3 (b). 
Thus, under these circumstances the significantly reduced HR bandwidth 
erroneously appeared to be broad and similar to or in some cases even much 
greater than the ones obtained from Group I. In some cases the program also 
erroneously detected dual peaks in some of these participants. In the 
remaining 65% (25 out of 38), the HR bandwidths calculated were found to be 
similar to those obtained in Group II. Sharp, narrow bandwidths indicating 
reduced HR variability were obtained in this set of Group III participants as 
shown in figure 6.3 (a).
Visually the bandwidths calculated from Groups I and II were distinctively 
different from each other. The bandwidth calculated from a subset of Group III 
participants showed similar characteristics to the ones obtained from Group II. 
The erroneous detection of the HR peak within the HF end of the spectrum in 
the 13 individuals from Group III also resulted in the erroneous calculation of
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their beat-by-beat HR trace. Thus a need arose to exclude the data from 
these 13 individuals within Group III from all future analysis using the HF end 
of the spectrum. Thus the new subset generated with only 25 group III 
participants was called Group Ilia. Statistical analyses were however 
performed using both, Group III as a whole and with the new subset Group 
Ilia, to understand the affect of the data from these 13 individuals on the 
results from the statistical analysis.
Fig 6.3: The variation in the HR bandwidth obtained from the participants in Group III. 65% of 
the participants produced the bandwidth shown in (a) while 35% produced bandwidth as
shown in (b)
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6.2.2 Statistical Analysis using data from participants in Group III
Statistical analyses were carried out to understand the distribution of the 
mean bandwidths calculated within each group and across the three groups. 
The mean HR bandwidth calculated for groups I, II and III were 27.6 bpm, 
22.4 bpm and 32.6 bpm respectively. A reduction in the mean HR bandwidth 
for Group II was observed as compared to the value obtained from Group I. 
The participants of Group III were diabetic patients with varying degree of 
neuropathy. Some form of autonomic dysfunction was expected to be 
prevalent in most of these participants and the mean HR bandwidth from this 
group was therefore expected to be smaller to or at least similar to that of 
Group II. However the mean HR bandwidth of 32.6 bpm obtained from Group 
III was larger than the bandwidths obtained for the other two groups. This 
unexpected rise in the mean HR bandwidth value could be due to the 
presence of very large outliers resulting from the erroneous calculation of the 
mean HR bandwidth for more than 35% of its participants.
Descriptive analysis was performed using SPSS to obtain statistical 
parameters such as the mean, standard deviation, the median value, etc for 
all three groups. The results were tabulated as shown in figure 6.4. A 
normality test was performed on the variable to identify its statistical 
distribution. Histogram and the Q-Q plot of the mean HR bandwidths 
calculated for participants of each of the three groups were analysed and it 
was determined that the variable did not follow a normal distribution. Thus the 
distribution of the variable in each of the groups was better expressed using 
the median rather than the mean bandwidth value.
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Group Group II Group III
M ean 26 .9 M ean 24.2 Mean 30.3
Standard Error 1 .53 Standard Error 1.73 Standard Error 1.77
Median 2 3 .5 M edian 20 Median 29
Standard
Deviation 9 .15 Standard Deviation 10.2 Standard Deviation 10.9
Sam ple Variance 83 .8 S am ple  V ariance 105 Sam ple Variance 119
Kurtosis 1.3 Kurtosis 2 .38 Kurtosis -1 .26
Skewness 1.27 Skew ness 1.82 Skewness 0.29
Range 38 R ange 38 Range 37
Confidence Level 
(95 .0% ) 3.1
C onfidence Level 
(9 5 .0 % ) 3.52
Confidence Level 
(95 .0% ) 3.59
Fig 6.4: Com parison of the descriptive statistics of the m ean HR bandwidth obtained from
Groups I, II and III
Kruskal-Wallis Test 
Ranks
I group N Mean Rank
mean bandwidth for each group I 32 54.22
participant -Group I group II 33 38.21
group III 37 61.00
Total 102
Test Statistics(a,b)
mean 
bandwidth for 
each 
participant - 
Group I
Chi-Square
df
Asymp. Sig.
10.740
2
.005
a Kruskal Wallis Test 
b Grouping Variable: group
Figure 6.5: k®1 sam ple non-param etric test to obtain the inter-group relation of the m ean HR  
bandwidth calculated from the three groups
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The inter-relation of the variable calculated from the three groups was also 
statistically analysed using the hypothesis-testing model. The null hypothesis 
for this analysis was set as there being no difference in the mean bandwidth 
obtained from all three groups at a statistically significant level. Since the 
mean HR bandwidth calculated for the three groups were continuous, 
independent and followed a non normal distribution, a non-parametric test 
was used. Since three groups were compared, a kth sample non-parametric 
test also known as the Kruskal Wallis Test was chosen as a suitable test. The 
test was performed using the SPSS package. The first output table produced 
the mean ranks for each group and the second table produced the detailed 
test statistics as shown in figure 6.5. The Chi-square value of 10.740 with 2 
degrees of freedom gave a p value of 0.005 indicating that the results were 
statistically significant and subsequently rejecting the null hypothesis. Thus it 
could be rightly concluded from the above test that the mean bandwidths of 
the three groups were different from each other. This test however did not 
provide any further information regarding the relationship of the variable 
between each pair of groups. In order to do so the two groups were taken at a 
time and the 2 sample non-parametric test i.e. the Mann -  Whitney test was 
performed. The results of these tests indicated statistically significant 
difference in the mean HR bandwidth calculated from Groups I and II and 
between Groups II and III. However no significant difference could be 
established between the mean HR bandwidth from Groups I and III.
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6.2.3 Statistical Analysis using the subset Group Ilia
The statistical analysis detailed in the previous section was repeated to 
compare the HR bandwidth obtained from Groups I and II to those obtained 
from the new subset created from Group III called Group Ilia. This subset 
excluded the data from the thirteen individuals whose HR information could 
not be accurately extracted from the raw PPG signal. By performing statistical 
analysis using both the whole group and its subset separately, the results thus 
obtained were expected to provide valuable information of the influence of the 
data from these 13 individuals on the entire group (Group III). The descriptive 
statistics for Group III and Ilia were obtained and compared using EXCEL 
spreadsheet. The results have been tabulated in figure 6.6.
Group III Group Ilia
Mean 3 0 .3 M ean 24.2
Standard Error 1 .77 Standard Error 1.47
Median 29 Median 21
Mode 17 M ode 17
Standard Deviation 10 .9 Standard Deviation 7 .37
Sam ple Variance 119 Sam ple Variance 54.3
Kurtosis -1 .2 6 Kurtosis 0 .27
Skewness 0 .29 Skew ness 1.01
R ange 37 R ange 27
Largest(1) 53 Largest(1) 43
S m a lle s t 1) 16 Sm allest(1) 16
Confidence Level (95 .0% ) 3 .59 Confidence Level (95 .0% ) 3.04
Figure 6.6: Com parison of the descriptive statistics of Groups III and its subset Ilia
From the above tabulation is can been seen that by excluding the data from 
the thirteen individuals, the mean HR bandwidth of the group decreased from 
30.3 bpm to 24.2 bpm. The mean bandwidth obtained from the subset was
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similar to bandwidth obtained from the participants of Group II. Visual analysis 
of the raw PPG signal and the HR bandwidth in the subset had revealed 
similar characteristics to Group II data. The participants of Group III were at 
varying stages of their neuropathy. All the 13 participants, whose data was 
excluded from the new subset, had a VPT score of greater than 30 mV in both 
legs, indicating sensory loss probably due to diabetic sensory neuropathy. 
Though we did not have any direct test to measure the autonomic function of 
the individuals in this group, the possibility of having both autonomic and 
sensory dysfunction due to diabetic neuropathy in these individuals is highly 
probable. The inability to extract reliable HR information from the HF end of 
the spectrum from these signals could be due to the early parasympathetic 
damage in these individuals due to autonomic dysfunction. The remaining 25 
participants however had an intact HF end of the spectrum and hence the HR 
information could be reliably extracted from these raw PPG signals.
A Man-Whitney test was performed to obtain the statistical relationship 
between the groups using the new subset created. The results have been 
tabulated in figure 6.7. The mean bandwidth for Group I was higher than the 
other two groups, indicating greater HR variability within this group as 
expected. Although the mean bandwidth of Group Ilia was smaller than Group 
I, no statistical difference could be established between the two groups. This 
could be due to the difference in the group size as the non-parametric test 
involved ranking of each data and their summation. However statistical 
difference could be established between Groups I and II with a very small p 
value.
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Analysis of the HR bandwidth highlighted the failure of the Vascular Assist in 
picking up reliable HF information from 13 participants of Group III. The PPG 
signals from these patients had a severely reduced or absent HR information. 
The HR bandwidth characteristics of the remaining 25 participants of this 
group were similar to those obtained from diabetics with no neuropathy. 
Statistical difference could be established only between the mean bandwidths 
of Groups I and II. On analysing the bandwidth information from Group III as a 
whole, the mean bandwidth for this group was similar to the value obtained 
from Group I. This was not an expected result as the two groups represented 
the extreme ends of the disease spectrum. The healthy participants of Group I 
were expected to have the highest HR variability, followed by Group II and the 
least variability was expected in participants of Group III. Statistical analysis of 
the new subgroup Ilia formed by excluding the signals from these 13 
individuals also could not statistically differentiate between Groups I and Ilia. 
However the mean bandwidth of this group was similar to Group II and was 
more in line with the expected result. The next part of the HF analysis 
involved extracting the beat-by-beat HR trace from these PPG signals. The 
HR traces could not be extracted from 13 neuropathic participants and hence 
could not be assessed any further. Therefore from the signal analysis point of 
view it became necessary to exclude them from the group for the remaining 
HF analysis. Signals from all 38 participants of Group III were considered for 
the LF analysis discussed in the next chapter.
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Ranks
groups N Mean Rank Sum of Ranks
bandwidth normal 36 40.99 1475.50
diabetic 35 30.87 1080.50
Total 71
Test Statistics(a)
bandwidth
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
450.500
1080.500 
-2.069
.039
a Grouping Variable: groups
Ranks
groups N Mean Rank Sum of Ranks
bandwidth diabetic 35 29.24 1023.50
neuropathic 25 32.26 806.50
Total 60
Test Statistics(a)
bandwidth
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
393.500
1023.500 
-.662 
.508
a Grouping Variable: groups
Ranks
groups N Mean Rank Sum of Ranks
bandwidth normal 36 33.44 1204.00
neuropathic 25 27.48 687.00
Total 61
Test Statistics?
bandwidth
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
362.000
687.000  
-1.294
.196
a. Grouping Variable: groups
Figure 6.7: M an-W hitney test to com pare the intergroup relation. Statistical difference could 
be established betw een G roups l& II but statistical difference could not be established
between Groups II & Ilia  and I & Ilia
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6.3 Analysis of the beat-by-beat HR trace
The analysis of the HR bandwidth was followed by the analysis of the beat-by- 
beat HR trace. The MATLAB program written to extract the HR bandwidth 
from the raw PPG signal was further modified to extract the beat-by-beat HR 
trace.
The upper and the lower limits of the HR bandwidth calculated using the 
previous program was used in the next stage. These values were used as cut 
off frequencies of the band pass filter used for filtering the original raw PPG 
signal. The filtered signal was then complex demodulated at the frequency of 
the mean fundamental HR (frequency with the largest amplitude) calculated 
from both feet. The complex demodulated signal was then passed through a 
peak detection program using the zero crossing detector principle to detect 
the peaks on the demodulated signal. The time of the occurrence of each of 
these peaks was calculated. Their difference provided the information of the 
time between two consecutive peaks otherwise known as the R-R interval. 
The inverse of the R-R interval calculated for every beat produced the HR for 
that beat. The beat-by-beat HR trace extracted contained spikes that were 
effectively removed using a spike filter. The final filtered HR trace was then 
plotted against the time vector as a new figure in MATLAB. The program 
generated the beat-by-beat HR trace from both legs for each participant. They 
were then visually analysed and compared using objective methods. The flow 
chart of the program steps for generating the HR trace is shown in figure 6.8.
124
Raw PPG signal 
Fs = 1 KHz
BPF
H R -B W
UppecLimit Lower Limit
HR trace
FFT PDP
Spike Filter
HR
( L / R )
BPF 
(60-130cpm)
Down sample 
Fs = 6 Hz
COM 
(fundamental HR)
HR BW = Heart Rate band-width
CDM = complex demodulation
PDP = Pulse Detection Program
HR = Heart Rate
Fs = sampling frequency
BPF = Band Pass Filter
FFT = Fast Fourier Transform
Figure 6.8: F low  C hart representing the heart rate extraction program
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6.3.1 HR Agreement Analysis
Once the HR trace was extracted from the spectrum, the agreement between 
the traces obtained from both feet was studied. Ideally the traces extracted 
from both feet should be identical as they both represent the beat-by-beat HR 
of the individual. However inherent errors in programming and the data 
collection could result in some discrepancies in the two traces. The degree of 
discrepancies between the two traces was a measure of the success in 
extracting the HR from the spectrum. A Bland-Altman plot was used to 
measure the degree of agreement between the HR trace extracted from the 
left and the right foot signal.
A MATLAB program was written to produce this plot. The difference between 
the HR extracted from the left and the right foot for every beat and the mean 
of this difference were calculated for each participant. The standard deviation 
of the difference between the two traces was calculated and the upper (mean 
difference + standard deviation) and the lower (mean difference -  standard 
deviation) limit were determined for each individual. The mean HR for every 
beat from the two traces for the whole 10 minutes of the signal was also 
calculated. The difference between the two traces was plotted against the 
mean HR along with the mean of the difference and the ±one standard 
deviation limit. The upper and the lower limit of the difference indicate the 
degree of agreement between the two HR trace. Tighter limits indicate better 
fit between the left and the right HR trace. However these limits were also 
influenced by the presence of very large outliers. Hence, in cases where the 
HR from both feet were in good agreement with each other for most part of
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the signal but had spikes which produced huge differences in other instances, 
the limits were pushed further apart from each other giving a rather erroneous 
picture. Therefore, the mean of the difference between the two HR trace 
provided a better insight to the degree of agreement between the left and the 
right HR trace where a smaller mean difference indicated fewer discrepancies 
between the two traces and hence a better agreement. The degree of 
agreement between the left and the right HR trace were both visually and 
statistically analysed and the mean difference for each individual was noted.
6.3.1.1 Visual Analysis of Group I
The beat-by-beat HR trace for both feet was plotted using MATLAB along with 
the Bland-Altman plot. The trace obtained from each of the participants was 
visually analysed for all three groups. Certain observations were made after 
the visual analyses of the traces from Group I. An example of the HR trace 
and its Bland Altman agreement plot obtained from a participant in Group I is 
illustrated in figures 6.9 and 6.10.
As expected the HR for an individual was not constant for the whole ten 
minutes but varied with every heartbeat. This beat-by-beat variability was 
found to be very high in the participants of this group. Beat-by-beat variation 
of up to 30 bpm was observed in this group. The difference between the 
minimum and the maximum HR in most participants was greater than 20 bpm. 
A strong response of the HR to the two stress tests was also observed with a 
steady rise in the HR especially during the breathing test. Overall, the 
response to the grip test was not as effective as the breathing test. This could
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be due to the fact that the individuals during the grip test were not exerted 
enough to produce any visible results.
The high beat-by-beat variability in the HR trace introduced some phase shift 
among the left and the right HR trace in 53% of the participants in this group. 
Further examination of these phase shifts did not produce any specific 
pattern. However of this 53%, 14% of the traces were found have phase shifts 
only in parts of the signal with perfect phase in the rest of the signal. Those 
participants with smaller beat-by-beat variability were found to have perfect 
phase matching.
Important information was also obtained from the Bland Altman plots. The 
beat-by-beat mean HR for this group varied from 65-105 bpm suggesting 
excellent variability. The mean difference in the two traces was found to be 
around 0 with a ±1 SD of less than 10bpm in most participants of this group.
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Figure 6.9: The HR trace extracted from left and right foot of a healthy individual
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6.3.1.1.1 Discussion
Visual analysis of the HR trace showed a strong response to the two stress 
tests. The HR bandwidths among the healthy individuals were expected to be 
large due to the inherent high beat-by-beat variability present among healthy 
individuals. The greater variability in the HR meant an increase in the number 
of frequencies present within the bandwidth. This high HR variability within the 
normals could also push the program to its limits by introducing larger 
discrepancies between the two traces. Thus though the mean absolute 
difference in the HR extracted from both feet was usually a small value nearer 
to zero, the presence of outliers increased considerably pushing the upper 
and lower limits of 1 SD further apart.
Increased variability in the HR was also found to increase the occurrences of 
phase shifts in the HR trace for both the left and the right leg. The program 
processed the data from each leg individually and hence used the individual 
upper and lower limits of the HR bandwidth calculated for each leg as the 
upper and the lower cut-off for the band-pass filter to be used on the raw 
signal from each side. This was thought to be a possible source of introducing 
the phase shift into the signal due to the different filter parameters being used. 
Ideally these parameters should be as close as possible but for some signals 
there could be a huge difference between these parameters calculated from 
both feet and this was thought to be a possible reason for the phase shift. 
However no change was observed when the mean upper and lower limit was 
used instead of their absolute values obtained from each leg. This could 
indicate the possibility of some physiological explanation for this apparent
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phase shift in the HR trace obtained from both the legs, observed only within 
this group.
6.3.1.2 Visual Analysis in Group II
The visual analysis of the HR traces from Group II revealed certain features 
specific to this group. An example of a HR trace and its corresponding Bland 
Altman plot obtained from this group are illustrated in figure 6.11 and 6.12. 
The beat-by-beat variability in the HR was comparatively lower than that 
observed in Group I. The maximum variability in this group was less than 15 
bpm. The low variability in the HR trace produced much better agreement 
between the left and the right leg traces. Even in the event of any discrepancy 
between the left and the right foot HR trace the absolute difference calculated 
was significantly smaller resulting in fewer outliers. Thus the resulting Bland 
Altman plot produced a smaller spread of the difference in the HR trace.
The low variability also produced good phase matching between the two 
traces keeping the mean absolute difference between the left and the right HR 
trace to very small values. In spite of reduced HR variability, strong responses 
to the two stress tests were observed in 13 participants (37%) of this group. 
The HR traces from 14 patients (40%) were found to have a moderate 
response to the tests as shown in figure 6, while the traces from 7 patients 
(20%) were absolutely flat with no response to the two tests. In the HR trace 
as shown in figure 6.11, a slight increase (approx of about 5 bpm) in the HR 
during the breathing test was observed but it was still less than the normals 
where the HR increased by about 15 bpm or more in most participants. The
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program was unable to extract the HR from the signal of 1 patient (2%) 
resulting in a noisy HR trace.
The analysis of the Bland Altman plots reflected the results from the visual 
analysis of the HR traces from this group. The mean HR for every beat 
ranged between 70bpm and 90bpm. This was significantly lower than Group I. 
The mean absolute difference in the two traces was zero or near zero with 
tight ± 1 SD limits of less than ± 2 bpm with the presence of very few outliers.
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Figure 6.11: The HR trace extracted from left and right foot of a diabetic participant
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mean difererce in the HR in bpm
Figure 6.12: The Bland Altman plot of the HR shown in the previous figure with the ±1 SD
limits o f less than ± 2bpm
6.3.1.2.1 Discussion
Figure 6.11 and 6.12 is an example of the HR trace obtained from a diabetic 
patient and represents the HR extracted from nearly 40% of the participants 
within Group II. Reduced beat-by-beat variability was a general characteristic 
that could be extended to the whole group. Though a moderate response of 
the HR to the two stress tests was observed, it was much reduced when 
compared to the traces obtained from the healthy individuals. The diabetics 
were expected to have reduced beat-by-beat variability with a narrow HR 
frequency bandwidth. The program was also able to extract the HR trace from 
both legs more accurately with better phase matching and reduced 
discrepancies due to this decreased variability.
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In the example given in figure 6.12, the mean absolute difference was nearly 
equal to zero indicating an excellent agreement between the two traces. 
Besides, the ± 1 SD limits were also tighter with a value of less than ± 2 bpm 
with very few outliers. After the overall analysis of the HR traces from this 
group, three different patterns were observed. Strong, moderate and poor 
responses to the two stress tests were observed in this group. This mixed 
result could be due to the presence of diabetics in this group at various stages 
of their disease. Severely reduced HR variability was a general feature 
observed throughout this group.
6.3.1.3 Visual Analysis in Group III
Visual analysis of the HR trace from all participants of this group did not 
reveal a common pattern. Variations in the HR trace were observed in the 38 
neuropathic participants. Overall the HR variability was significantly reduced 
as compared to the other two groups. The HR trace from 9 participants (24%) 
had very little or no variability and also showed no response to any of the 
stress tests. These traces were similar to the ones obtained from 20% of the 
participants in Group II. The traces from 5 of the participants (13%) had a 
moderate response to the tests similar to the 40% of the participants in Group 
II. The HR trace from 4 participants of Group III (10%) had a good response to 
the two stress tests (especially the breathing test) similar to 37% of Group II. 
Finally a unique pattern of HR trace was obtained from 7 of the participants 
(18%) in this group. These traces had a very slow beat-by-beat variability with 
practically no response to the stress tests. Of these seven individuals three 
were associated with severe cardiovascular complications and neuropathic
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symptoms and two were severely neuropathic with very high VPT score. The 
latter however did not have any known cardiovascular problems. The last two 
of these seven participants did not have any neuropathic or cardiovascular 
symptoms in spite of high VPT score. The program was unable to extract the 
HR accurately from 13 participants (35%) of this group due to severely 
reduced HF response in their spectrum.
The example illustrated in Figure 6.13 represents the HR trace obtained from 
around 25% of the participants in Group III. Decreased HR variability along 
with little or no response to the two stress tests was observed in this 
participant. The corresponding Bland Altman plot as shown in figure 6.14 also 
produces similar conclusions. The mean difference between the two traces 
was found to be zero with very tight ± 1 SD limit of less than ± 2bpm.
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Figure 6.13: The HR trace extracted from left and right foot of a neuropathic participant
135
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Figure 6.14: The Bland Altman plot of the HR shown in the previous figure with the ±1 SD
limits of less than ± 2bpm
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Figure 6.15: HR trace extracted from one o f the 13 participants of the group with absent HF 
information. Note the difference in the traces obtained from the left and the right foot
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Figure 6.16: Bland Altman plot of the above HR traces with the 1 SD limits over 26pm and
with very high outliers
The example illustrated in Figure 6.15 and 6.16 represents the HR trace 
obtained from one of the 13 participants whose HR trace could not be 
extracted accurately in Group III. As illustrated by the figure, significant 
differences were observed between the HR traces obtained from the left and 
right foot of these participants. The corresponding Bland Altman plot also 
showed very wide upper and lower 1 SD limits indicating greater 
discrepancies between the left and the right HR traces.
6.3.1.3.1 Discussion
47% of the neuropaths behaved in a manner similar to the diabetics with no 
neuropathy. The VPTscore of 25 V or greater, was the only inclusion criterion
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used to recruit participants for Group III. A VPT score of 25 V is a value widely 
used as a threshold to identify diabetics at a greater risk of developing 
diabetic foot disease due to sensory neuropathy (Young et al 1994; Lavery et 
al 1998). Though in most cases the sympathetic denervation overlaps with 
sensory neuropathy, they can also occur individually. Damage to the 
sympathetic nerves causes disruption in the blood volume changes within the 
microcirculation that can be picked up by the PPG signal. Thus it is a 
possibility that this 47% of the neuropaths, though having sensory 
neuropathy, may not have sympathetic neuropathy or they may be in the early 
stage of sympathetic dysfunction where disruption to the blood volume 
changes has not set in as yet.
Eighteen percent of the neuropaths had a unique HR trace. The patient 
history suggests that 71% of these 7 neuropaths had a high VPT score and 
also complained of loss of sensation and tingling indicating severe sensory 
neuropathy. However some of them also had cardiovascular complications 
that can influence the peripheral blood flow. There is also a distinct possibility 
of these individuals suffering from sympathetic denervation as well. Figure 
6.13 & 14 are the HR trace and its Bland Altman plot respectively obtained 
from a neuropathic patient of Group III. The HR trace in the given example 
shows little or no response to the two stress tests as compared to the traces 
obtained from the other two groups. The beat-by-beat variability was also 
reduced significantly with the difference in the maximum and minimum mean 
heartbeat being less than 10 bpm. This kind of trace was obtained from some 
diabetic patients with no known neuropathy as well. Decreased response of
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the HR to the stress tests could indicate sympathetic dysfunction among the 
neuropathic patients. The diabetics with no known neuropathy in Group II 
could have non-symptomatic sympathetic dysfunction and this could be the 
possible explanation for obtaining similar trace from individuals within this 
group as well. Decreased variability similar to the diabetics once again 
produced a Bland Altman plot with tighter limits suggesting a better 
agreement of the HR trace extracted from both legs. In the given example, the 
± 1 SD was also less than ± 2 bpm. It should however be noted that the given 
example only represents one type of the trace obtained from this group. The 
mean absolute difference in the HR trace extracted from both feet for each 
individual across the three groups was used for further objective analysis. 
Since different types of traces were obtained in this group, the value of this 
variable was spread out and hence appeared erroneously similar to data 
obtained from participants in Group I or the healthy individuals. However the 
HR traces from both these groups were visually very distinct from each other.
The inability to obtain a proper HR trace from 13 individuals could be due to 
several factors. Peripheral vascular disease is a common complication among 
diabetics resulting in decreased flow in the legs. Though these patients did 
not have a confirmed diagnosis of PVD, some of them did have a history of 
intermittent claudication, one of the many symptoms of PVD. This could be a 
probable explanation for the inability of the probes to pick up the pulses. 
However some of these individuals also had a very high VPT and had been 
diabetic for a long period of time indicating severe sensory loss that could be 
accompanied by sympathetic dysfunction. Autonomic or sympathetic
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dysfunction among diabetics remains largely asymptomatic despite an early 
onset. In those individuals damage to the sympathetic nerves may cause the 
AV shunts to collapse and excessive blood to pass though them by passing 
the capillaries. Thus the foot feels warm but the skin does not receive any 
nutritive flow. These vessels under such circumstances act as a large 
capacitance with excessive pooling of blood but the pulsatile changes in the 
blood volume is heavily dampened. PPG was used in this study to detect the 
changes in the skin microcirculation observed mostly in the event of 
sympathetic dysfunction. Patients suffering from diabetes over a long period 
of time tend to develop very poor thick callus skin and also may suffer from 
water retention in the legs. Both these factors could greatly influence the PPG 
signals collected from these individuals.
Visual analysis of the HR traces and their corresponding Bland Altman plots 
produced certain interesting observations. Further objective analysis were 
carried out by studying the characteristics of the distribution of mean beat-by- 
beat HR for each of the participants across the three groups.
6.3.2 Analysis of the beat-by-beat HR distribution
Further detailed analysis of the Bland Altman plots also revealed some 
interesting facts about each individual’s beat-by-beat HR distribution. The 
nature of the distribution of any variable can be studied by plotting its 
histogram. Fig 6.17 is a histogram of the beat-by-beat HR distribution
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obtained from a healthy individual over ten minutes and is representative of 
the whole group.
In normal healthy individuals greater HR variability resulted in a wider spread 
of the mean beat-by-beat heart rate. On average a mean increase in the beat- 
by-beat HR of approximately 30 bpm was observed during the breathing and 
the handgrip phase of the study protocol for Group I. This was also reflected 
in the Bland Altman plot and in the histogram. Although most of the mean 
beat-by-beat heart rates were clustered around 70 bpm -  90 bpm, higher 
beat-by-beat heart rates of around 100-120 bpm were also observed. The 
presence of these higher HR values could be possibly explained as the 
systemic response to the two stress tests. Their presence was also observed 
to skew the individual’s HR distribution.
250
Mean Heart Rate
Figure 6.17: Histogram of the HR distribution of a participant from G roup I
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As explained in section 6.3.1, the beat-by-beat HR variability was observed to 
be comparatively lower in Group II than that obtained in Group I. The degree 
of rise in the HR in response to the two stress tests was also reduced to less 
than 20 bpm in this group. Once again most HR values were strongly 
clustered between 70 bpm -  90 bpm with very few high HR values of greater 
than 90 bpm. Fig 6.18 is a histogram of the HR values from a diabetic patient 
in Group II. This is a good representation of the whole group where most 
values lie within a tight limit with very few outliers. The distributions observed 
in this group were found to be closer to a normal distribution than the 
distributions observed in Group I and hence lower skewness value of the 
distribution was expected from this group when compared with normals in 
Group I.
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Figure 6.18: Histogram of the HR distribution of a participant from G roup II
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In Group III mixed results were obtained. The program was unable to 
accurately extract the HR trace from 13 individuals of this group as explained 
in the previous section. This analysis was performed using data from the 
remaining 25 individuals whose HR could be successfully extracted by the 
program. A spectrum of variations in the HR trace was observed in individuals 
from Group III. However in general there was little or no HR response to the 
two stress tests. Amongst those individuals who showed some response to 
these stresses, the increase in the HR was observed to be even less than 
10bpm. In general the HR traces obtained from these 25 individuals were 
observed to be nearly flat. Figure 6.19 illustrates the histogram for the beat- 
by-beat HR values obtained from a participant in Group III. This histogram can 
be considered a good representative of the participants in Group Ilia. From 
the figure it can be seen that the distribution of the HR values is nearly normal 
with most values lying within 66 bpm and 76 bpm. Most individuals in this 
group did not have HR values greater than 90 bpm indicating the absence of 
any HR response to the 2 stress tests. However in some cases the outliers 
were in the form of the smaller HR values (less than 66pm) present within the 
distribution. Though most distributions obtained from this group followed a 
near normal distribution, occasionally distributions with negative skewness 
value were also obtained from this group. A MATLAB program was written to 
calculate the histogram and the skewness of the distribution for each 
participant across the three groups.
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Figure 6.19: Histogram of the HR distribution of a participant from G roup Ilia Note the 
presence of lower HR values producing a negative skewness in the distribution.
6.3.3 Statistical Analysis of the beat-by-beat heart rate
Most of the HF analysis so far involved the visual analysis of the HR trace 
extracted from the raw PPG signal, the degree of their agreement between 
the left and the right HR trace, and the histogram of the beat-by-beat HR 
values. These methods were however mainly subjective in nature. Further 
object analysis was performed on the HF end of the spectrum using statistical 
analysis. The skewness of the distribution calculated from participants from all 
three groups were further analysed in detail. The descriptive statistics were 
calculated using an Excel spread sheet and the result obtained is tabulated in 
figure 6.20.
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Group 1 Group II Group Ilia
M ean 0.64 M ean 0.17 M ean 0.14
Standard Error 0 .18 Standard Error 0.1 Standard Error 0.1
Median 0.45 Median 0.13 Median 0.16
Standard Deviation 1.05 Standard Deviation 0.61 Standard Deviation 0.5
Kurtosis 17.5 Kurtosis 2 .27 Kurtosis 0 .45
Skewness 3.67 Skewness 0 .17 Skewness 0 .47
Range 6.55 Range 3.24 R ange 1.94
Minimum -0.8 Minimum -1.3 Minimum 0.64
Maximum 5.78 Maximum 1.99 Maximum 1.3
Confidence Level 
(95 .0% ) 0.36
Confidence Level 
(95 .0% ) 0.21
Confidence Level 
(95 .0% ) 0.21
Figure 6.20: Descriptive Statistics for the skewness of the HR distribution
The mean skewness of the HR distribution in Group I was 0.64 and this value 
was found to be considerably larger than the mean values obtained in Group 
II (0.17) and Group III (0.14). These results therefore indicate the presence of 
increased HR variability in healthy individuals as compared to the diseased 
group. The mean skewness obtained from Groups II and Ilia were very similar 
indicating a similar HR distribution within the two groups. As explained earlier, 
around 47% of the Group III participants had HR trace similar to the ones 
obtained from Group II. Only 18% of them had a unique trace specific for the 
group. Thus in this analysis most of the participants in Group III had HR 
traces similar to those obtained from Group II and this could possibly explain 
the similarity in the mean values for these two groups.
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The skewness of the HR distribution calculated from all the three groups was 
also plotted using a scatter plot, shown in figure 6.21. From the scatter graph 
it was not possible to completely distinguish between the three groups and the 
skewness of the HR distribution calculated were within similar ranges. A 
larger difference was observed between the skewness values calculated from 
Groups I and III. Hence a threshold of a skewness value of +0.31 was set and 
the sensitivity and specificity of the test was calculated. The participants with 
a skewness value of less than 0.31 was considered to be diseased while 
those with values greater was considered to be non diseased. The true 
positives and negatives and false positives and negatives were noted and the 
sensitivity and the specificity of the test were calculated. Using the skewness 
of the HR distribution as a variable to distinguish between the two groups, the 
test was found to have a sensitivity of 68% with a specificity of 72%.
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Figure 6.21: Scatter plot of the skewness of the beat by bear HR distribution calculated from
each participant across the three groups
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The observed differences between the three groups were further statistically 
analysed using non-parametric tests. The statistical package SPSS ® was 
used for the analysis. The three groups were analysed in pairs therefore a 
two-sample non-parametric test called the Man -  Whitney test was used for 
the purpose. The results are tabulated in figure 6.22.
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Ranks
1 groups N Mean Rank Sum of Ranks
skewness 1.00 35 41.57 1455.00
2.00 35 29.43 1030.00
Total 70
Test Statistics(a) -  Groups I & II
skewness
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
400.000
1030.000 
-2.496 
.013
a Grouping Variable: groups 
Ranks
I groups N Mean Rank Sum of Ranks
skewness 2.00 35 31.34 1097.00
3.00 25 29.32 733.00
Total 60
Test Statistics(a)- Groups II & III
skewness
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
408.000
733.000 
-.442 
.658
a Grouping Variable: groups
Ranks
I groups N Mean Rank Sum of Ranks
skewness 1.00 35 35.46 1241.00
3.00 25 23.56 589.00
Total 60
Test Statistics(a)- Groups I & III
skewness
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
264.000
589.000 
-2.601 
.009
a Grouping Variable: groups
Figure 6.22: Non -param etric  test results for the inter-group comparison of the skewness of 
the HR distribution. Values 1.00, 2 .00  and 3 .00  represent Groups I, II and III respectively.
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The variable skewness calculated from the three groups were analysed in 
pairs. Both the Man-Whitney (U) and the Wilcoxon (W) parameter were 
calculated. The test statistics from the comparison of Groups I and II revealed 
a small p value of 0.013. A p value of less than 0.05 indicates that the 
observed difference in the mean skewness value between the two groups is 
at a 5% statistically significant level. A similar comparison between Groups II 
and III however resulted in a very high p value of 0.7. Such a high p value 
indicates that the difference in the mean skewness calculated from the 
diabetics (Group II) and diabetics with neuropathy (Group Ilia) are not 
statistically significant, i.e. no difference could be statistically established 
between Groups II and III. Comparison between the skewness calculated 
from the healthy normal individuals (Group I) and diabetics with neuropathy 
also resulted in a very small p value of 0.009. Thus the difference in the mean 
skewness calculated from the two groups was also statistically significant.
Comparing and statistically analysing the skewness of the HR distribution 
calculated from all three groups resulted in some interesting results. A 
statistical difference could be established between Groups I and II and 
between Groups I and III. However no statistical difference could be 
established between the diabetics with and without neuropathy (Groups II and 
Ilia). Although a very small p value of 0.009 was obtained indicating a very 
significant statistical difference between the skewness calculated from Group I 
and the Group Ilia, the test was only able to distinguish between the two 
groups with a sensitivity and specificity of 68% and 72% respectively.
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Chapter VII - Results 
Low Frequency Analysis
7.1 Introduction
The raw PPG signal contains valuable information regarding the autonomic 
control of the skin microcirculation. The simultaneous occurrences of the 
prominent frequency bands in the spectrum from both legs of the participants 
indicate the central origin of this control. The analysis of the HF end of the 
spectrum in the previous chapter produced some interesting results. In this 
chapter the results from the analysis of the LF end of the spectrum will be 
discussed.
The LF end of the spectrum was represented by frequency bands from 0.016 
Hz (1cpm) to 0.42 Hz (25cpm). Several studies have been conducted to 
explore this LF end as they provide valuable information regarding the local 
and central activity of the skin microcirculation. For example the frequency 
band around 0.02 Hz (1.6 cpm) represented the thermoregulatory response of 
the body also called the Burton Waves while the frequencies around 0.1 Hz (6 
cpm) represented the autonomic regulation of blood pressure (Kamal et al 
1989). A MATLAB program was written to extract the LF information from the 
raw PPG signal. The program used a 2nd order high pass Butterworth filter 
with a cut off frequency of 0.001 Hz (0.08 cpm) and a 3rd order low pass 
Butterworth filter with a cut-off frequency of 0.42 Hz (25 cpm). The band pass
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filter thus generated allowed all frequencies between 0.0001 Hz (0.08 cpm) 
and 0.42 Hz (25 cpm) of the signal to pass through unaltered while 
attenuating all other frequencies outside this range. The filtered raw PPG 
signal therefore contained only the LF information. The time domain signal 
was then converted to the frequency domain using the Fast Fourier Transform 
(FFT) to extract the frequency information present within the signal. The 
signal was windowed using a Hanning window prior to the FFT. The Fourier 
spectrum generated from all the participants across the three groups was both 
visually and objectively analysed.
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Figure 7.1: The spectrum of a raw PPG signal that was band pass filtered with cut o ff 
frequencies of 0.001 Hz (0.08 cpm) and 0.42 Hz (25 cpm)
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7.2 Visual analysis
An example of a typical LF spectrum generated using MATLAB is shown in 
figure 7.1. In the figure, several prominent frequency bands were observed 
between 0.016 Hz (1 cpm) and 25 cpm (0.42 Hz). The very LF (VLF) bands 
between 1cpm (0.016 Hz) and 10 cpm (0.17 Hz) represented the vascular 
changes under autonomic influence and the LF bands between 10cpm (0.17 
Hz) and 20 cpm (0.33 Hz) represented the vascular changes influenced by 
the breathing cycle. Apart from these physiologically important frequency 
ranges within the LF end of the spectrum, a very strong, high amplitude peak 
was also observed between 0.2 cpm (0.003 Hz) and 0.5 cpm (0.008 Hz). This 
prominent peak at the extremely LF end of the spectrum was obtained even 
after eliminating the strong D.C offset. This probably represents the 
instantaneous skin vascularisation under the probe depicted as the very slow 
variations of the raw PPG signal around the baseline over the entire 10 
minutes of the signal (Kamal 1989).
Most of these prominent frequency bands were present in the spectrum 
obtained from both legs of the participant. The visual analysis of these spectra 
involved the analysis of the degree of correlation between the left and right leg 
spectrums from each of the participants. The main criterion for good 
correlation was the similar location of the spectral peaks along the frequency 
axis of the spectrum in both legs. The amplitude or the intensity of the signal 
was not considered for this purpose. Both the filtered raw PPG signal and the 
LF spectrum were analysed across the three groups.
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7.2.1 Visual Analysis in Group I
fa^HxyiicpTi
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Figure 7.2: LF spectrum obtained from a healthy participant o f Group I
Figure 7.2 illustrates a typical LF spectrum obtained from participants in 
Group I. Good correlation between the spectra from both legs were observed 
in 67.5% (25) of the participants in this group. The spectrums were 
considered to have poor correlation if more than two of the prominent 
frequency bands were absent or different in both the spectrums. Poor co­
relation between the two spectrums from both legs was observed in 32.5% 
(12) of the participants.
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Visual analysis of the filtered raw PPG signal in its time domain revealed 
significant slow moving amplitude variation around the zero baseline level 
over the whole 10-minute period. These variations were represented in its 
frequency domain as a strong high amplitude peak at frequencies of less than 
0.02 Hz/ 1 cpm (0.0003 Hz/ 0.02 cpm to .0008 Hz/ 0.05 cpm). Most of the 
prominent peaks observed at the LF end of the spectrum were present. The 
presence of these prominent peaks in both the left and the right foot spectrum 
also indicates a strong autonomic influence.
7.2.2 Visual Analysis in Group II
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Figure 7.3: LF spectrum obtained from a diabetic patient with no known neuropathy of Group
II
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A typical LF spectrum obtained from participants in Group II is illustrated in 
figure 7.3. As in the figure, the number of prominent peaks at the LF end of 
the spectrum was fewer when compared to the spectrum from Group I. Good 
correlation between the left and the right LF spectrum was observed only in 
47% (17) of the participants while 53% (18) had poor co-relation. The slow 
moving amplitude variations of the raw PPG signal over the ten-minute period 
was also significantly reduced in this group, with any variation in the signal 
amplitude mostly restricted to the two stress tests.
7.2.3 Visual Analysis in Group III
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Figure 7.4: LF spectrum obtained from a neuropathic patient of Group III. Note the 
dissimilarities between the left and the right foot spectrums
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Figure 7.4 illustrates a typical LF spectrum obtained from Group III. 
Participants in this group were diabetic patients with known neuropathy. The 
spectrums from both legs were observed to be dissimilar in most cases. Poor 
correlations between the left and right spectrums with at least two prominent 
frequency bands being absent or different were observed in 26.3% (10) of the 
participants in this group, while 73.7% (26) showed no correlation at all as 
illustrated in figure 7.4. The reduced or absent correlation between the left 
and the right foot LF spectrum indicate a probable loss of the various 
autonomic responses of the skin vascularisation. The amplitude of the peaks, 
if present within the spectrum, was significantly reduced when compared to 
the other two groups. This decrease in amplitude suggests reduced response 
received by the probe at these frequencies. The raw PPG signals from this 
group were observed to have very little or in most cases no variation (almost 
flat) in their amplitudes even during the two stress tests. This was also 
reflected in its frequency domain where frequency bands less than 0.02 Hz 
that represent the very slow moving amplitude variations of the raw PPG 
signal were observed to have significantly reduced amplitude as compared to 
the values obtained from Groups I and II.
7.3 Objective analysis
The visual analysis of the LF spectrums obtained from all three groups 
revealed some differences between them. The need arose to devise a method 
to quantify these differences in order to be able to objectively and statistically 
separate the spectrums into their respective groups. An average spectrum for
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each group was generated using MATLAB. A program was written to obtain 
the LF spectrum for each leg and average the spectrums obtained from all 
participants for each of the three groups. The averaged left and the right 
spectrum of the three groups were visually analysed to identify the prominent 
frequency bands present within the spectrum. Frequency bands around 0.005 
Hz (0.3 cpm), 0.033 Hz (0.2 cpm), 0.067 Hz (0.4 cpm), 0.08 Hz (0.5 cpm), 0.1 
Hz (0.6 cpm) and 0.13 Hz (0.8 cpm) were identified as the prominent very LF 
bands. The frequency band representing the breathing cycle was obtained 
between 0.2 Hz (12 cpm) and 0.42 Hz (25 cm). The number of frequency 
bands present in the spectrum obtained from the neuropathic group was 
considerably reduced as compared to the other two groups. The signal was 
split into the various segments of the experiment protocol. Five segments viz, 
initial resting phase, breathing phase, intermediate resting phase, grip phase 
and the final resting phase were analysed in the similar manner but the 
averaged spectrum for each phase did not reveal any useful information. 
Further objective analysis were performed on the spectrums using these 
prominent frequency bands.
7.3.1 Analysis using 'Area under the Curve’
Visual analysis of the spectrum revealed a significant reduction in both the 
number of frequency bands present and in their amplitude in the spectrum 
from Group III as compared to the other two groups. Thus in order to 
objectively differentiate the three groups, the area under the curve over a 
specific range of bandwidth was thought to be a useful variable for further 
investigation. A program was written in MATLAB to calculate this variable. In
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order to analyse the LF end of the spectrum, a maximum sampling frequency 
of 2 Hz (120 cpm) was sufficient. The sampling frequency of 1 kHz (60,000 
cpm) used in this study far exceeded the requirement. Thus, in order to 
decrease the run time of the program, the signal was down sampled to 120 
cpm or to 2 Hz. In this study the PPG signals were acquired at sampling rate 
of 1 kHz. Reducing the sampling rate of the raw signal by 500 times can result 
in aliasing due to under sampling of the data. Thus in order to prevent this, an 
anti aliasing filter was used. It was applied to the signal to attenuate the very 
HF components using a low pass Butterworth filter with a cut-off equal to a 
quarter of the proposed sampling frequency. This low pass filtered signal was 
down sampled to 2 Hz. The filtered down sampled raw PPG signal was then 
subjected to a band pass filter generated using a combination of a high pass 
and low pass Butterworth filters to attenuate all frequency components 
outside the range of 0.03 Hz -  0.25 Hz (2-15 cpm). Visual analysis revealed 
the most prominent frequency bands present at the lower end of the spectrum 
to be between 2 and 8 cpm and hence the area under the curve was 
calculated by summing all the data points of the spectrum between 0.03 Hz (2 
cpm and 0.13 Hz (8 cpm). Finally the mean area of the left and the right leg 
spectrum was calculated for each participant. The mean area under the curve 
between 0.03 Hz -  0.13 Hz for each participant for each of the three groups 
was obtained and plotted as a scatter plot as shown in figure 7.5.
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The mean area under the curve between 2-8cpm for three groups
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Figure 7.5: The scatter plot of the mean area under the curve between 2-8cpm for all three
groups
Visual analysis of the scatter plot revealed a significant difference in the mean 
area between diabetics with no known neuropathy (Group II) and the 
neuropaths (Group III). However normals (group I) showed a reduced area 
under the curve similar to the neuropaths.
Closer analysis of the spectrum obtained from the three groups revealed the 
frequency bands present in the spectrum from Group II were well defined and 
with high amplitudes resulting in a larger area under the curve. The frequency 
bands in the spectrum from Group III however, were erratic resulting in a 
smaller area under the curve. Though the mean area under the curve for 
Group I and Group III were within a similar range, visually they were very
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dissimilar, with the former spectrum having well defined frequency bands and 
the latter being more erratic and with a poor signal to noise ratio.
The significant difference in the mean area under the curve for the spectrums 
from groups II and III was a positive result. The principle aim of this project 
was to identify those diabetic patients who may be at risk for developing leg 
ulcers due to neuropathy. In order to achieve this goal there was a greater 
need to separate the diabetics with no neuropathy from the neuropathic 
group. Thus for subsequent analysis, attempts were made to differentiate the 
LF information obtained from groups II and III.
As shown in the scatter plot in figure 7.5, a threshold in the mean area under 
the curve of 0.6 was set, such that all participants with a mean area equal to 
or less than the threshold were considered to be neuropathic while those with 
an area greater than 0.6 were considered to be diabetics with no neuropathy. 
The number of true positives, true negatives, false positives and false 
negatives were calculated and the specificity and the sensitivity of the test 
were obtained. The sensitivity and specificity of a test is a measure of its 
diagnostic capability. The sensitivity of a test is the proportion of true positives 
correctly identified by it and the specificity is the proportion of the true 
negatives rightly ruled out by the test. These statistical variables have been 
discussed in detail in chapter 3. With a threshold of 0.6, 28 true positives and 
23 true negatives were identified with a sensitivity and specificity value of 74% 
and 64% respectively for the test. This result indicates that using the area 
under the curve for 0.03 Hz -0.13 Hz, 74% of the neuropathic patient could be
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identified while ruling out 64% of the diabetic participants. The purpose of 
good screening tool is to identify as many true positives as possible, even 
sometimes at the cost of including few false positives. This means that for a 
test to be classified as a good screening tool, it must aim for a high sensitivity. 
All LF analysis conducted from here on was aimed at identifying the best 
possible method to differentiate between Groups II and III with the highest 
possible sensitivity without drastically reducing the specificity.
7.3.2 Analysis using spectral density
Spectral density is a measure of the total power of a specific bandwidth of 
frequencies and its contribution to the Fourier spectrum. It was calculated by 
dividing the area under the curve by the bandwidth that defines the curve. The 
MATLAB program written to calculate the area under the curve was used to 
calculate the spectral density with some modifications. A frequency band 
between 2-8 cpm was selected as most of the physiologically important 
frequency bands were thought to be present within this range. The spectral 
density for this bandwidth was calculated for each of the participants for all 
three groups. The final output of the program was the mean of the spectral 
densities obtained from both the feet for each participant across the three 
groups. The variable was potted using a simple scatter plot in Excel as shown 
in figure 7.6
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Comparison of the mean spectral density (2-8cpm)
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Figure 7.6: The scatter plot of the mean spectral density for the frequency bandwidth o f 2-
8cpm for the three groups
Visual analysis of the scatter plot revealed similar results as the previous 
analysis for the mean area under the curve. A significant difference in the 
mean area between groups II (diabetics) and III (neuropathic participants) was 
observed. However once again signals from group I (normal) showed reduced 
spectral densities similar to group III. Once again for reasons explained in the 
previous section, attempts were made to differentiate Groups II and III. This 
time the sensitivity and specificity of the test were calculated using two 
different thresholds values. As explained earlier the sensitivity and specificity 
of a test are a measure of its screening capability and is often a trade off 
between the two values. The aim of any good screening test is to have the 
maximum sensitivity while still maintaining a good specificity.
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Two threshold values were used to identify the best possible value that would 
provide the optimum separation between groups II and III. First the sensitivity 
and specificity of this test were calculated by setting the mean spectral density 
of 1.20 as the threshold such that any participant with a value equal to or less 
than this threshold were considered to be neuropathic and those with value 
above 1.20 were considered to be non neuropathic. Using this threshold the 
test was able to identify 28 out of 38 as to be positively neuropathic and 
exclude 22 out of 34 diabetics with no known neuropathy as negatives. The 
sensitivity and specificity of the test were calculated to be 74% and 65% 
respectively. The threshold was then slightly raised to a mean spectral density 
value of 1.50. Using this new value the test was now able to rightly identify 31 
out of 38 as to be positively neuropathic but managed to exclude only 15 out 
of 34 diabetics with no known neuropathy as negatives. By increasing the 
threshold of the study, the sensitivity of the test was raised to 82% but the 
specificity decreased to 44%.
Thus by altering the threshold values, the sensitivity and the specificity values 
of the test could be adjusted. A range of thresholds was considered for all 
subsequent analysis and the sensitivity and specificity for each of the 
thresholds were calculated and compared. The threshold that differentiated 
between the diseased and the non-diseased with the highest sensitivity and 
maintained the specificity of the test at above 60% was considered to be the 
best choice.
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In the HF analysis as explained in Chapter 6, the HR could not be extracted 
from the raw PPG signal from 13 individuals in Group III due to the greatly 
reduced activity at the HF end of the spectrum It was essential to rule out 
similar possibility in the LF analysis as well. Hence the whole analysis was 
repeated using data from the subset Group Ilia.
The mean spectral densities calculated from the Groups I, II and Ilia were 
plotted using a scatter plot as shown in figure 7.7. Visual analysis of the 
scatter plot does not reveal any obvious difference between figure 7.6 (using 
Group III) and 7.7 (using Group Ilia). However a similar threshold of 1.2 was 
set to calculate the sensitivity and specificity of the test.
Comparison of the mean spectral density (2-8cpm) using Group Ilia
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Figure 7.7: The scatter plot o f the mean spectral density for the frequency bandwidth of 2-8
cpm for the Groups I, II and Ilia
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Visual analysis of the scatter plot indicates reduced spectral density in 
participants from Group Ilia when compared to Group II. Thus participants 
with a mean spectral density value equal to or less than 1.2 were considered 
to be neuropathic and those with values greater than the threshold were 
considered to be diabetics with no neuropathy. By using data from Groups Ilia 
instead of the whole group, the test was able to distinguish between the 
diseased and the non -diseased with a sensitivity of 76% and specificity of 
65%. The test using both Group III as a whole and the new subset Group Ilia 
produced similar sensitivity and specificity values.
Though the sensitivity and specificity of the test remained relatively 
unchanged with using the whole group or its subset, the descriptive statistics 
of the two were compared to identify any statistical differences between them. 
The descriptive statics of Groups III and Ilia were calculated using Excel and 
have been tabulated in figure 7. 8.
Group III Group Ilia
M ean 1 .1174 M ean 1.1102
Standard Error 0 .1 0 5 6 Standard Error 0 .1 2228
Median 1.0134 M edian 1.0254
Standard Deviation 0.6511 Standard Deviation 0 .6114
Range 2 .533 R ange 2 .4 6 7 3
Minimum 0.3047 Minim um 0.3704
M axim um 2 .8377 M axim um 2 .8 3 7 7
Confidence Level 
(95 .0% ) 0 .214
Confidence Level 
(9 5 .0 % ) 0 .25237
Figure 7.8: Descriptive statistics for G roups ill and Ilia
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The descriptive statistics for the whole group and the subset were almost 
identical suggesting no possible statistical difference between the two. These 
results indicate that the LF information can be extracted from all the 
participants in Group III and the data from the whole group can be used for all 
further LF analysis.
7.3.3 Statistical Analysis using spectral density
The scatter plot as shown in figure 7.6 and 7.7, revealed decreased spectral 
densities for group III as compared to the other groups. There was a need to 
identify if these differences between the groups picked up by visual analysis 
of the scatter plot were at a statistically significant level. The spectral densities 
of the three groups were statistically analysed using the hypothesis testing 
method. A null hypothesis that ‘there is no difference in the mean spectral 
densities obtained from the three groups’ was set for the purpose. Both the 
histogram and the Q-Q plot were generated to test if the variable had a 
normal distribution. Mean spectral densities from all three groups were found 
to follow a near-normal distribution.
A parametric test such as the one-way ANOVA was chosen as a suitable 
statistical test to compare the mean spectral densities of the three groups. 
Both Tukey HSD (Highly significant difference) and LSD (least significant 
difference) tests were chosen for the multiple comparisons using SPSS 
statistical package. In SPSS the one-way ANOVA generated two sets of 
result. This test has been explained in detail in chapter 3 section 3.4.2. The 
results from the test were tabulated in figure 7.9.
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The F value of 5.4 indicates unequal variances both between groups and 
within the group. The p value of 0.006 obtained was also a statistically 
significant result Thus, the first part of the test established that the mean 
spectral densities obtained for the three groups were not equal.
The second part of the test further looked into the inter group variability in the 
mean spectral density values. Both the Tukey HSD and the LSD comparison 
methods indicate that the difference observed in the mean spectral densities 
of group II and III were at a statistically significant level with a p value of 
0.008. The tests were however unable to establish any significant difference 
in the mean spectral densities calculated for groups I and III due to the very 
high p value of 0.974. These results were consistent with those obtained in 
the HF analysis and in the analysis using area under the curve.
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A N O V A
Mean spectral density of the LF bandwidth between 2-8 cpm
Sum of Mean
Squares df Square F Sig.
Between
Groups
5.319 2 2.659 5.438 .006
Within Groups 52.329 107 .489
Total 57.647 109
Multiple Comparisons
Dependent Variable: mean spectral density
Mean
95%  Confidence Interval
(0
group
(J)
group
Difference (I- 
J) Std. Error Sig.
Lower
Bound
Upper
Bound
Tukey group I group II
HSD
.4 4 9 9 6 1 1 1 0
.16483199 .020 -.8417285 -.0581937
group III .03448363 .16264869 .976 -.3520946 .4210618
group II group I .4 4 9 9 6 1 1 1 0 .16483199 .020 .0581937 .8417285
group III .4 8 4 4 4 4 7 4 0 .16264869 .010 .0978665 .8710229
group III group I -.03448363 .16264869 .976 -.4210618 .3520946
group II
.4844 4 4 7 4 0
.16264869 .010 -.8710229 -.0978665
LSD group I group II
.449961110
.16483199 .007 -.7767213 -.1232009
group III .03448363 .16264869 .833 -.2879484 .3569157
group II group I 
group III
.449961110
.484444740
.16483199
.16264869
.007
.004
.1232009
.1620127
.7767213
.8068768
group III group I -.03448363 .16264869 .833 -.3569157 .2879484
group II
.484444740
.16264869 .004 -.8068768 -.1620127
* The mean difference is significant at the .05 level
Figure 7.9: Parametric test or one-way ANOVA to compare the mean spectral density of the
three groups
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7.3.3 Spectral density of various combination of bandwidths
The LF analysis performed so far only used the frequency bandwidth of 0.03-
0.13 Hz. The visual analysis of the LF spectrum from healthy individuals 
revealed the presence of several prominent frequency bands between 0.03 
Hz 0.42 Hz. Most of these frequency bands were also physiologically 
important. Using a single bandwidth of frequency (0.03-0.42 Hz) the test both 
visually and to some extent statically was able to separate the groups from 
each other. The mean spectral densities of different bandwidths were further 
analysed.
The analysis was not only performed on the spectrum obtained from the 
whole PPG signal, but also on the three main exercise segments viz, the 
breathing phase, the intermediate resting phase and the grip phase as well. 
The bandwidths chosen were 0.03-0.13 Hz (2-8 cpm), 0.08 -.13 Hz, (3-7 
cpm), 0.06-0.12 Hz (5-7 cpm), 0.05- 0.33 Hz (3-20) cpm and 0.08- 0.33 Hz (5- 
20 cpm). The last two were chosen to include the breathing components as 
well. MATLAB was used to perform the analysis and was done in two steps. 
The first step involved generating a scatter plot for the mean spectral 
densities for the different bandwidths being analysed. After visual examination 
of the scatter plots a range of possible threshold values of the mean spectral 
density was selected for each bandwidth. The main aim of the study was to 
find a suitable method that could best distinguish between the three groups. 
As explained earlier efforts were made to establish the best possible method 
to separate groups II and III. The scatter plots generated for the mean 
spectral density values across the three groups did not have any clear
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demarcation between them as the values were spread out with a wide range. 
Thus a range of threshold values was analysed to obtain the most optimum 
level of separation between the two groups.
The second step involved calculating the number of true positives and 
negatives that could be identified using a particular threshold value. The 
scatter plots revealed reduced spectral densities for participants in group III. 
Hence if the value of the spectral density for a participant was equal to or less 
than the threshold value, the participant was regarded as diseased (in this 
case neuropathic) or else regarded as non diseased (in this case diabetics 
with no neuropathy). The true positives and true negatives thus generated 
were used to calculate the sensitivity and specificity of the test for that 
particular threshold. This analysis was performed on the whole signal, the 
breathing phase, the intermediate resting phase and the grip phase 
individually.
The MATLAB Program
The above-mentioned analysis was performed using both MATLAB and 
Microsoft Excel. Three lists namely normal, patient and neuropathic list were 
created in MATLAB containing the data from groups I, II, and III respectively. 
Though the program was written to analyse all three groups, only the data 
from Groups II and III were used for calculating the sensitivity and specificity 
of each of the tests. The lists were loaded one at a time, analysed, and the 
final set of results were outputted after going through all three groups. In the
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next few paragraphs the sequence of the program to analyse the data from a 
single participant would be explained.
The flow chart for the program is illustrated in figure 7.10. The sequence as 
shown in the figure was repeated for all participants in one list before moving 
on the next list where the whole sequence was once again repeated. This 
program was not only used to analyse the whole PPG signal but with slight 
modifications was also used to analyse the individual segments of the whole 
PPG signal.
Once loaded the huge DC offset was removed by subtracting the signal from 
its mean. The sampling rate of the Assist was very high at 1 KHz and it 
exceeded our sampling rate requirement while analysing the LF end of the 
spectrum. Thus in order to decrease the run time of the program, it was 
decided to resample the raw PPG signal at a much smaller sampling rate of 
120 cpm or 2 Hz. In order to avoid any possible aliasing during the re­
sampling of the PPG signal, an anti-aliasing filter was used. A second order 
low pass Butterworth filter with a cut-off frequency of 0.5 Hz cpm was used for 
the purpose. The filtered signal was then re-sampled at the new sampling rate 
and was band pass filtered between 2 cpm and 15 cpm. A Combination of 2nd 
order high pass filter with a cut off of 0.03 Hz (2 cpm) and 3rd order low pass 
filter with a cut off of 0.42 Hz (25 cpm) was used to band pass the signal such 
that all frequencies above and below the cut-off frequencies were attenuated 
producing a signal mainly containing the LF information. The spectral analysis 
was then carried out on the modified raw PPG signal. The signal was
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windowed using a Hanning window before a full length FFT was performed. 
Once the spectrum was generated the mean spectral density of the bandwidth 
of interest was calculated from the left and the right spectrum.
A range of possible threshold values of the mean spectral density were 
analysed. For each threshold value the number of true positives and 
negatives were calculated. If the mean spectral density of a participant was 
equal to or less than the threshold value then they were considered positives,
i.e. positively neuropathic and if their mean spectral density was above the 
threshold value they were considered negatives or only diabetic (with no 
neuropathy). The final output of the program generated the true positives and 
true negatives calculated for all three groups, however only the data from 
Groups II and III were used for the analysis.
The program generated two column vectors for each group, containing the 
number of positives and negatives calculated for each threshold selected 
within the group for a particular bandwidth of interest. The values calculated 
for Group II and III were noted and transferred to the Excel spread sheet. 
Using Excel the sensitivity, specificity, positive predictive value, negative 
predictive value and the accuracy of the test were calculated. This program 
was repeated for 6 different ranges of bandwidth and also for the different 
segments of the PPG signal. These values were carefully studied and the 
threshold that provided the best sensitivity and specificity for the test was 
selected for each bandwidth and these results were tabulated in figure 7.11.
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Normals Patients neuropathies
Raw PPG signal 
fs = 1 KHz
Anti- Aliasing Filter
BPF = Band pass Filter 
FFT = Fourier Transform 
L& R = left & right 
Fs = Sampling frequency
Resample Data 
fs = 120cpm
BPF 
(2 - 25cpm )
FFT
Mean Spectral density ( L& R 
msd Count = 1:6
Threshold value 
threshCount = 1 : n
msd <= thresh?
NegativesPositives
Threshcount = 0 ?
Ye^
msd count = 0 ?
End
O/P list positives and negatives 
of the 3 groups
173
Fig
ure
 
7.1
0: 
Flo
w 
Ch
art
 o
f t
he 
MA
TL
AB
 
pro
gra
m 
to 
ca
lcu
lat
e 
the
 
se
ns
itiv
ity
 
& 
sp
ec
ific
ity
 o
f t
es
t
usi
ng
 
me
an
 
sp
ec
tra
l d
en
sit
y
Whole
Signal
Bandwidth
(cpm)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Accuracy
(%)
2-8 73.7 63.88 68.29 69.69 68.91
5-8 71.0 61.1 65.8 66.7 66.2
3-7 71.0 61.1 65.8 66.7 66.2
4-7 73.7 50 61 64.2 62.2
3-20 76.3 53 63 68 65.0
5-20 71.0 55.6 62.8 64.5 63.5
Breathing
Phase
2-8 71.05 61.11 65.85 66.67 66.22
5-8 76.32 58.33 65.91 70.00 67.57
3-7 68.42 66.67 68.42 66.67 67.57
4-7 73.68 61.11 66.67 68.75 67.57
3-20 84.2 61.1 69.57 78.57 62.97
5-20 84.21 58.33 68.08 77.78 71.62
Resting
Phase
2-8 76.3 58.3 65.9 70.0 67.57
5-8 78.9 50.0 62.5 69.23 64.86
3-7 71.05 69.44 71.05 69.44 70.27
4-7 68.4 64.0 66.7 65.71 66.21
3-20 79.0 55.6 65.2 71.43 67.57
5-20 79.0 55.6 65.22 71.4 67.60
Grip
Phase
2-8 65.78 75.00 73.52 67.50 70.27
5-8 76.31 47.22 60.41 65.39 62.16
3-7 65.78 61.11 64.10 62.85 63.51
4-7 65.78 61.11 64.10 62.85 63.51
3-20 78.9 41.66 58.82 65.21 60.81
5-20 73.68 41.67 57.14 60.00 58.10
Figure 7.11: The sensitivity and specificity of the test obtained for various bandwidth 
combinations on the whole and the individual test segments of the signal
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The breathing, the intermediate resting and the grip phase represented the 
different stages of the experiment protocol. The breathing phase was a two 
minute segment during which the participant was asked to breathe in and out 
across some resistance using the Power Lung®, while the grip phase was 
another two minute segment during which the participant was asked to grip 
the dynamometer at 10% of their maximum grip strength. The resting phase 
represented the intermediate resting period of three minutes between the two 
stress tests and could be used as representative of a signal with no stress 
tests. However there is a strong possibility of observing some spill over effect 
of the breathing phase onto this phase. The aim of analysing the different 
segments of the PPG was to determine the extent of influence of these stress 
tests on the raw PPG signal and their importance is identifying the true 
positives (group III) and ruling out the true negatives (group II).
Visual analyses of the HF and LF end of the spectrum so far have revealed 
far greater response of the peripheral circulation to the breathing exercise as 
compared to the grip test. The blood pressure response to the grip test is a 
commonly used diagnostic test for autonomic neuropathy. The grip test used 
in this study was intended to replicate similar pressure changes which being a 
sympathetic response was thought to be reflected in the peripheral circulation. 
The reduced response may be influenced by the level of stress chosen for the 
study. Prior to the actual study, two different levels of grip test viz; 10% and 
20% were tested on volunteers within the department and the 10% level was 
found to be more user friendly. As most patients requiring screening were the 
elderly it was essential for the tests chosen to be patient compliant. Hence the
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stress level was kept to only 10% of the person’s maximum grip strength. 
However later during the analysis of the data reduced response to the grip 
test was observed across the three groups, mainly Groups II and III. This 
could be perhaps due to the lower level of stress used for the study. Visual 
analysis of the signals have revealed a good response to the breathing test in 
both the normals and the diabetics with no neuropathy and this response was 
found to be severely reduced in neuropathic patients. The table in figure 7.11 
illustrates the different sensitivity and specificity values calculated for different 
frequency bandwidths on the whole signal and the three segments of the raw 
PPG signal. The table depicts the different degrees of success achieved in 
separating groups II and III. Some interesting conclusions were drawn after a 
detailed analysis of the table.
Analysis on the grip phase of the segment resulted in the poorest sensitivity 
and specificity calculation for the test. The sensitivity and specificity 
calculation is often a trade off between the two. The best combination of the 
two was obtained when the mean spectral density for a bandwidth of 0.05- 
0.12 Hz (3-7 cpm) was calculated and compared between the diabetics and 
the neuropathies. A sensitivity of approx 66% and specificity of approx 61% 
was calculated. However, including the whole spectrum of the LF components 
including the breathing components (3-20 cpm) increased the sensitivity of the 
test to 79% but the specificity dropped to around 42%.
Analysis on the resting phase produced better results than the analysis on the 
whole signal and the grip phase. The best combination of specificity and
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sensitivity were obtained while comparing the mean spectral density of 
bandwidth of 0.05-0.12 Hz (3-7 cpm). A sensitivity of 71% and specificity of 
69% was achieved. Once again it was observed that the sensitivity of the 
study was higher while comparing the mean spectral density of the whole LF 
spectrum including the breathing components 0.05-0.33 Hz (3-20 cpm). The 
sensitivity rose to 79% but the specificity fell to 56%.
Similar conclusions can be extended to the results of analysing the whole 
PPG signal. Once again the best combination of optimum sensitivity and 
specificity of the test was obtained by comparing the mean spectral densities 
of 0.05- 0.12 Hz (3-7 cpm). A sensitivity of 71% and specificity of 61% was 
obtained using this method of analysis. Once again by including the breathing 
components 0.05- 0.33 Hz (3-20 cpm) as well the sensitivity of the study could 
be increased to 76% but at the cost of reduced specificity of 53%.
Amongst all the different signal segments, the analysis on the breathing 
phase produced a significantly better result. Analysis of the mean spectral 
density for 0.03- 0.12 Hz (3-7 cpm) produced a sensitivity of 68% with a 
specificity of 66%. However the analysis of the mean spectral density for 3-20 
cpm achieved the best results with a sensitivity and specificity value of 84% 
and 61% respectively.
The above results indicate that the analysis on the breathing phase of the 
signal and calculating the spectral density for 0.05- 0.33 Hz (3-20 cpm) 
including the breathing components produced the best possible results. The
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spectral density is a measure of the contribution of a frequency band in the 
spectrum. Of the various bandwidths analysed, the results improved 
significantly with the addition of the breathing components. There must be a 
significant difference in the spectral density of the breathing components 
between the two groups. The group mean value ± SD was obtained by 
evaluating the descriptive statistics of the mean spectral density values from 
all three groups. The mean spectral density for Groups 1,11 and III were 0.65 ± 
0.47, 0.97 ± 0.83 and 0.48 ± 0.3 respectively. The mean spectral density 
values for Group III was lowest amongst the three groups and it was also 
found to be significantly lower than the mean value obtained for Group II. 
Previous analysis of both the raw signal and the spectrum revealed reduced 
response to the breathing test amongst group III participants as compared to 
the other two groups. The results from this analysis also indicate a reduced 
LF response in the neuropathic group as compared to the diabetics with no 
known neuropathy.
7.3.4 Analysis using the spectral density of very LF bandwidths
In all the analysis so far, the LF bandwidths (0.03 Hz- 0.13 Hz) and high LF 
bandwidth (0.16 Hz -  0.33 Hz) have been analysed. As mentioned previously, 
almost all the spectrums from across the three groups also presented with a 
high amplitude peak at the very LF end of the spectrum at frequencies below 
1 cpm (0.2 cpm -  0.5 cpm). These very low frequencies represent the 
instantaneous skin vascularisation under the probe. Skin microcirculation is a 
dynamic environment where the blood flow changes with the local metabolic 
demand. The flow at the microcirculatory level is controlled by the AV shunts.
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The selective opening and closing of these shunts causes this change in the 
capillary flow. The sympathetic branch of the autonomic nervous system, as 
mentioned in the first chapter, controls these AV shunts. In healthy individuals 
opening of these shunts are usually maintained at a higher resistance 
allowing most of the nutritive blood to flow through the capillaries as per the 
local metabolic demand while limiting the flow through these shunts into the 
venules. In the event of any autonomic dysfunction, this high resistance 
pathway is completely lost and almost all the blood is shunted into the venular 
circulation, bypassing the capillaries. In these individuals the PPG probably 
detects mainly the flow through the AV shunts and not the capillary flow. Also 
in such individuals, the microcirculation loses the capacity to alter capillary 
blood flow as per the local metabolic demand and therefore the very slow 
amplitude changes picked up by the probe may be absent in their raw PPG 
signal obtained over the whole 10-minute period.
During the visual analysis of the raw signal, the slow moving amplitude 
changes were found to be prominent in the healthy individuals with an 
exaggerated response during the two stress tests. On the contrary the signals 
from Group III were almost flat with very little or no amplitude variations over 
the whole 10 minutes of the signal. Thus it was essential to identify if the 
spectral densities of these very LF bands could distinguish Groups I, II and III. 
The program used in the previous sections with some minor modifications in 
the band pass filter specifications, was used to calculate the mean spectral 
density at these low frequencies. The cut off frequency of the band pass filter 
was altered to allow the very LF to pass through it.
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The mean spectral density for bandwidths of 0.002 -  0.005 Hz (0.1-0.3 cpm) 
and 0.002 -  0.008 Hz (0.1-0.5 cpm) were calculated and compared for all 
three groups. The peak frequency for both bandwidths was at 0.003 Hz (0.2 
cpm). Figure 7.12 and 7.13 are the scatter plots for the mean spectral 
densities calculated for both bandwidths. The mean spectral densities 
calculated were absolute values and hence had no units.
Mean spectral density (0.1 cpm -0.3 cpm) for Groups I. II and III
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Figure 7.12: Comparison of the mean spectral density for a bandwidth of 0.1 cpm -  0.3 cpm 
calculated from Groups I, II and III. The optimum threshold o f the mean spectral density value 
that could best separate between Groups II and III was observed to be 0.45 x 10
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Mean spectral density (0.1-0.5cpm) of Groups I, II & III
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Figure 7.13: Comparison of the mean spectral density for a bandwidth o f 0.1 cpm -  0.5 cpm 
calculated from Groups I, II and III. The optimum threshold o f the mean spectral density value 
that could best separate between Groups II and III was observed to be 2.3 x 10
The mean spectral density analysis for both bandwidths generated similar 
scatter plots. As with other LF analysis, the variable calculated from Group I 
was spread across the plot with a wide range of values. Group I could not be 
separated from the other two groups. However the mean spectral density 
calculated from Group II could be separated from the values generated from 
Group III with some success. The participants with a mean spectral density 
value equal to or less than the threshold were considered to be diseased, 
while those with values greater than the threshold were considered to be non­
diseased. Using both bandwidths separately the test was able to rightly
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identify 29 out of 38 as neuropathies and rule out 24 out of 35 participants as 
diabetics with no neuropathy thereby separating the two groups with a 
sensitivity of 76% and a specificity of 69%.
Further statistical analysis was performed to identify if the differences 
observed between the two groups were true or only by chance. Since the 
analysis on both the sets of bandwidths produced similar scatter plots, it was 
decided to do further tests on only one. Descriptive statistics of the mean 
spectral density (0.002 -  0.008 Hz) calculated from all three groups were 
calculated using Excel and are tabulated in figure 7.14.
Group 1 Group II Group III
M ean 2.5 M ean 2.8 M ean 2 .2
Standard Error 0.2 Standard Error 0.2 Standard Error 0.2
Median 2 M edian 2.6 M edian 1.9
Standard Deviation 1.2 Standard Deviation 1.2 Standard Deviation 1.4
Sam ple Variance 1.4 Sam ple V ariance 1.4 S am ple  V ariance 1.9
Kurtosis 1.2 Kurtosis 0 .02 Kurtosis 0 .8
Skewness 1.3 Skew ness 0.5 Skew ness 1.4
Range 4.6 R ange 5.1 R ange 5
Minimum 0.8 Minimum 0.7 Minim um 0.8
Maxim um 5.5 M axim um 5.7 M axim um 5.8
Confidence Level 
(95 .0% ) 0.4
C onfidence Level 
(95 .0% ) 0.4
C onfidence Level 
(9 5 .0 % ) 0 .5
Figure 7.14: Descriptive statistics on the m ean spectral density for bandwidths o f 0.1 -  0 .5
cpm calculated from all three groups.
From the above table we can see that Group II had the highest mean spectral 
density value, while the participants from Group III had the smallest mean 
spectral density value. Though the scatter plot failed to distinguish between 
the healthy individuals (Group I) and the neuropathic group (Group III), their
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mean spectral density values were different. The participants of Group I were 
observed to have a higher mean spectral density value compared to the 
neuropathies and this was more in line with the expected result. The 
histograms of the variable calculated from the three groups were also 
analysed. They have been illustrated in figure 7.15.
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Figure 7.15: The histogram of the mean spectral density calculated for Groups I (a), II (b), and 
III (c). O f the three groups, only the variable calculated from Group II follow a near normal 
distribution with very small skewness and kurtosis values
On analysing the histograms generated for the three groups, only the variable 
from Group II followed a near normal distribution. The descriptive statistics for 
this group also revealed a very small kurtosis and skewness value indicating a 
normal distribution. However since the variables generated from the other two 
groups do not follow a normal distribution, a non-parametric test was used to 
test the null hypothesis. The inter-group relations of the three groups were 
tested in pairs. The results of the test are illustrated in figure 7. 16.
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Ranks
groups N Mean Rank Sum of Ranks
0.1-0.5cpm normal 36 31.94 1150.00
diabetic 35 40.17 1406.00
Total 71
Test Statistics?
0.1-0.5cpm
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
484.000
1150.000
-1.679
.093
a. Grouping Variable: groups
Ranks
groups N Mean Rank Sum of Ranks
0.1-0.5cpm diabetic 35 44.40 1554.00
neuropathic 38 30.18 1147.00
Total 73
Test Statistic^
0.1-0.5cpm
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
406.000
1147.000
-2.860
.004
a- Grouping Variable: groups
Ranks
groups N Mean Rank Sum of Ranks
0.1-0.5cpm normal 36 42.28 1522.00
neuropathic 38 32.97 1253.00
Total 74
Test Statistics?
0.1-0.5cpm
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
512.000
1253.000
-1.860
.063
a. Grouping Variable: groups
Figure 7.16: M an-W hitney test to com pare the m ean spectral densities calculated from the
three groups; a pair a t a  tim e
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The null hypothesis that was established for this analysis was that there was 
no difference in the mean spectral density values between the two groups. 
The relation between the groups were analysed using a pair at a time. The 
mean ranks, the sum of mean ranks, the Mann-Whitney variable (U), the 
Wilcoxon variable (W), the z value and its corresponding p value for the given 
degree of freedom were all calculated using the statistical package SPSS. On 
comparing the variable calculated from Groups I and II, the p value (0.093) 
generated for the test was found to be greater than 0.05 and the null 
hypothesis could not be rejected. Thus no statistical difference could be 
established between the mean spectral density calculated for Groups I and II 
and any difference observed is only by chance.
A high p value of 0.063 was also obtained while comparing the mean spectral 
densities obtained from Groups I and III. Though no statistical difference could 
be established between the two groups, the p value was smaller than the 
previous comparison and was closer to 0.05. As expected from the scatter 
plot, a statistically significant difference could be established between the 
mean spectral density values calculated from Groups II and III. The p value 
generated was very low at 0.004 suggesting a highly significant difference 
between the two groups. In chapter 4B and so far in this chapter, we have 
seen that Groups II and III can be separated with some success using both 
HF and LF information from the Fourier spectrum of the raw PPG signal. In 
the next part of this chapter, both the HF and LF analysis were combined with 
an aim to further improve the screening capability of the test.
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7.4 Combination of HF and LF analysis of the spectrum
Both the low and the HF analysis individually were able to differentiate 
between groups II and III at a statistically significant level. It was decided to 
combine the two analyses by calculating a new variable called the ‘hrbylf, 
which is a ratio of the mean spectral density of the HR bandwidth to the mean 
spectral density of the selected LF bandwidth. From the discussion of the 
table in figure 7.11, it was observed that the LF spectral density analysis on 
the whole signal and the resting phase produced similar results, which were 
satisfactory while the same analysis on the breathing phase gave better 
sensitivity and specificity value for the tests. It was also revealed that 
analysing the LF spectrum over the bandwidths of 0.05-0.11 Hz (3-7cpm) and 
0.05-0.33 Hz (3-20cpm) produced the best sensitivity and specificity values 
for the test.
Although the mean spectral density of the very LF end of the spectrum also 
produced favourable results, they were not used throughout this analysis. At 
low frequencies like 0.003 Hz, it takes nearly five minutes to complete one 
cycle. Thus over a whole ten minute of the raw signal, we can only obtain 2 of 
these cycles. The new variable ‘hrbylf was calculated for the whole, resting 
and the breathing phases of the signal. Such low frequencies cannot be 
obtained within the segments of the raw PPG signal as each of the phases 
only lasts between 2-3minutes. However, in the calculation of the hrbylf on the 
whole signal the spectral densities at the very LF end of the spectrum were 
also used. Thus it was decided to calculate and analyse the variable hrbylf, 
with the LF spectrum defined by the bandwidths of 0.05- 0.12 Hz (3-7cpm)
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and 0.05- 0.33 Hz (3-20cpm) for all three combination of signals with the 
addition of LF bandwidth of 0.002- 0.008 Hz (0.1-0.5 cpm) for the whole 
signal.
Through out the LF analysis, data from all participants in Group III were used 
for the analysis as no difference in the LF spectrum could be established both 
visually and statistically between Groups III as a whole and the new subset 
Group Ilia (as explained in section 7.3.2). However the HF information was 
completely lost in the thirteen individuals excluded from the subset Group Ilia. 
The new variable ‘hrbylf involves both the HF and the LF end of the 
spectrum. Thus it was necessary to use the new subset Group Ilia rather than 
the data from all the participants in Group III for calculating this variable.
The MATLAB program written for the HF and the LF analysis were combined 
with slight modification to calculate the new variable hrbylf for all three groups. 
This variable was calculated as a ratio of the mean spectral density of the HR 
frequencies to the mean spectral density of the selected bandwidth. The flow 
chart illustrating the different stages of the analysis is shown in figure 7.17. 
The program was written in two stages.
The first part was used to calculate the ratio called hrbylf for each of the 
participants within a group and to produce a scatter plot of the distribution of 
this variable across a group for all the three groups. The mean spectral 
densities of the HR frequencies and the low frequencies were calculated as 
two separate sections within the program. The signal was re-sampled to a
188
suitable sampling frequency in the two sections before any further analysis. 
An anti-aliasing filter was also used in both cases. The signal was subjected 
to an anti-aliasing Butterworth 2nd order low pass filter with a cut off frequency 
of 0.5 Hz (30cpm) in order to attenuate the signal beyond the cut-off limit. The 
signal was then re-sampled at a lower sampling rate of 2 Hz deemed 
sufficient to analyse the frequency components between 0.03- 0.45 Hz (2 and 
27 cpm). This re-sampled signal was then band-pass filtered using a high- 
pass 1st order Butterworth filter with a cut-off frequency of 0.02 Hz and a low- 
pass 3rd order Butterworth filter with a cut-off of 0.45 Hz in combination. This 
band-pass filtered signal was then spectrally analysed using the FFT function. 
The area under the curve between 0.05- 0.12 Hz (3-7cpm) and 0.05- 0.33 Hz 
(3-20cpm) bandwidths were calculated and the mean spectral density was 
obtained for the two bandwidths.
In order to calculate the spectral density of the HR bandwidth the signal was 
first re-sampled to 8.7 Hz (520cpm). The re-sampled signal was then band­
pass filtered using a high-pass 3rd order Butterworth filter with a cut-off 
frequency at 1 Hz (60cpm) and a low pass 1st order Butterworth filter with a 
cut-off frequency of 1.7 Hz (100cpm) to preserve the signal between 1-1.7 Hz 
while attenuating the rest of the signal beyond these cut-off limits. A Fourier 
transform was performed on the band-pass filtered signal and the location of 
the maximum amplitude of the spectrum was determined. The HR in man is a 
highly variable entity and does not constitute of only a single frequency, 
instead it is represented by a band of frequencies with a main central 
frequency. The bandwidth of the HR frequencies was determined by
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calculating the lower and upper limit of the bandwidth. These limits were 
calculated as the upper and lower 70% of the maximum amplitude 
determined. The next step was to calculate the mean spectral density of the 
HR bandwidth determined earlier. The ratio of the two mean spectral densities 
was calculated to obtain the variable hrbylf.
The variable hrbylf calculated for all participants of all three groups was 
presented as a scatter plot and analysed. Once again the normals and the 
neuropathic groups produced similar results. On detailed visual analysis of the 
plot it was observed that the patients with no known neuropathy produced 
smaller ratios as compared to the neuropathic patients. This was an expected 
result. In the HF analysis, the spectral activity at the HF end of the spectrum 
was observed to be around similar values in Groups II and Ilia, while in the LF 
analysis the spectral density was observed to be much greater in Group II 
when compared with Group III, thereby generating a higher hrbylf ratio in 
Group II than in Group Ilia participants. Visual analysis revealed a marked 
separation between the ratios obtained from Group II (diabetics with no 
neuropathy) and Group Ilia (neuropathic patients). A range of possible values 
of the hrbylf index were chosen as thresholds that could best separate the 
ratios of the two groups.
The second part of the program was used to apply each threshold value from 
the selected range to calculate the number of positives (neuropaths) and 
negatives (diabetics with no neuropathy) identified by the program. If the 
hrbylf index of a participant was equal to or greater than the chosen threshold
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value then the participant was considered positively neuropathic or else they 
were considered as negative or diabetics with no neuropathy. Since no clear 
demarcation could be obtained between the ratios of the two groups (Group I 
and Group II), some degree of cross over was expected.
The positives and the negatives calculated for Group Ilia were called the true 
positives and the false negatives respectively. Similarly the positives and the 
negatives calculated from patients within group II were called false positive 
and true negatives of the study respectively. These variables were calculated 
for each threshold within the range of values selected. These numbers were 
then exported to Excel spread sheet to calculate the sensitivity, specificity, the 
positive predictive value, the negative predictive value and the accuracy of the 
tests for each selected threshold value. The analysis was repeated on the 
breathing and the intermediate resting segment of the signal as well. For each 
segment of raw signal analysed, the variable hrbylf was calculated with LF 
bandwidths of 0.05-0.12 Hz (3-7cpm) and 0.05-0.33 Hz (3-20cpm). The hrbylf 
variable was calculated for LF bandwidths of 0.05-0.12 Hz, 0.05-0.33 Hz and 
0.0002-0.0008 Hz (0.1-0.5 cpm) for the whole signal. The results were 
tabulated as shown in figure 7.18.
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List 
For i = 1:3
Normals Patients neuropathies
Raw PPG signal 
fs = 1 KHz
Anti- Aliasing Filter 
wc = 30cpm
Anti- Aliasing Filter 
wc = 130cpm
Resample Data 
fs = 120cpm
Resample Data 
fs = 520cpm
BPF 
(60 -1 0 0  cpm )
BPF 
(2 - 25 cpm )
Mean Spectral densityof 
the HR bandwidth ( L& R )
Mean Spectral density of the 
Low Frequency bandwidth ( L& R 
msd Count = 1:2
msd LF/msd HR 
hrbylf
Threshold value 
threshCount = 1 : n
hrbylf <= thresh?
Yes, No
PositivesNegatives
No
Threshcount = 0 ?
Yes
No
msd count = 0 ?
No
End
O/P lists positives and negatives of 3 groups
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Bandwidth
(Hz)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
Accuracy
(%)
Whole 0.05-0.12 76 54 54 76 63
Signal
0.05-0.33 76 63 59 79 68
0.0002-
0.0008
76 63 59 79 68
Resting 0.05-0.12 72 63 58 76 67
Phase
0.05-0.33 84 60 60 84 70
Breathing 0.05-0.12 68 63 57 73 65
Phase
0.05-0.33 80 63 60 81 70
Figure 7.18: The screening capability of the study expressed in the form of sensitivity, 
specificity, positive predictive value, negative predictive value and accuracy. T h e  variable  
‘hrbylf w as calculated for the whole, resting and breathing phase with different LF bandwidths
The two main bandwidths of the LF spectrum i.e. 0.05-0.12 Hz (3-7 cpm) and 
0.05-0.33 Hz (3-20 cpm) that produced the best separation between groups II 
and III were used for further analysis in the calculation of the hrbylf index. A 
combination of the HF analysis and the LF analysis was expected to further
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increase the sensitivity of the test. From the conclusions drawn in the LF 
study it was decided to perform this analysis on the whole signal, the 
breathing segment of the signal and the intermediate resting segment. Both 
the HF and the LF analysis were combined with an aim to improve the 
screening capability of the test, however using hrbylf the sensitivity of the test 
was observed to slightly drop, while a small increase was observed in its 
specificity.
The hrbylf index was calculated for 0.05-0.12 Hz (3-7 cpm), 0.05-0.33 Hz (3- 
20 cpm) and 0.0002-0.0008 Hz (0.1-0.5 cpm) bandwidths on the whole signal. 
Similar scatter plots were generated when the LF bandwidth of 0.05-0.12 Hz 
and 0.05-0.33 Hz were used. With a threshold value of hrbylf set at 0.0014 
absolute units, the test generated a sensitivity value of 76% and specificity of 
54% while using 0.05-0.12 Hz and sensitivity and specificity value of 76% and 
63% while using 3-20 cpm. Using the very LF information of 0.0002-0.0008 
Hz, the variable hrbylf thus calculated was able to separate Groups II and Ilia 
with exactly the same sensitivity and specificity values as generated using 
0.05- 0.33 Hz LF information.
Similar analysis on the resting phase produced slightly better results as 
compared to analysis on the whole signal. On comparing the hrbylf calculated 
for LF bandwidth of 0.05-0.12 Hz between groups II and III, the study was 
able to distinguish between the two with a sensitivity of 72% and specificity of 
63%. Using 0.05-0.33 Hz the study generated a very good sensitivity of 84% 
with a specificity of 60%.
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As expected the analysis on the breathing segment of the whole signal 
produced the best results as compared to the analysis on the other segments 
of the signal. Similarly analysis of the hrbylf ratio with LF bandwidth of 0.05- 
0.33 Hz (3-20cpm) produced better results as compared with LF bandwidth of 
0.05- 0.12 Hz (3-7cpm). Using the latter as the LF bandwidth, the hrbylf 
calculated could only separate the two groups with sensitivity and specificity 
value of 68% and 63%. However the hrbylf calculated with LF bandwidth of 
0.05- 0.33 Hz separated the diseased (Group Ilia) from the non diseased 
(Group II) with the best sensitivity of 80% and specificity of 63%. The scatter 
plot with the threshold selected has been illustrated in figure 7.19.
Comparing hrbylf (LF :3-20 cpm) on breathing phase 
calculated from Groups II and Ilia
0.014
0.012
0.01
♦ Group
0.008 Group Ilia 
threshold£
0.006
0.004
0.002
35 400 15 20 25 305 10
participant no
Figure 7.19: ‘h rbylf calculated for groups I, II and Ilia. The best separation between Groups II 
and Ilia was achieved at the threshold value of hrbylf set at 0.0028 absolute units
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As mentioned earlier, the sensitivity and specificity value of any test is a trade 
off between each other. Hence most of the analysis done so far a higher 
sensitivity of the test could be achieved only at the cost of very low specificity 
value. However analysis of the hrbylf index i.e. ratio of the mean spectral 
density of the HR bandwidth to the mean spectral density of the LF bandwidth 
between 0.05- 0.33 Hz (including the breathing components) on the breathing 
segment of the whole signal resulted in a reasonably good sensitivity value of 
80% while still maintaining the specificity at 63%.
7.4.1 Statistical Analysis of ‘hrbylf’
Analysis on the breathing segment of the raw PPG signal by calculating the 
hrbylf index using the LF bandwidth between 0.05- 0.33 Hz provided 
satisfactory separation between Group II and Ilia. The objective analysis 
used, was able to rightly identify 20 out of 25 neuropathic patients and rule out 
22 out of 35 diabetics as true negatives. Further statistical analysis was 
carried out to determine if the difference in the hrbylf index observed for the 
two groups was statistically significant.
The descriptive statistics of the variable hrbylf were calculated for all the three 
groups and compared as shown in figure 7.20. The variable hrbylf is a ratio of 
the mean spectral density of the HF information to the LF information. The 
mean hrbylf value generated for Group II was found to be the lowest at 
0.0027, while the mean hrbylf values for Groups I, and Ilia were very similar at 
0.0041 and 0.0042 respectively. Both the HF and LF analysis could not 
separate the normals from the neuropathic group successfully as the mean
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wspectral densities at both ends of the spectrum were found to be around a 
similar range of values for the two groups. Thus similar values of ‘hrbylf was 
expected and observed for these two groups.
Group 1 Group II Group Ilia
M ean 0.0041 M ean 0 .0 0 2 7 M ean 0 .0 0 4 2
Standard Error 0 .0006 Standard Error 0 .0 0 0 3 Standard  Error 0 .0 0 0 5
Median 0 .0034 M edian 0 .0 0 2 2 M edian 0 .0 0 3 4
M ode 0 .0033 M ode 0 .0 0 1 8 M ode 0 .0 0 2 8
Standard Deviation 0 .0034 Standard Deviation 0 .0 0 1 5 Standard  Deviation 0 .0 0 2 4
Kurtosis 11.316 Kurtosis 0 .0 0 6 4 Kurtosis 2 .3441
Skewness 2 .8617 Skew ness 0 .8 0 2 4 Skew ness 1 .4013
Range 0 .0187 R ange 0 .0 0 5 8 R ange 0.0101
Minimum 0.0007 M inim um 0 .0 0 0 4 M inim um 0 .0 0 1 4
Maxim um 0.0194 M axim um 0 .0 0 6 2 M axim um 0 .0 1 1 5
Largest(1) 0 .0194 Largest(1) 0 .0 0 6 2 Largest(1) 0 .0 1 1 5
Sm allest(1) 0 .0007 S m a lle s t 1) 0 .0 0 0 4 S m allest(1) 0 .0 0 1 4
Confidence Level 
(95 .0% ) 0.0011
C onfidence Level 
(9 5 .0 % ) 0 .0 0 0 5
C onfidence Level 
(9 5 .0 % ) 0 .001
Figure 7.20: The descriptive statistics of ‘hrbylf calculated for all three groups.
The very high skewness value obtained for Groups I and Ilia indicate a much- 
skewed distribution of the variable in these groups. The histograms generated 
for the variable for all three groups corroborate these values. They are 
illustrated in figure 7.21.
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Groupl
Std. Dev =0.00337843
Groupl
Groupll
Mean =0 0026629 
Std. Dev. =0 00153816
N =35
Groupll
Grouplll
Mean-0.004150D 
Std Dev. -0.00239323C 
N -2 5
Figure 7.21: H istogram s o f hrbylf fo r G roups I, II and Ilia
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The histograms generated indicate that the variable hrbylf follows a non 
normal distribution in all the three groups. Thus a non- parametric test was 
selected to test the null hypothesis that no difference exists between the 
mean hrbylf values calculated for the three groups. The groups were 
statistically analysed in pairs and hence a 2  sample non-parametric test called 
the Mann-Whitney test was used for the purpose. The results have been 
shown in figure 7.22.
Analysing the variable hrbylf, statistically significant difference was observed 
between the healthy individuals and the diabetics, i.e. Groups I and II. 
Statistically significant difference was also observed between the hrbylf 
calculated from Groups II and Ilia, i.e. between the diabetics with and without 
neuropathy. However once again the healthy individuals could not be 
differentiated from the neuropathic group as the high p value of 0.55 indicate 
that any difference observed between these two groups are only by chance 
and not statistically significant.
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Ranks
groups N Mean Rank Sum of Ranks
3-20cpm normal
° n . diabetic 
breathing
phase Total
36
35
71
41.21
30.64
1483.50
1072.50
Test Statistics?
0.1-0.5cpm
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
442.500
1072.500
-2.157
.031
a. Grouping Variable: groups
Ranks
groups N Mean Rank Sum of Ranks
3-20cpm diabetic 35 25.43 890.00
on
breathing
phase
neuropathic
Total
25
60
37.60 940.00
Test Statistics?
0.1-0.5cpm
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
260.000
890.000
-2.663
.008
a- Grouping Variable: groups
Ranks
groups N Mean Rank Sum of Ranks
3-20cpm normal 36 29.88 1075.50
on
breathing
phase
neuropathic
Total
25
61
32.62 815.50
Test Statistics?
0.1-0.5cpm
Mann-Whitney U 
Wilcoxon W  
Z
Asymp. Sig. (2-tailed)
409.500
1075.500
-.594
.552
a- Grouping Variable: groups
Figure 7.22: M ann- W hitney tests used to statistically com pare the hrbylf generated for all
three groups using a pair a t a  time.
200
7.5 Summary
A detailed explanation of the various signal processing analysis preformed on 
the raw Photoplethysmographic signal have been provided through out the 
results chapter. The spectral analysis of the raw PPG signal revealed 
activities at both the higher and the lower end of the spectrum. While the 
higher end of the spectrum represented the cardiac activity of the individual, 
the lower end of the spectrum represented a combination of the breathing, 
sympathetic and local activity within the skin microcirculation.
The difference observed between the HR traces obtained from groups I and II 
and the HR traces obtained from groups II and Ilia were statistically 
significant. Attempts to distinguish groups I and III were not successful even 
though they were visually distinctively different from each other. The normals 
and the neuropathic patients represent the two end of the disease spectrum. 
Thus the results obtained from these two groups were expected to be 
significantly different both visually and statistically. However for some 
unexplained reasons the analysis on both end of the spectrum revealed 
similar results for normals and the neuropathic group. Since the main aim of 
this study was to identify those diabetic patients who could be at risk of 
developing foot ulcers, several analysis were performed to identify the best 
possible method that could separate the neuropathies from the diabetic 
patients with no known neuropathy.
Reduced LF spectral density was observed in participants from Group II as 
compared to the spectral density values obtained from the neuropathic group.
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Analysis on the LF end of the spectrum alone was able to differentiate 
between the diabetics with and without neuropathy with reasonable success 
of 84% sensitivity and 61% specificity. The variable hrbylf used both HF and 
LF information. The screening ability of the test using this variable remained 
more or less the same with a slight decrease in the sensitivity at 80% and a 
relative increase in the specificity at 63%.
The best sensitivity and specificity values were obtained from the analysis on 
the breathing phase of the raw PPG signal suggesting the importance of the 
breathing test in the test protocol. The breathing exercise was included in the 
protocol to obtain an exaggerated response of the autonomic system. The 
breathing activity altered the instantaneous skin blood volume, which was also 
reflected in the raw PPG signal. The strength of this response decreased to a 
considerable extent among the participants of group III as compared to the 
response from the other two groups.
The grip test was the second stress test used in this study. The participant 
was asked to grip the dynamometer at 1 0 % of his or her maximum grip 
strength. The decreased response to this stress test could be due to the 
inadequate level of stress and better results could perhaps be obtained by 
increasing the level of grip to 30% of his or her maximum grip strength. 
However at such high percentage of the grip strength, the test fails to remain 
patient compliant that is a vital requirement for any good screening tool. The 
results of the test could also be further improved by using a PPG probe with a 
higher signal to noise ratio.
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Thus results from the visual, LF and the HF analysis of the raw PPG signal 
can be summarised as follows:
• Visual analysis of the raw PPG signal and its Fourier spectrum 
revealed characteristic differences between the three groups
• In the HR bandwidth analysis-
o The bandwidth was found to be largest in Group I participants 
indicating high HR variability, while similar values were observed 
in participants from Group II and Ilia 
o Statistical difference could be established only between Groups
I and II
• In the analysis o f the skewness of HR distribution-
o Maximum mean skewness value was observed in Group I 
participants, while similar mean skewness values were obtained 
from Groups II and Ilia 
o The test was able to distinguish between healthy individuals 
(Group I) and the diseased (Group Ilia) with a sensitivity of 6 8 % 
and a specificity of 72% 
o Statistical difference could be established between Groups I and
II and between Groups I and Ilia but not between the diabetics 
with and without neuropathy
• The HF analysis in general was able to statistically and visually 
separate Groups I and ll/llla but not between the diabetics with and 
without neuropathy. This could be because the new subgroup Group 
Ilia contained data from patients with similar characteristics as Group II 
participants
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• In the LF analysis, reduced spectral activity was observed in 
participants from Group III and I when compared to Group II
• The mean spectral density of LF bandwidth of 0.05- 0.33 Hz (3- 20 
cpm) on the breathing segment of the PPG signal produced the best 
separation between Groups II and III with a sensitivity and specificity 
value of 84% and 61% respectively
• Analysis of the mean spectral density of LF bandwidth of 0.0003- 
0.0008 Hz (0.1 -  0.5 cpm) on the whole PPG signal also helped to 
separate between the two groups with a sensitivity and specificity of 
76% and 69% respectively
• Using the information at the very LF end of the spectrum, statistical 
difference could only be established between Groups II and III
• Analysis using ‘hrbylf -
o Decreased ratio observed in Group II as compared with Groups 
III and I
o Using hrbylf calculated over the breathing phase, a sensitivity of 
80% with a specificity of 63% was achieved in separating 
Groups II and Ilia 
o Statistical difference was established between Groups I and II 
and between Groups II and Ilia 
o No statistical difference could be established between Groups I 
and III
The results obtained indicate that the foot microcirculation in diabetics with 
and without neuropathy behave differently and can be separated using PPG 
with moderate success.
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Chapter -  VIII
Summary and Conclusion
8.1 Aim of the Study
Constant effort has been made towards the early detection of diabetic 
neuropathy, as it not only helps to prevent the serious complications of the 
disease but also to improve the prognosis of the patients to a considerable 
extent. Foot ulcers below the knee are a common but serious complication of 
diabetes. In most cases the primary aetiology of these ulcers is a combination 
of microvascular and macrovascular dysfunction and if left untreated can even 
lead to lower limb amputations. Diabetic neuropathy affecting both the 
sensory and the autonomic neurons is a major risk factor in developing ulcers. 
Sensory neuropathy leads to a loss of sensation in the feet that may cause 
any kind of trauma in the affected limb to go un-noticed. Autonomic 
sympathetic dysfunction on the other hand can cause a delay in the wound 
healing process and subsequent alterations in the skin blood flow due to 
increased shunting of blood flow through the arterio-venous shunts. 
Autonomic neuropathy can remain asymptomatic for a long period of time 
despite an early onset.
The main aim of this study was to identify methods to devise a simple, low 
cost screening tool to detect DAN in the early stages of diabetes and thereby 
help to identify those diabetic patients who may be at risk of developing
205
diabetic foot ulcers. The simple electronics and the low manufacturing cost of 
the photoplethysmographic (PPG) technique makes it a promising tool for the 
desired purpose. In this study PPG probes were used to obtain vascular 
signals from the soles of the feet of the test subjects. The signals collected 
were then post processed using different signal processing methods as 
explained in the earlier chapters.
8.2 Participant Groups
Signals were collected from three different groups of people. By doing so the 
study population represented the whole spectrum of the disorder, ranging 
from healthy individuals to patients with severe diabetic neuropathy. The 
participants in group II (diabetic patients) and group III (diabetics with known 
neuropathy) had an age range of 45-76 years and 55-79 years respectively. 
Participants from group I had an age range of 24-61 years and were not age 
matched to the other two groups. Participants for this group were specifically 
recruited with a younger age range so that the signals obtained from this 
group could be analysed and the general characteristics of what a “normal” 
signal should be like could be determined. These “normal” signals provided 
the baseline with which signals from diseased individuals could be compared 
with.
The analysis of the raw PPG signals were done in stages with a view to 
achieve the ultimate aim of the study i.e. to identify if PPG could be used to 
pre- diagnose diabetic neuropathy. Though the signals from all three groups 
were compared at each stage, the primary aim was to identify if the analysis
▼methods used in this study could rightly distinguish the signals obtained from 
neuropathic patients and those obtained from diabetics with no known 
neuropathy.
8.3 Results Summary
The visual analysis of the raw PPG signals from all three groups revealed 
certain features individual to its own group. However due to the large inherent 
variations in the signals within the groups, characteristic models of the PPG 
signal specific to each group could not be determined. Variations in the 
instantaneous skin blood volume under the probe were represented by the 
changes in the signal amplitude. The raw PPG signals from Group I exhibited 
a strong response to the two stress tests. This response was fairly reduced in 
signals from Group II and was nearly absent in signals from Group III.
The instantaneous changes in the skin microcirculation regulated by both 
intrinsic and extrinsic factors were reflected in its frequency spectrum. The 
Fourier spectrum of a raw PPG signal obtained from participants in Group I 
showed prominent peaks both at the HF and the LF end of the spectrum. At 
the HF end of the spectrum, the prominent peak along with side bands 
observed between 1- 2 Hz (60-120 cpm) represented the microvascular 
changes due to the cardiac events and the prominent peak represented the 
individual’s fundamental HR (Kamal 1989).
At the LF end of the spectrum, several prominent frequency bands were 
observed between 0.03- 0.33 Hz (2-20 cpm). Frequency bands of 0.012- 0.05
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1Hz (1- 3 cpm) representing the thermoregulatory changes, 0.67- 0.13 Hz (4-8 
cpm) representing the vasomotor changes and 0.17- 0.33 Hz (10-20 cpm) 
representing the respiratory changes were observed at the LF end of the 
spectrum (Kamal et al 1989). These frequency bands represent the 
autonomic influence on the microcirculation. Thus both visual and objective 
analyses of the frequency spectrum were performed in this study.
Visual analysis of the whole frequency spectrum obtained from all three 
groups revealed certain interesting observations. The HF end of the spectrum 
was preserved to a large extent among the participants from Group II. 
However decreased activity was observed at the lower end of the spectrum 
where two or more prominent frequency bands had decreased amplitudes or 
were totally absent. The spectrums obtained from participants of group III had 
a distinctively different appearance from the ones obtained from the other two 
groups. Prominent frequency bands at both ends of the spectrum were either 
severely reduced in amplitude or were totally absent. The presence of these 
frequency bands in both the left and the right foot indicated its central origin.
In the HF analysis, the mean bandwidth and the beat-by-beat HR trace were 
compared between the three groups. However the MATLAB program written 
to extract the beat-by-beat HR traces failed to extract the beat-by-beat HR 
from 13 participants in Group III. All of these 13 participants had a very high 
VPT score suggesting the increased progression of neuropathy in these 
patients. These patients had severely reduced HF response thereby making it 
difficult for the program to detect the HR bandwidth accurately. Therefore by
A
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fomitting the data from these 13 individuals of Group III a new subgroup called 
Group Ilia was created for the HF analysis. The HR traces obtained from the 
new subgroup Ilia, had similar properties to the ones obtained from Group II. 
The participants in Group III were selected on the basis of their VPT score 
and they were at varying stages of the progression of the disease. It is 
therefore possible that the participants in Group Ilia may be at the early 
neuropathic stage where the microvascular characteristics are similar to the 
participants of Group II. Thus the HR analysis could not statistically
differentiate between the participants of Groups II and Ilia. However
statistically significant difference was observed between Groups I and II and 
between Groups I and Ilia. Using the HF analysis, the participants of Groups I 
and Ilia could be separated with a sensitivity of 6 8 % and a specificity of 72%.
The LF analysis of the frequency spectrum mostly involved the comparison of 
the spectral densities of the various frequency bands present at the LF end of 
the spectrum. The prominent spectral peaks along with the sidebands present 
in the LF spectrum could be grouped together in different combinations to 
produce several frequency bandwidths of interest. The bandwidth defined by 
frequencies of 0.03 Hz to 0.13 Hz (2-8 cpm) was considered a good starting 
point as these were considered to be representative of the vascular changes 
due to the sympathetic activities like blood pressure regulation, vasomotion,
etc (Kamal 1989). Some of the other frequency bandwidths that were
analysed include 0.08 Hz to 0.13 Hz (5-8 cpm), 0.05 Hz to 0.11 Hz (3-7 cpm), 
0.06 Hz to 0.11 Hz (4-7 cpm), 0.05 Hz to 0.33 Hz (3-20 cpm) and 0.08 Hz to 
0.33 Hz (5-20 cpm).
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In this study the effect of the stress tests on the LF spectrum were also 
analysed individually. Ten minutes of the raw PPG signal was split into three 
main segments viz; two minutes of breathing phase, two minutes of the grip 
phase and three minutes of the resting phase, intermediate to the two stress 
tests. These phases were also individually analysed along with the whole raw 
PPG signal. Although the visual analysis revealed significant differences in 
the physical appearances of the LF spectrum obtained from Group I as 
compared to Group III participants, the spectral densities calculated from the 
healthy individuals (Group I) were observed to be low and comparable to the 
values obtained from the neuropathic group (Group III). Thus the LF analysis 
similar to the HF analysis failed to statistically separate Groups I and III even 
though they represented the two extremes of the disease spectrum used in 
this study. However statistical significant differences were observed between 
the values calculated from Groups II and III.
Meyer, et al in their work compared the amplitude of vasomotion obtained 
from Type 1 and Type 2 diabetics. The test subjects were also subjected to 
the standard protocol of CAN tests. In their study they observed higher 
amplitude of vasomotion amongst diabetics with normal CAN tests as 
compared to those with one or more abnormal CAN test result (Meyer et al. 
2003). The results obtained in this study were also in line with these findings 
where the spectral densities obtained from Group III (neuropathic group) were 
significantly lower than the values obtained from Group II (diabetic group).
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Of all the different combination of bandwidths analysed, 0.05- 0.33 Hz 
frequency bandwidth deserved special mention. This bandwidth included the 
thermoregulatory components, the vasomotor and blood pressure response 
and the breathing components. This bandwidth contained almost all the 
prominent spectral peaks that generally occur at the LF end of the spectrum 
and represented both the sympathetic and the parasympathetic controls. Also 
on comparing the two stress tests used in this study, the breathing test 
produced stronger responses in the peripheral circulation when compared to 
the grip test. The analysis on the breathing phase by calculating the spectral 
density of 0.05 - 0.33 Hz bandwidth produced the best result of separating 
Groups II from III with a sensitivity of 84% and a specificity of 61%. A high 
sensitivity and specificity value is vital for a test to be able to be used, as a 
successful screening tool i.e. ideally the test must be capable of identifying 
maximum number of diseased patients while simultaneously ruling out all the 
non-diseased individuals. Thus with an attempt to further improve the 
sensitivity and specificity value of this study, both HF and LF information was 
combined and new variable called the ‘hrbylf was calculated. This variable 
was the ratio of the spectral density of the HF bandwidth to the LF bandwidth.
The variable ‘hrbylf was calculated on the resting, breathing and the whole 
signal for various combinations of frequency bandwidths. Of all the different 
phases, once again the analysis on the breathing phase, the hrbylf calculated 
for the LF bandwidth of 0.05- 0.33 Hz and the HR bandwidth produced the 
best separation between the diabetics and the neuropathic group with a 
sensitivity of 80% and a specificity of 63%. Although the over all sensitivity of
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the test fell by 4% by combining both the HF and LF information, the 
specificity rose by 2 %.
8.4 Discussion and Conclusions
Combining both the HF and LF information did not improve the overall 
sensitivity and specificity of the test. In the HF analysis the participants of 
Groups II and Ilia exhibited similar characteristics hence using the HR 
information alone the two groups could not be objectively or statistically 
separated from each other. However significant differences were observed 
between the two groups while analysing the LF spectrum. Thus not much 
improvement was observed in the performance of the test by combing both 
the HF and LF analysis.
The participants selected for both Groups II and III were at varying stages of 
both diabetes and its complications. In Group III the 13 participants that were 
excluded from the analysis had a very high VPT score and 85% of them (11 
out of 13) had a VPT score greater than 30 in at least one of their feet. Also 
70% of them (9 out of 13) complained of other cardiovascular problems. The 
very high VPT score suggests a greater sensory loss in these patients. The 
program failed to detect the HF response in these individuals due to severely 
reduced amplitude of the HR bandwidth. However in all other participants 
apart from these 13 patients, the HR information although reduced when 
compared to the response from the healthy individuals, was found to be intact. 
The HF analysis used in this study mainly involved comparing the HR 
bandwidth and the skewness of the beat-by-beat HR distribution. Both these
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variables were a measure of the degree of HR variability in an individual. The 
HR variability tests used commonly in the CAN assessment are primarily 
indicative of the cardiac parasympathetic integrity, although both sympathetic 
and parasympathetic innervations play some role in all these tests (Meyer et 
al. 2003).
The LF analysis in this study mainly involved comparing of the spectral 
densities of 3-20 cpm frequency bandwidth. This bandwidth as mentioned 
earlier represents both sympathetic and parasympathetic controls and 
contains several physiologically important spectral peaks. The mean spectral 
density of the LF bandwidth for Group III was significantly lower than the value 
obtained from Group II. As mentioned in section 7.3.2 no statistical difference 
was observed between Groups III and Ilia. Therefore reduced spectral 
densities were obtained not only from those 13 participants with reduced HF 
information, but also from the remaining 25 participants with intact HR 
response. This observation was in line with some of the previous studies, 
where the 6  cpm vasomotor response was found to be reduced not only in 
patients with one or more altered CAN tests, but also in some of those with 
intact CAN assessment test (Bernardi et al. 1997) (Meyer et al. 2003)
These findings suggest the possibility of the sympathetic dysfunction 
preceding parasympathetic dysfunction as assessed by the HR variability 
tests. No significant differences could however be established between the 
healthy individuals of group I and the neuropathic patients of Group III using 
both the HF and LF analysis. Although the HF analysis in this study failed to
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▼separate Groups II and III, the LF analysis was able to achieve the same with 
moderate success.
The failure to achieve a 100% sensitivity and specificity using the LF analysis 
could be due to few shortcomings identified in the study. The participants for 
group III were recruited on the basis of their VPT (vibration perception 
threshold) score recorded three years prior to this study as part of another 
trial. Those individuals with a VPT score of 25 or over and with no peripheral 
vascular disease were selected for this study. However due to limitation in the 
resources, these individuals could not be assessed by a doctor to review their 
medical condition at the time of the recruitment. They were selected for the 
study on the assumption that with time the disease would progress further as 
it was an irreversible condition. Current diagnosis of autonomic dysfunction is 
very elaborate and consists of a battery of tests.
Studies have revealed that autonomic dysfunction could set in at the early 
stages of diabetes. Previous studies have also found that often damage to the 
sensory neurons is also accompanied by damage to the autonomic neurones. 
The detailed medical history of the participants recorded prior to the 
recruitment revealed that almost all of them suffered from symptoms relating 
to sensory neuropathy. Though being symptomatic to sensory neuropathy, 
there is a strong possibility that some of them may not have autonomic 
dysfunction. The group III participants therefore could be at various stages of 
neuropathic dysfunction (either autonomic or sensory) ranging from early to 
the advance stage of the disease. This could possibly explain the spread in
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the variables calculated from this group across the spectrum making it difficult 
to separate Group II and III with higher sensitivity and specificity values.
The two stress tests were used to produce an exaggerated vascular 
response. However with the aim to make it patient compliant the level of 
stress had to be kept at minimum. Though some positive response was 
recorded for the breathing test, the grip test proved to be clearly inadequate 
as it failed to provide any satisfactory response from any of the three groups. 
Better PPG probes have been developed since the study by Huntleigh 
Diagnostics with better signal to noise ratio. Finally the limitation in the 
MATLAB program to detect very low amplitude of the HF response in 
neuropathic participants accurately may have also contributed to the inability 
to further improve the sensitivity and specificity of the test
8.5 Future W ork
Though the various analysis methods used in this study could only 
differentiate the neuropathic patients from the diabetic group with a sensitivity 
of 84%, the results have shown that some microvascular changes does occur 
in participants of Group III. Better results could be expected if the study were 
to be carried out only on formally diagnosed neuropathic patients with 
autonomic dysfunction. However the participants in Group II and III represent 
the true patient population that are screened for high-risk patients for 
developing diabetic foot disease. It is a well-established fact that the very LF 
end of the PPG spectrum represents the autonomic activity. The participants
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of Group III were suffering from severe sensory neuropathy. Signal analysis 
indicated severely altered LF information in this group as compared to 
participants of Group II. This change could be mainly attributed to the 
sympathetic dysfunction in these patients.
The primary aim of this study was to identify if PPG technique could be used 
to detect changes in skin microcirculation and results from this study indicate 
that PPG could be used to detect these vascular changes with moderate 
success. A more robust and improved MATLAB program for extracting the HF 
information from raw PPG signal along with new PPG probes with better 
signal to noise ratio could be used to develop a successful screening tool for 
identifying diabetic patients who may be at risk of developing diabetic foot 
disease. Further research work needs to be carried out on a larger sample 
size and the participants should also be tested with the gold standard tests 
used in the diagnosis of DAN. This way it becomes possible to compare the 
study with a standard method and also help to identify the true diagnostic 
capability of the method. The study also demonstrated the importance of the 
breathing test in the study protocol as compared with the grip test. An 
improved version of the protocol could be used in future with greater 
preference to the breathing exercise. Increasing the level of difficulty of the 
grip test would reduce the patient compliance of the study significantly and 
hence is better omitted from the protocol.
Although the general review of the diabetic patients include tests to detect 
sensory neuropathy, the tests for detecting autonomic dysfunction are not
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very common. This is because these tests are elaborate and require highly 
skilled professionals to perform and report them. Diagnosis of DAN has 
always drawn less interest as they remain asymptomatic for most part of the 
disease. Often intervention at the later symptomatic stages of DAN results in 
poor prognosis of the disease. A report presented at a conference on 
management of diabetes indicated a trend prevalent amongst the physicians 
of not giving due importance to the early diagnosis of DAN. This could be due 
to the limited treatment options and poor prognosis of the disease (Vinik et al 
2003).
There is however a strong potential for developing a screening tool that could 
be used in primary care as part of their routine review of the diabetic patients. 
Previous studies have found that DAN could set in during the early stages of 
diabetes (Braune 1997). Changes in the skin microcirculation may be one of 
the earliest manifestations of DAN and is also one of the primary causes for 
developing diabetic foot disease (Vinik et al 2003). The single most important 
benefit of the early diagnosis of DAN is the possibility of early tight glycaemic 
control. Studies have found that near normal glycaemic control is the most 
effective was to delay the progression of DAN (Vinik et al 2003).
Early diagnosis of DAN can aid in providing necessary help to those 
individuals who may be at risk, in the form of counselling and spreading 
awareness regarding the benefits of healthy lifestyle, tight glycaemic control 
etc. Three types of tests viz; HRV with deep breathing, Valsalva manoeuvre 
and the sustained grip test were recommended by the expert panel at the
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1988 San Antonio for routine clinical use in the diagnosis of CAN (Vinik et al 
2003). However no tests were recommended for diagnosis of other types of 
autonomic dysfunction. Thus even though there is a strong evidence of early 
changes in skin microcirculation, currently no tests are being clinically used 
that looks into these changes.
Several studies however have been reported that have analysed the changes 
in skin microcirculation using LASER Doppler technique. Once again the 
design complexity and the expensive nature of LASER Doppler do not make it 
a suitable screening tool. With increasing awareness regarding diabetes and 
its microvascular complications, several research projects are being carried to 
try and develop new methods to stop or even reverse the effects of 
neuropathy. Any significant break through in this area would increase the 
need for pre diagnosis of DAN significantly thereby increasing the demand for 
cheap, simple screening device. Even in the absence of any such 
pharmacological breakthrough, the early detection of DAN can at least help to 
delay the progression of the dysfunction. Results from this study have 
demonstrated the use of PPG technique in analysing the microvascular 
changes in the skin. Efforts have also been made to study both the 
advantages and the disadvantages of this technique and in recognising its 
future as an efficient screening device in the pre diagnosis of autonomic 
dysfunction among diabetic patients.
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Appendix
MATLAB programs used to analyse the DPPG signal 
in this study
MATLAB codes used in this study are included in this section. They are as 
follows:
Appendix A: MATLAB code generated to extract the heart rate information 
from raw PPG signal as shown in figure 6 . 8
Appendix B: MATLAB code generated to measure the sensitivity and 
specificity of the test by generating the mean spectral densities of six different 
low frequency bandwidth combinations as shown in figure 7.10
Appendix C: MATLAB code generated to measure the sensitivity and 
specificity of the test by calculating the hrbylf index as shown in figure 7.17
Appendix D: MATLAB code generated as functions that were called in the 
main program written to extract the heart rate trace from raw PPG signals
Appendix A: Heart rate extraction
%This program extracts the HR trace from the raw PPG signals obained from 
%each of the participants of the three groups.
close all 
clear all 
clc
%
o_____________________________________________________________________________
O-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
O.____________________________________________________________________________________________________________________________________________________________________________t>------------------------------------------------------------------------------------------------------------------------------------------------------------------
% Constants
fs = 1000 * 60; % samples per minute
fN = fs / 2;
fsNEW = 520 %240,360; % new sampling rate
fNNEW = fsNEW / 2; % new Nyquist point
N = round (fs / fsNEW); % downsample parameter ie every Nth sample
LF = 1; RF = 2;
% READ RAW PPG SIGNALS AND CALCULATE THE TIME AXIS!!!
o.
*o
N4 = ('../data_file/trial3/rlgrlO/patients/P35.csv');
% N4 = ('../data_file/trial3/rlgrlO/normals/N36.csv') ;
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tom**-
% N4 = (1../data_file/trial3/rlgrlO/neuropaths/PB38.csv1);
%
Name = N 4 (1,39:42)
N4 = csvread (N4,4,0);
VMLF = N 4 ( : , LF );
VMRF = N 4 ( :, RF );
VMLF = VMLF - mean(VMLF);%removing the mean and hence the large DC offset 
VMRF = VMRF - mean(VMRF);
% % = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =
% % = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =
% % = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = = =
%%Step 1: BPF the raw signal for the high freq components
tNEW = downsample( tl, N );
[ Bhi Ahi ] = butter( 3, 60/fN, 'high' );
[ Bio Alo ] = butter( 1,100/fN, 'low* );
CPLF = filtfilt ( Bhi, Ahi, VMLF );
CPRF = filtfilt( Bhi, Ahi, VMRF );
CPLF = filtfilt ( Bio, Alo, CPLF );
CPRF = filtfilt( Bio, Alo, CPRF );
% % = = = = = = = = = = = = = = = = = = = = = = = = = = =
% % = = = = = = = = = = = = = = = = = = = = = = = = = = =
cplf = downsample( CPLF, N ); 
cprf = downsample( CPRF, N );
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siglen = length( cplf ); 
win = hanning( 1, siglen );
cplf = cplf .* win; 
cprf = cprf .* win;
fftlen = siglen;
fftlendiv2 = floor( fftlen / 2 );
FFTCPLF = a b s ( fft( cplf, fftlen ) );
FFTCPRF = a b s ( fft( cprf, fftlen ) );
% FFT envelope
[ Bfftlo Afftlo ] = butter( 2, 0.005 ); 
fftcplf = filtfilt( Bfftlo, Afftlo, FFTCPLF );
fftcplf = fftcplf . / m a x ( fftcplf( 1:fftlendiv2 ) );
fftcprf = filtfilt( Bfftlo, Afftlo, FFTCPRF );
fftcprf = fftcprf ./ m a x ( fftcprf( l:fftlendiv2 ) );
% Find the N% thresholds of the FFT
O"O
iq = find( round( faxis ) == 60 ) 
iq = iq ( 1 ) 
faxis( iq )
thresh = 0.7;
[ MAXFFTLF ILF ] - m a x ( fftcplf( iq:fftlendiv2 ) );
MAXFFTLF 
ILF
ILF = ILF + iq
THRESH = thresh * MAXFFTLF
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lfindexLF = 0; hfindexLF = 0 ;  i = ILF;
while ( fftcplf( i ) > THRESH ) && ( i > 10 )
i = i - 1;
end
lfindexLF = i; 
i = ILF;
while ( fftcplf( i ) > THRESH ) && ( i < fftlendiv2 - 10 )
i = i + 1;
end
hfindexLF = i;
[ MAXFFTRF IRF ] = m a x ( fftcprf( iq:fftlendiv2 ) )
IRF = IRF + iq
THRESH - thresh * MAXFFTRF; 
lfindexRF = 0; hfindexRF = 0 ;  i = IRF;
while ( fftcprf( i ) > THRESH ) && ( i > 10 )
i = i - 1;
end
lfindexRF = i; 
i = IRF;
while ( fftcprf( i ) > THRESH ) && ( i < fftlendiv2 - 10 )
i = i + 1;
end
hfindexRF = i;
  = = = = ="o------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -
% Plot the FFTs
faxis = ( fNNEW/fftlendiv2:fNNEW/fftlendiv2:fNNEW );
figure( 1 ) 
subplot( 2, 1, 1 ) 
hold on
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for i = 1:fftlendiv2
plot( [ faxis( i ) faxis( i ) ], [ 0  fftcplf( i ) ], ' r' )
end
plot( faxis, fftcplf ( l:fftlendiv2 ), 'r-1 )
plot( [ faxis( lfindexLF ) faxis( lfindexLF ) ], [ 0  MAXFFTLF + 0 ], 'k' ) 
plot( [ faxis( hfindexLF ) faxis( hfindexLF ) ], [ 0  MAXFFTLF + 0 ], 'k' ) 
grid on
title ( 'Heart Rate bandwidth from the left foot' )
xlabel( 'cycles per minute' )
ylabel ( ' amplitude ' )
subplot ( 2, 1, 2 )
hold on
for i = l:fftlendiv2
plot( [ faxis( i ) faxis( i ) ], [ 0  fftcprf( i ) ], 'r' )
end
plot( faxis, fftcprf( l:fftlendiv2 ), 'r' )
plot( [ faxis( lfindexRF ) faxis( lfindexRF ) ], [ 0  MAXFFTRF + 0 ], 'k ' ) 
plot ( [ faxis( hfindexRF ) faxis( hfindexRF ) ], [ 0  MAXFFTRF + 0 ], 'k ' ) 
grid on
title ( 'Heart Rate bandwidth from the right foot ' ) 
xlabel( 'cycles per minute' ) 
ylabel ( ' amplitude ' )
o  ________________________________________________________________________________________________________________________________________________
"O "O---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
a a ____________________________________________________________________________________________________________________—= = = = = = = = = = = = = = = = =”o o -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
% Band pass CPLF and CPRF using LP filter with fc equal to the N%
% thershold level at the high frequency side of the FFT main lobe and a
% HP filter with fc equal to the N% threshold level at the low frequency 
% side of the FFT main lobe
"O
[ Bhi Ahi ] = butter( 4, faxis( lfindexLF )/fN, 'high' );
[ Bio Alo ] = butter( 2, faxis( hfindexLF )/fN, 'low' );
CPLF = filtfilt( Bhi, Ahi, CPLF );
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CPLF = filtfilt( Bio, Alo, CPLF );
[ Bhi Ahi ] = butter( 4, faxis( lfindexRF )/fN, 'high'
[ Bio Alo ] = butter( 2, faxis( hfindexRF )/fN, 'low'
CPRF = filtfilt( Bhi, Ahi, CPRF );
CPRF = filtfilt( Bio, Alo, CPRF );
% Complex demodulation of the high pass filtered raw signal at a frequency 
% eaqual to the mean of the freq at which the peak occurs at both left and 
% right foot. This is achieved by calling a separate function - complex_demodl 
% This program calculates the CDM of the input signal
CDLF = complex_demodl( CPLF, mean( [ faxis( ILF ), faxis( IRF ) ] ), 20, fs );%20 
CDRF = complex_demodl( CPRF, mean( [ faxis( ILF ), faxis ( IRF ) ] ), 20, fs );
% Peak detection program. This section generates the HR trace from the complex 
% demodulated signal by calling another separate function called DNAVPPGPEAKDETECT5
ctLF = DNAVPPGFHRPEAKDETECT5( CDLF( :, 1 ), tl );
ctRF = DNAVPPGFHRPEAKDETECT5( CDRF( :, 1 ), tl );
CILF = ( diff( ctLF ) ) ;
CIRF = ( diff( ctRF ) );
HRLF = 1 ./ CILF;
HRRF - 1 ./ CIRF;
al = length( HRRF ) 
a2 = length( HRLF )
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if al > a2
HRRF = HRRF( 1:a2 ) ; 
tHR = ctLF( 1:length( ctLF ) - 1 ); 
elseif a2 > al
HRLF = HRLF( l:al ); 
tHR = ctRF( 1:length( ctRF ) - 1 ); 
else
tHR = ctRF( 1:length( ctRF ) - 1 );
end
%%=====================================
%% Once again a separate function called spikefiltl was used to remove the 
%% spikes from the generated heart rate trace and plot the HR traces calculated 
%% from the PPG signals from both the left and the right foot.
HRLF = spikefiltl( HRLF ) ;
HRRF = spikefiltl( HRRF );
MEANHR = mean( [ HRLF'; HRRF' ] );
MEANHR=MEANHR(MEANHR<110);
HRmeans = zeros( 1, 10 );
HRvar = zeros( 1, 10 ); 
p = floor( length( tHR ) / 10 ) ;
M = 1: p ; 
for m = 1:10
HRmeans( 1, m ) = mean( HRLF( M ) );
HRvar( 1, m ) = var( HRLF( M ) );
M = M + p;
end
M = 1:p;
figure(2 ) 
subplot ( 2 , 1, 1 )
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hold on
plot( tHR, HRLF ) 
for m = 1:10
plot( [ tHR( M ( 1 ) ) tHR( M ( p ) ) ], [ HRmeans( m ) HRmeans( m ) ], 'r' )
% plot( [ tHR( M( 1 ) ) tHR( M( p ) ) ], [ HRmeans( m ) + HRvar( m ) HRmeans( m
M = M + p;
M(p)
end
grid on
xlabel('time in mins');
ylabel('beats per min');
title( 'HR trace from left leg' );
% legend(Name,1);
axis( [ 0 10 60 140 ] )
HRmeans = zeros ( 1, 10 );
HRvar = zeros ( 1, 10 ); 
p = floor ( length( tHR ) / 10 );
M = 1:p;
for m = 1:10
HRmeans( 1, m ) = mean( HRRF( M ) ); 
HRvar( 1, m ) = var( HRRF( M ) );
M = M + p;
end
M = l:p;
subplot ( 2, 1, 2 ) 
hold on
plot( tHR, HRRF ) 
for m = 1:10
plot( [ tHR( M ( 1 ) ) tHR( M ( p ) ) ], [ HRmeans( m ) HRmeans( m ) ], 'r' )
plot( [ tHR( M ( 1 ) ) tHR( M ( p ) ) ], [ HRmeans( m ) + HRvar( m ) HRmeans( m ) 
M = M + p;
M(p)
end
grid on
) + HRvar( m ) ], 'g ' )
+ HRvar( m ) ], 'g ' )
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xlabel('time in mins');
ylabel('beats per min');
title( 'HR trace from Right Leg');
% legend(Name,1);
axis( [ 0 10 60 140 ] ) 
figure (9) 
subplot ( 2, 1, 1 ) 
plot( tl, VMLF ) 
grid on
axis( [ 0 1 0  -300 300 ] ) 
xlabel('time in mins'); 
ylabel('amplitude'); 
title ( 'VASOMOTION LF' );
% legend(Name,1);
subplot( 2, 1, 2 ) 
plot( tl, VMRF ) 
grid on
axis( [ 0 1 0  -300 300 ] ) 
xlabel('time in mins'); 
ylabel('amplitude'); 
title ( 'VASOMOTION RF' );
% legend(Name,1)
o, o .______________________________________________________________________________________________________________________ = = = = = = = = = = = = --------------------------------------------x> *o------------------------------------------------------------------------------------------
a  a ___________________________________________________________________________________________________________________________________
'O  "O ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
% The HR trace obtained from the left and the right foot were tested for 
%% their synchronicity by generating a BlandAltman plot of the left and the right 
%% HR trace using another function called BlandAlman.
BlandAltman( HRLF, HRRF, 'HR agreement' );
% legend(Name,1);
xlabel ( ' mean difference in the HR in bpm ' ) 
ylabel ( ' absolute ifference in the HR in bpm ' ) 
title ( ' The Bland-Altman plot for the HR agreement ' )
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Appendix B: Mean spectral density
close all 
clear all 
clc
% Constants used in this program
FIXEDfs = 1000 * 60;% sampling frequency of the device was 1 kHz
FIXEDfN = FIXEDfs / 2;
fs = 120; % cpm the new smapling rate
resamplecoefficient = FIXEDfs / fs; % co-efficent to downsample the original signal 
fN = fs / 2;
LF = 1; RF = 2;
[ Baa, Aaa ] = butter( 2, 30 / FIXEDfN );
lists = [ 1 Nor.mat';...
'Pat.mat'; . . .
'Neu.mat';...
] ;
col = [ 'b 1;...
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%%
%%
% Three lists were generated for the three groups containing the raw PPG signals
%% from each of the participants. This section loads each list at a time
%% and analyses the raw PPG signals colected from that group
%
figure 
hold on
for K = 1:3
eval ( [ 'load ' lists ( K, : ) ] );
[r c] = size (LIST);
% s = 3 
for i = l:r
N4 = csvread(LIST(i,:),4,0);
Name = LIST(i,36:42)
VMLF = N 4 ( :, LF );% raw PPG signal
VMRF = N 4 ( :, RF ) ;
VMLF = VMLF - mean ( VMLF ); % removing the effect of the large DC offset
VMRF = VMRF - mean ( VMRF );
%% filtering the raw PPG signal to prevent aliasing while downsampling the 
%% signal later in the program
VMLF = filtfilt ( Baa, Aaa, VMLF );
VMRF = filtfilt( Baa, Aaa, VMRF );
VMLF = VMLF ( 1 : resamplecoefficient : end ); %% resampling the original signal
VMRF = VMRF ( 1 : resamplecoefficient : end ) ;
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%%===
%% low pass filter the original signal to obtain very low frequency
[ Bhi Ahi ] = butter( 1, 1 / fN, 'high' );
[ Bio Alo ] = butter( 3, 25 / fN, 'low' );
VMLF = filtfilt( Bhi, Ahi, VMLF );
VMRF = filtfilt( Bhi, Ahi, VMRF );
VMLF := filtfilt( Bio, Alo, VMLF );
VMRF = filtfilt( o
i—
1
PQ Alo, VMRF );
a  9,*6 --
o, a -----
%% FFT of the low frequency signal
len = length ( VMLF ); 
win = hanning ( 1, len );
VMLF = VMLF .* win;
VMRF = VMRF .* win;
vmlffft = abs ( fft ( VMLF ) );
vmrffft = abs ( fft ( VMRF ) );
1 = round ( ( length ( vmlffft ) ) / 2 ) ;
vmlf = vmlffft ( 1 : 1 ) ;  
vmrf = vmrffft ( 1 : 1 ) ;
vmlfnew = vmlf; 
vmrfnew = vmrf;
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%=========================:=======================================
% calculate the area under the curve
faxis = fN / 1 : fN / 1 : fN;
x = 1.0 ; % lower limit of bandwidth to be analysed 
y = 20.0 ; % upper limit of bandwidth to be analysed 
z = y - x ; % bandwidth 
a = find ( round ( faxis ) == x ); 
a = a ( 2 ) ;
b = find ( round ( faxis ) == y ) ; 
b = b ( 2 ) ;
specarea ( i, 1 ) = ( sum ( vmlfnew ( a : b ) ) ) / z ; % calculating the spectral density of the bandwidth
specarea ( i, 2 ) = ( sum ( vmrfnew ( a : b ) ) ) / z ;
end
specarea ;
meanarea = mean ( specarea, 2 )
plot ( meanarea, [ ' + 1 col( K ) ] )
xlabel ( ' ID ' )
ylabel ( ' mean spectral density ' )
legend ( ' normal ', ' patients ', ' neuropaths ' )
grid on
0, 0.      _____________________________________-g -g ----------------------- ----------------------------
%% this section of the program calculates the sensitivity and specificity 
%% values generated for a range of thresholds
b = length ( meanarea );
range = [ 0.5 : 0.05 : 1.2 ]; % the range of mean spectral density to be used as threshold
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■a
a = length ( range ); 
scorematrix = zeros ( b, a ); 
for p = 1 : a
thresh = 1.0e+004 * range ( p ) ;
for q = 1 : b
if meanarea ( q ) <= thresh 
score ( q ) = 1; 
scorematrix ( q, p ) = 1;
else
score ( q ) = 0; 
scorematrix ( q, p ) = 0;
end
end
score;
scorematrix;
end
scorematrix;
[ m, n ] = size (scorematrix);
for r = 1 : n
positive = 0; 
negative = 0;
for s = 1 : m
if scorematrix ( s, r ) == 1
positive = positive + 1; % number of participant with mean spectral area below the threshhold
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else
negative = negative + 1 ;  % people above the threshold
end
end
pos ( r ) = positive; 
neg ( r ) = negative;
end
pos
neg
clear neg 
clear pos 
clear scorematrix 
end
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Appendix C: Code used to generate the hrbylf index
%%12/-9/07 % calcualte the ratio of the mean spectral density of bandwidth 
%%with the mean spectral density of the hr frequencies 
close all 
clear all 
clc 
%O______________ _________________________________-------------------------------------------
"O   =  =  :
a ____________________________________________ — = = = = = = — = — — — — — — — — — ----------------------------------------------------------------------------------------------------------------"O  =  =  =  =  — =  :
% Constants 
FIXEDfs = 1000 * 60;
FIXEDfN = FIXEDfs / 2;
fsLF = 120; % cpm the new smapling rate 
fsHF = 520;
resamplecoefficientLF = FIXEDfs / fsLF; 
resamplecoefficientHF = FIXEDfs / fsHF;
fNLF = fsLF / 2; 
fNHF = fsHF / 2;
LF = 1; RF = 2;
[ BaaLF, AaaLF ] = butter ( 2, 30 / FIXEDfN );
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[ BaaHF, AaaHF ] = butter( 2, 130 / FIXEDfN );
lists = [ 'Nor.mat';...
'Pat.mat1;...
'Neu.mat';...
] ;
col — [ 'b ';.. .
' g '; . . .
' r '; . . .
];
% % = = = = = == === == == == === == == === == == == === == == ===
% READ SIGNALS AND CALCULATE THE TIME AXIS
a*o
figure 
hold on
for K  = 1:3
eval ( [ 'load ' lists ( K, : ) ';' ] );
[r c] = size (LIST);
% s = 3 
for i = l:r
N4 = csvread(LIST(i,:),4, 0);
Name = LIST(i,36:42);
% VMLF = N 4 ( :, LF );
% VMRF = N 4 ( :, RF );
■ p *t
%%%% LF ANALYSIS
%% low pass filter the original signal to obtain very low frequency
LFLF = filtfilt( BaaLF, AaaLF, VMLF );
LFRF = filtfilt( BaaLF, AaaLF, VMRF );
LFLF = LFLF ( 1 : resamplecoefficientLF : end ) ;
LFRF = LFRF ( 1 : resamplecoefficientLF : end ) ;
[ Bhi Ahi ] = butter( 1, 1 / fNLF, 'high' );
[ Bio Alo ] = butter( 3, 25 / fNLF, 'low' );
vmlf = filtfilt( Bhi, Ahi, LFLF );
vmrf = filtfilt( Bhi, Ahi, LFRF );
vmlf = filtfilt( Bio, Alo, vmlf );
vmrf
a o.___
= filtfilt( Bio, Alo, vmrf );
%% FFT of the low frequency signal
len = length ( vmlf ); 
win = hanning ( 1, len );
vmlf = vmlf .* win;
vmrf = vmrf . * win;
vmlffft = abs ( fft ( vmlf ) );
vmrffft = abs ( fft ( vmrf ) );
1 = round ( ( length ( vmlffft ) ) / 2 ) ;
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vmlf = vmlffft ( 1 : 1 ) ;  
vmrf = vmrffft ( 1 : 1 ) ;
vmlfnew = vmlf; 
vmrfnew = vmrf; 
%%=============
% % = = = = = = = = = = = = =
%%HF analysis
HFLF = filtfilt( BaaHF, AaaHF, VMLF );
HFRF = filtfilt( BaaHF, AaaHF, VMRF );
HFLF = HFLF ( 1 : resamplecoefficientHF : end 
HFRF = HFRF ( 1 : resamplecoefficientHF : end
[ Bhi Ahi ] = butter( 3, 60/fNHF, 'high' );
[ Bio Alo ] = butter( 1,100/fNHF, 'low' );
cplf = filtfilt( Bhi, Ahi, HFLF );
cprf = filtfilt( Bhi, Ahi, HFRF );
cplf = filtfilt( Bio, Alo, cplf );
cprf = filtfilt( Bio, Alo, cprf );
siglen = length( cplf ); 
win = hanning( 1, siglen );
cplf = cplf .* win; 
cprf = cprf .* win;
fftlen = siglen;
fftlendiv2 = floor ( fftlen / 2 );
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FFTCPLF = abs( fft( cplf, fftlen ) ); 
FFTCPRF = abs( fft( cprf, fftlen ) ) ;
%
% FFT envelope
[ Bfftlo Afftlo ] = butter( 2, 0.005 ); 
fftcplf = filtfilt( Bfftlo, Afftlo, FFTCPLF );
fftcplf = fftcplf ( l:fftlendiv2 ) . / max( fftcplf( l:fftlendiv2 ) );
fftcprf = filtfilt( Bfftlo, Afftlo, FFTCPRF );
fftcprf = fftcprf ( l:fftlendiv2 ) . / max( fftcprf( l:fftlendiv2 ) );
0 ,                                                                                  __"O---------------------------------
Q.______________________________________ __ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _*0-------------------------------
% Find the N% thresholds of the FFT
faxisHF = ( fNHF / fftlendiv2 : fNHF / fftlendiv2 : fNHF );
iq = find( round( faxisHF ) == 60 ); 
iq = iq( 1 ) ; 
faxisHF( iq );
thresh = 0.7;
[ MAXFFTLF ILF ] = max( fftcplf( iq:fftlendiv2 ) );
MAXFFTLF;
ILF;
ILF = ILF + iq;
THRESH = thresh * MAXFFTLF; 
lfindexLF = 0; hfindexLF = 0 ;  k  = ILF;
while ( fftcplf( k  ) > THRESH ) && ( k  > 10 )
k  =  k  -  1 ;
end
lfindexLF = k ;  
k  = ILF;
while ( fftcplf ( k  ) > THRESH ) && ( k  < fftlendiv2 - 10 )
k  =  k  + 1 ;
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end
hfindexLF = k;
[ MAXFFTRF IRF ] = max( fftcprf( iq:fftlendiv2 ) );
IRF = IRF + iq;
THRESH = thresh * MAXFFTRF; 
lfindexRF = 0; hfindexRF = 0 ;  k = IRF;
while ( fftcprf( k ) > THRESH ) && ( k > 10 )
k = k - 1;
end
lfindexRF = k; 
k = IRF;
while ( fftcprf( k ) > THRESH ) && ( k < fftlendiv2 - 10 )
k = k + 1;
end
hfindexRF = k;
O._____________________________  =  =  =  =  =  =  =  =  =  =  =  = = =  =  =  =  =  ■'O-----------------
% calculate the area under the curve
faxisLF = fNLF / 1 : fNLF / 1 : fNLF;
x = 3.0 ; % lower limit of bandwidth to be analysed 
y = 20.0 ; % upper limit of bandwidth to be analysed 
z  = y - x ; % bandwidth 
a = find ( round ( faxisLF ) == x ); 
faxisLF( a ( 1 ) : a ( end ) ) 
a = a (2 ) ;
b = find ( round ( faxisLF ) == y ); 
faxisLF( b ( 1 ) : b ( end ) ) 
b = b ( 2 ) ;
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4specareaLF ( i, 1 ) = ( sum ( vmlfnew ( a : b )  ) ) / z ; % 6  being the bandwidth
specareaLF ( i, 2 ) = ( sum ( vmrfnew ( a : b ) ) ) / z ;
%
0,'o
% calculate the area under the curve
xl = lfindexLF ; % lower limit of bandwidth to be analysed 
yl = hfindexLF ; % upper limit of bandwidth to be analysed
xr = lfindexRF ; % lower limit of bandwidth to be analysed
yr = hfindexRF ; % upper limit of bandwidth to be analysed
meanx = round ( mean ( [ xl , xr ] ) ); % mean lower index of left and right
s = round ( faxisHF ( meanx ) );
meany = round ( mean ( [ yl , yr ] ) ); % mean upper index of left and right
t = round ( faxisHF ( meany ) );
z = t - s ; %bandwidth of interest
% FFTCPLF = FFTCPLF ( l:fftlendiv2 ) ;
% FFTCPRF = FFTCPRF ( l:fftlendiv2 ) ;
specareaHF ( i, 1 ) = ( sum ( fftcplf ( meanx : meany ) ) ) / z ;
specareaHF ( i, 2 ) = ( sum ( fftcprf ( meanx : meany ) ) ) / z ;
end
specareaLF;
specareaHF;
meanareaLF = mean ( specareaLF, 2 ); 
meanareaHF = mean ( specareaHF, 2 );
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w = length ( meanareaLF );
for ii = 1 : w
hrbylf ( ii ) = meanareaHF ( ii ) / meanareaLF (ii );
end
hrbylf = hrbylf'
plot ( hrbylf, [ ' + ' col( K ) ] )
xlabel ( ' ID ' )
ylabel ( ' meanHRspecden/ meanLFspecden ' )
legend ( ' normal ', ' patients ', ' neuropaths ' )
title ( ' The ratio of the spedenof HR to speden of LF ' ) 
grid on
b = length ( hrbylf ) ;
range = [ 2.0 : 0.2 : 4.0 ]; % the range of mean spectral density to be used as threshold 
a = length ( range ); 
scorematrix = zeros ( b, a );
for p = 1 : a
thresh = 1.0e-003 * range ( p ) ;
for q = 1 : b
if hrbylf ( q ) <= thresh
score ( q ) = 1;
scorematrix tJ ii o
else
score ( q ) =  0 ;
scorematrix ( q, P ) = l;
end
end
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% score;
scorematrix;
end
scorematrix;
[ m, n ] = size (scorematrix);
for r = 1 : n
positive = 0; 
negative = 0;
for s = 1 : m
if scorematrix ( s, r ) == 1
positive = positive + 1; % number of participant with mean spectral area below the threshhold
else
negative = negative + 1; % people above the threshold
end
end
pos ( r ) = positive; 
neg ( r ) = negative;
end
pos
neg
clear neg
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clear pos 
clear scorematrix 
clear hrbylf 
clear specareaLF 
clear specareaHF; 
clear meanareaLF 
clear meanareaHF
end
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Appendix D: Functions used in the main programs
%%Function Bland Altmen agreement plot: this program generates the Bland Altman plot to compare L and R HR trace 
function OUT = BlandAltman( vecl, vec2, TITLE )
[ a b ] = size ( vecl ); 
if a > 1
vecl = vecl';
end
[ a b ] = size ( vec2 ); 
if a > 1
vec2 = vec21;
end
MEAN = mean( [ vecl; vec2 ] );
DIFF = ( vecl - vec2 );
DIFFSTD = std( DIFF );
DIFFMEAN = mean( DIFF );
Uplimit = DIFFMEAN + DIFFSTD; 
Lolimit = DIFFMEAN - DIFFSTD; 
figure
hold on
plot( MEAN, DIFF, )
plot( [ min( MEAN ) - 0.1*min( MEAN
] ,  'm'  )
plot( [ min( MEAN ) - 0.1*min( MEAN 
], 'm' )
plot( [ min( MEAN ) - 0.1*min( MEAN
axis( [ min( MEAN ) - 0.1*min( MEAN
DIFF ) +0.7* max( DIFF ) ) ] ) 
grid on 
title ( TITLE )
max( MEAN
max( MEAN
max( MEAN 
max( MEAN
+ 0.l*max( MEAN
+ 0.1*max( MEAN
+ 0.1*max( MEAN 
+ 0.l*max( MEAN
], [ DIFFMEAN + DIFFSTD DIFFMEAN + DIFFSTD 
], [ DIFFMEAN - DIFFSTD DIFFMEAN - DIFFSTD
], [ DIFFMEAN DIFFMEAN ], 'm'
( min( DIFF ) - 0.7*min( DIFF max
OUT = [ Uplimit, Lolimit,DIFFMEAN ] ;
This program complex demodulates the I/P signal using the specified cut off
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%% frequency and the sampling frequency
function OUT = complex_demod( Data, w_demod, LP_cutoff, fs )
NyquistPoint = (fs / 2);
LP_cutoff = ( LP_cutoff / NyquistPoint );
LP_order = 4;
[ B ,  A ] = butter( LP_order, LP_cutoff );
t = ( 1/fs:1/fs:length( Data ) * (1/fs) )' * 60;
w_demod = w_demod / 60; 
w_demod = 2 * pi * w_demod;
signal_l = Data . * ( 2 * exp( -i * ( w_demod ) .* t ) );
% Low pass filter the resulting signal
signal_2 = filtfilt( B ,  A, signal_l );
% Turn the signal back into its real equivalent
M = sqrt( real( signal_2 ).A2 + imag( signal_2).A2 );
PHI_ATAN = atan( imag( signal_2 ) ./ real ( signal_2 ) );
PHI_ANGLE = angle( signal_2 );
a ___________________________________ = ==———= = = = —= ——= —— ---------------------------------------------------U----------- ---------------------------
signal_3 = 1 .* sin( w_demod .* t + PHI_ANGLE );
OUT = [ signal_3, M, PHI_ANGLE, PHI_ATAN ];
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%This program removes the spikes from the HR trace extracted from the raw 
%PPG signal
function OUT = spikefilt( IN )
SDthresh = 2.0 
In = IN;
1 = length(IN);
ps = length( IN )/10; % the pseudo sampling rate is the number of HR detected over one min 
pn = ps / 2 % This is the pseudo Nyqyst freq
L_cutoffl = 25 %25,30 cpm
L_cutoff2 = 10;%15
[ Bhil Ahil ] = butter( 2, L_cutoffl / pn , 'high' );
[ Bio Alo ] = butter( 2, L_cutoff2 / pn );
in = filtfilt( Bhil, Ahil, IN ); % filtering to remove all the high frequency noise 
SD = std( in ); 
for i = 2:1
if ( in( i ) >= SDthresh*SD ) || ( in( i ) <= -SDthresh*SD )
IN( i ) = IN( i - 1 );
end
end
o.*o
OUT = filtfilt( Bio, Alo, IN ); % low pass filtering the HRV signal which has had 
%its spikes removed to obtain the very low frequency trend of the HR
o o_
"o t> -----
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